var title_f24_8_24704="Ca channel sympathetic activity";
var content_f24_8_24704=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F68194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F68194&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 536px\">",
"   <div class=\"ttl\">",
"    Interaction between sympathetic activation and the calcium channel",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 516px; height: 466px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Acceleration of sinus node automaticity by sympathetic stimulation results from an increase in the influx of sodium (If) during diastolic depolarization and an increase in calcium (Ca++) influx during phase 0; both are due to a direct stimulatory effect of the alpha subunit of the guanosine nucleotide binding protein (G protein) on the respective channels. In the resting nonstimulated state (panel A) guanosine diphosphate is bound to the alpha subunit of the G protein. With beta receptor activation (panel B), guanosine triphosphate (GTP) displaces GDP, stimulating adenyl cyclase; this generates cyclic adenosine monophosphate (cAMP) from adenosine triphosphate (ATP) (panel C). Generation of cAMP activates protein kinase A and phosphorylation of the regulatory component of the CA++ channel; the opening of the Ca++ channel in response to membrane depolarization is increased. Activation of the alpha subunit of the G protein may also activate the Ca++ channel. With deactivation of the beta receptor, an intrinsinc GTPase hydrolyzes GTP to GDP (panel D).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24704=[""].join("\n");
var outline_f24_8_24704=null;
var title_f24_8_24705="Tibial tubercle avulsion";
var content_f24_8_24705=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F65878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F65878&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 536px\">",
"   <div class=\"ttl\">",
"    Complete avulsion of the tibial tubercle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 516px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This 13-year-old fell after attempting a jump. The radiograph shows complete avulsion of the tibial tuberosity with a Salter-Harris IV proximal tibial fracture (black arrow), knee joint effusion (white arrow), and proximal patellar displacement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Eglal Shalaby-Rana, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24705=[""].join("\n");
var outline_f24_8_24705=null;
var title_f24_8_24706="Microsporidiosis spores";
var content_f24_8_24706=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78496&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Microsporidiosis spores",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 339px; height: 381px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Microsporida spores on stool swabs stained with modified Weber's trichrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Anane S, Attouchi H. Microsporidiosis: epidemiology, clinical data and therapy. Gastroenterologie Clinique et Biologique 2010; 34:450. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24706=[""].join("\n");
var outline_f24_8_24706=null;
var title_f24_8_24707="Cysteine: Drug information";
var content_f24_8_24707=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cysteine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/32/27138?source=see_link\">",
"    see \"Cysteine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F155952\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Nutritional Supplement",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F155949\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/32/27138?source=see_link\">",
"      see \"Cysteine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Nutritional supplement:",
"     </b>",
"     I.V.: Infants (receiving PN): Added as a fixed ratio to crystalline amino acid solution: 40 mg cysteine per 1 g of amino acids; dosage will vary with the daily amino acid dosage; 1.5-4 g/kg/day of amino acids has been recommended for preterm infants and would result in 60-160 mg/kg/day of cysteine (ASPEN Guidelines, 2002; ASPEN Pediatric Nutrition Support Core Curriculum, 2010). Weight-based doses of cysteine (~70-160 mg/kg/day) have also been added directly to the daily parenteral nutrition solution (Soghier, 2006).",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15795923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15795924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F155939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral, as hydrochloride: 500 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as hydrochloride: 50 mg/mL (10 mL, 50 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F155928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F155941\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: Use only after dilution into parenteral nutrition solution",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F155940\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Supplement to crystalline amino acid solutions, in particular the specialized pediatric formulas (eg, Aminosyn&reg; PF, TrophAmine&reg;) to meet the intravenous amino acid nutritional requirements of infants receiving parenteral nutrition (PN)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F155950\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Flushing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Fever",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Metabolic acidosis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Erythema, phlebitis, thrombosis, warm sensation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: Azotemia, BUN increased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F155943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients with hepatic coma or metabolic disorders involving impaired nitrogen utilization",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F155932\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Hypertonic glucose solutions should be used with caution in patients with diabetes or patients with glucose intolerance risk factors.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment. Use in this patient population may result in hyperammonemia, metabolic alkalosis, prerenal azotemia, serum amino acid imbalances, stupor and coma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment. Peripheral I.V. infusion of amino acids in patients with impaired renal or hepatic function could result in an increase in BUN. A slight rise in BUN is to be expected during increased protein intake.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Volume overload: Use with caution in patients who may be sensitive to volume overload (cardiac insufficiency, pulmonary disease, renal impairment).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tetracycline: Concomitant administration with amino acids may reduce the amino acid nitrogen sparing effect.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infants: Metabolic acidosis has occurred in infants related to the &ldquo;hydrochloride&rdquo; component of cysteine; each 1 mmol cysteine (175 mg) delivers 1 mEq chloride and 1 mEq hydrogen ion; to balance the extra hydrochloride ions and prevent acidosis addition to the PN solution of a 1 mEq acetate electrolyte salt for each mmol (175 mg) of cysteine may be needed; each 40 mg cysteine (equal to every 1 g amino acid when used in the recommended ratio) adds 0.228 mEq chloride and hydrogen.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Aluminum: Cysteine solution for injection contains aluminum; use caution in patients with impaired renal function or in premature neonates as toxic levels may occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Acetate: Use acetate-containing solutions with caution in patients with respiratory or metabolic alkalosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperammonemia: Patients without overt liver impairment have experienced asymptomatic hyperammonemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Potassium: Use potassium-containing solutions with caution in patients with renal impairment, hyperkalemia, or in conditions which potassium retention is present.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sodium: Use sodium-containing solutions with caution in patients with renal impairment, congestive heart failure, and conditions in which edema exists with sodium retention.",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F14079852\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cysteine is generally considered to be a nonessential amino acid in adults because it can be synthesized from methionine (an essential amino acid). The RDA for methionine + cysteine is increased in pregnant women (IOM, 2005).",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F14079853\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cysteine is found in breast milk. The RDA for methionine + cysteine is increased in breast-feeding women (IOM, 2005).",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323086\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Cystech Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     500 mg (100): $11.34",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Cysteine HCl Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg/mL (10 mL): $8.12",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F155937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     BUN, ammonia, electrolytes, acid-base balance, serum creatinine, liver function tests, blood glucose, cholesterol, WBC, and blood culture; urine osmolarity; growth curve; nitrogen intake",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F155931\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cysteine is a sulfur-containing amino acid synthesized from methionine via the transulfuration pathway. It is a precursor of the tripeptide glutathione and also of taurine. Newborn infants have a relative deficiency of the enzyme necessary to affect this conversion. Cysteine may be considered an essential amino acid in infants.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      ASPEN Board of Directors and the Clinical Guidelines Task Force, \"Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients,\"",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 2002, 26(1 Suppl):1-138.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Carney LN, Nepa A, Cohen SS, et al, &ldquo;Parenteral and Enteral Nutrition Support: Determining the Best Way to Feed,&rdquo; In: Corkins MR, Balint J, Bobo E, et al, eds,",
"      <i>",
"       The A.S.P.E.N Pediatric Nutrition Support Core Curriculum",
"      </i>",
"      , Silver Spring: MD: American Society of Parenteral and Enteral Nutrition, 2010, 440.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine),",
"      <i>",
"       Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients)",
"      </i>",
"      , Washington, DC: The National Academies Press, 2005.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Soghier LM and Brion LP, &ldquo;Cysteine, Cysteine or N-acetylcysteine Supplementation in Parenterally Fed Neonates,&rdquo;",
"      <i>",
"       Cochrane Database Syst Rev",
"      </i>",
"      , 2006, (4):CD004869.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/8/24707/abstract-text/17054219/pubmed\" id=\"17054219\" target=\"_blank\">",
"        17054219",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      te Braake FW, Schierbeek H, Vermes A, et al, &ldquo;High-Dose Cysteine Administration Does Not Increase Synthesis of the Antioxidant Glutathione Preterm Infants,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2009,124(5):978-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/8/24707/abstract-text/19822595/pubmed\" id=\"19822595\" target=\"_blank\">",
"        19822595",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8890 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-EBC78AF0D7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24707=[""].join("\n");
var outline_f24_8_24707=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155952\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155949\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15795923\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15795924\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155939\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155928\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155941\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155940\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155950\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155943\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155932\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14079852\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14079853\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323086\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155937\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F155931\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8890\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8890|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?26/32/27138?source=related_link\">",
"      Cysteine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_8_24708="Calcium polystyrene sulfonate: Drug information";
var content_f24_8_24708=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Calcium polystyrene sulfonate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?19/29/19924?source=see_link\">",
"    see \"Calcium polystyrene sulfonate: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9646930\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Resonium Calcium&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F9646932\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidote",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F9647025\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Hyperkalemia:",
"     </b>",
"     Initiate treatment if potassium level &gt;6 mmol/L (6 mEq/L); discontinue when potassium &le;5 mmol/L (5 mEq/L).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: 15 g 3-4 times/day",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rectal: 30 g once daily",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F9647024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Hyperkalemia:",
"     </b>",
"     Initiate treatment if potassium level &gt;6 mmol/L (6 mEq/L); discontinue when potassium &le;5 mmol/L (5 mEq/L). In small children and infants, employ lower doses by using the practical exchange ratio of 1 mEq potassium/g of resin as the basis for calculation.",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Neonates: Rectal: 0.5-1 g/kg/dose",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     Children:",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;\">",
"     Oral (preferred route): Initial: 1 g/kg/day in divided doses; Maintenance: May reduce dose to 0.5 g/kg/day in divided doses",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;\">",
"     Rectal: Initial: 1 g/kg/day in divided doses; Maintenance: May reduce dose to 0.5 g/kg/day in divided doses",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F9647026\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F10076207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for suspension, oral/rectal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Resonium Calcium&reg;: 300 g [contains calcium 1.6-2.4 mmol/g, sodium &lt;1 mg/g; packaging contains 15 g measuring device]",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11217371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F9647027\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Oral: Administer orally (via nasogastric tube if unable to swallow) as suspension or paste",
"     <b>",
"      Note:",
"     </b>",
"     More rapid lowering of potassium may be achieved with concomitant oral and rectal administration. Rectal route may be discontinued once orally administered resin has reached rectum.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rectal: Enema route is less effective than oral administration. Administer rectally as suspension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Enema should be retained as long as possible (product labeling suggests for at least 9 hours in adults or as long as possible) as greater amounts of potassium are excreted as retention time increases. Follow enema with irrigation to remove resin.",
"     <b>",
"      Note:",
"     </b>",
"     More rapid lowering of potassium may be achieved with concomitant oral and rectal administration. Rectal route may be discontinued once orally administered resin has reached rectum.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F9646933\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of hyperkalemia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F9646928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Calcium polystyrene sulfonate may be confused with sodium polystyrene sulfonate",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F9646965\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Endocrine &amp; metabolic: Hypercalcemia, hypokalemia, hypomagnesemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Anorexia, concretions (bezoars; oral administration), constipation, diarrhea, fecal impaction (rectal administration), gastric irritation, GI necrosis/ulceration, ischemic colitis, nausea, obstruction (rare), rectal hemorrhage, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Acute bronchitis, bronchopneumonia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F9646937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to polystyrene sulfonate resins or any component of the formulation; potassium &lt;5 mmol/L (5 mEq/L); conditions associated with hypercalcemia (eg, metastatic carcinoma, hyperparathyroidism); obstructive bowel disease; oral administration in neonates; use in neonates with reduced gut motility (postoperative, drug induced)",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F9646938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electrolyte disturbances: Use may be associated with electrolyte disturbances including hypokalemia, hypercalcemia, and/or hypomagnesemia. Closely monitor electrolytes during therapy. Discontinue use if potassium &le;5 mmol/L (5 mEq/L).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; GI necrosis/obstruction: Use of a similar agent (sodium polystyrene sulfonate) has rarely been associated with concretion formation and colonic necrosis/intestinal obstruction. Effects may be related to use of sorbitol enema with inadequate/absence of lavage after resin use. Avoid excess dosing or inadequate dilution with rectal administration to avoid resin impaction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Sudden increases in calcium may be observed with use in renal impairment and/or dialysis patients. Monitor calcium weekly (or more frequently if clinically indicated). Dosage adjustments may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sorbitol: Avoid concomitant use of oral/rectal sorbitol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neonates/infants: Avoid oral administration in neonates. Premature/low-birth-weight infants may be at risk for GI hemorrhage or colonic necrosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Constipation: Discontinue use for clinically significant constipation. May resume therapy with return of normal bowel function. Avoid magnesium-containing laxatives.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298944\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F9655296\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aluminum Hydroxide: Calcium Polystyrene Sulfonate may enhance the adverse/toxic effect of Aluminum Hydroxide. More specifically, concomitant use of these agents  may increase the risk for intestinal obstruction.  Management: Monitor for signs/symptoms of intestinal obstruction with concomitant use of calcium polystyrene sulfonate and aluminum hydroxide. Adequate fluid intake, laxative use, alternative antacid agents, and/or limiting duration of therapy may help reduce risks.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. The combined use of these two agents may result in metabolic alkalosis and/or loss of efficacy of the cation exchange resin. Management: To minimize this interaction, consider: a)separating doses by 2 or more hours; b)rectal administration of the exchange resin; or c)alternatives to antacids. Monitor for metabolic alkalosis and attenuation of CPS effects. Avoid magnesium hydroxide.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Calcium Polystyrene Sulfonate may enhance the adverse/toxic effect of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Laxatives: May enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. More specifically, concomitant use of calcium polystyrene sulfonate with magnesium-containing laxatives may result in metabolic alkalosis or with sorbitol may result in intestinal necrosis. Management: Avoid concomitant use of calcium polystyrene sulfonate (rectal or oral) and magnesium-containing laxatives or sorbitol.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Bisacodyl; Dehydrocholic Acid; Lactulose; Polycarbophil; Psyllium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium: Calcium Polystyrene Sulfonate may decrease the serum concentration of Lithium.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Meloxicam: May enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. More specifically, concomitant use of meloxicam oral suspension (which contains sorbitol) may increase the risk for intestinal necrosis.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sorbitol: May enhance the adverse/toxic effect of Calcium Polystyrene Sulfonate. More specifically, concomitant use of these agents may increase the risk for intestinal necrosis.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thyroid Products: Calcium Polystyrene Sulfonate may decrease the serum concentration of Thyroid Products.  Management: To minimize risk of interaction, separate dosing of oral calcium polystyrene sulfonate and thyroid products (eg, levothyroxine) or administer calcium polystyrene sulfonate rectally. Monitor for signs/symptoms of hypothyroidism with concomitant use (oral).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F9646934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Does not undergo GI absorption. There are no adequate and well-controlled studies in pregnant women. In general, medications used as antidotes should take into consideration the health and prognosis of the mother (Bailey, 2003)",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F9646936\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13333891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Does not undergo GI absorption",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F9646977\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May administer orally with honey, jam, or liquids with low potassium content. Do",
"     <b>",
"      not",
"     </b>",
"     mix in fruit juices (eg, orange juice) or other beverages with high potassium content. Some products may contain sodium.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F9647036\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Close monitoring of serum electrolytes (potassium, sodium, calcium, magnesium) is necessary; ECG",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F9647035\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Serum potassium: Adults: 3.5-5.2 mEq/L",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F9647033\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Removes potassium by exchanging calcium ions for potassium ions in the intestine before the resin is passed from the body",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F9646972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: May be delayed 2-3 days due to GI transit time",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: None",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces (100%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bailey B, \"Are There Teratogenic Risks Associated With Antidotes Used in the Acute Management of Poisoned Pregnant Women?\"",
"      <i>",
"       Birth Defects Res A Clin Mol Teratol",
"      </i>",
"      , 2003, 67(2):133-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/8/24708/abstract-text/12769509/pubmed\" id=\"12769509\" target=\"_blank\">",
"        12769509",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Bomback AS, Woosley JT, and Kshirsagar AV, &ldquo;Colonic Necrosis Due To Sodium Polystyrene Sulfate (Kayexalate),&rdquo;",
"      <i>",
"       Am J Emerg Med",
"      </i>",
"      , 2009, 27(6):753.e1-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/8/24708/abstract-text/19751641/pubmed\" id=\"19751641\" target=\"_blank\">",
"        19751641",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Garcia-Pardo G, Martinez-Vea A, Auguet T, et al, &ldquo;Intestinal Obstruction Complicating Calcium Polystyrene Sulphonate Therapy,&rdquo;",
"      <i>",
"       Nephol Dial Transpl",
"      </i>",
"      , 1996, 11(4):751.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/8/24708/abstract-text/8671882/pubmed\" id=\"8671882\" target=\"_blank\">",
"        8671882",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McLean M, Kirkwood I, Epstein M, et al, &ldquo;Cation-Exchange Resin and Inhibition of Intestinal Absorption of Thyroxine,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 1993, 341(8855):1286.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?24/8/24708/abstract-text/8098431/pubmed\" id=\"8098431\" target=\"_blank\">",
"        8098431",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8498 Version 27.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-217.117.136.88-F836DB8729-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24708=[""].join("\n");
var outline_f24_8_24708=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646930\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646932\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9647025\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9647024\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9647026\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10076207\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11217371\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9647027\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646933\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646928\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646965\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646937\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646938\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298944\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9655296\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646934\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646936\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13333891\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646977\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9647036\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9647035\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9647033\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9646972\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8498\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8498|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?19/29/19924?source=related_link\">",
"      Calcium polystyrene sulfonate: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_8_24709="Lymph nodes head neck PI";
var content_f24_8_24709=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F55189&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F55189&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 588px\">",
"   <div class=\"ttl\">",
"    Lymph nodes of the head and neck",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 568px; height: 480px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This drawing schematically depicts the major lymph nodes in the head and neck area that are likely to be enlarged on physical examination in patients with various local or systemic diseases. The major nodal groups are shown here in bold, with the areas draining into these nodal groups noted when appropriate. While enlargement of both the left and right supraclavicular lymph nodes may reflect disease in the thorax, left supraclavicular nodal enlargement, because of its drainage pattern, may also reflect the presence of abdominal involvement (ie, Virchow's node).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24709=[""].join("\n");
var outline_f24_8_24709=null;
var title_f24_8_24710="Prenatal ultrasound image of umbilical artery aneurysm";
var content_f24_8_24710=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78214&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Prenatal ultrasound image of umbilical artery aneurysm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 398px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Umbilical artery aneurysm.",
"    <br>",
"     Left upper and lower panels shows the aneurysm at the base of the cord at 30 weeks of gestation depicted by conventional and color Doppler ultrasound. Right upper and lower panels show increasing size at 35 weeks of gestation.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced from: Sepulveda W, Corral E, Kottmann C, et al. Umbilical cord aneurysm: prenatal identification in three fetuses with trisomy 18. Ultrasound Obstet Gynecol 2003; 21:292. Copyright &copy; 2003. Reproduced with permission from: John Wiley &amp; Sons, Inc.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24710=[""].join("\n");
var outline_f24_8_24710=null;
var title_f24_8_24711="Postoperative cardiac shift CT";
var content_f24_8_24711=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70082%7EPULM%2F67587%7EPULM%2F81115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70082%7EPULM%2F67587%7EPULM%2F81115&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Shift in mediastinal position following pneumonectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 240px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADwAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5hkJ7Co8nHtU0gPqPzqLac8nBoAmjbKqQPmHJPSiYlsbRx/jUcRK5HTPqalxk8nuOtAFZ2K8etRHJPT2qa4VvMY/5xUaDLfNQALnb096Uew59akwCDzzTSDjH5UATl1dSwUg9+c1GshB6Z9qWFtvBOAe5rWstEv71BKtuIYOvnTt5af8AAc8n8AaAMpWLSKCMirCncCOhxn/61dLZ+GrJJAJJ72/l/wCedpCY1/76bJ/Suy0T4f6jfKv2Tw7bW6HrPfMZDj3DcfkKAPLo0DLu3Zz6c1Imm3UhBitrhxjOREx7+wr6Q0f4Y3MCA3GseRnlktIhGPzGK6Jfh/o7qGme8mYcEtcN/LNAHyVLp15Eu6S1uVX3iYf0qm2VYB/lJ9RivsmHwNoaNgWjZPUGV8/zqK8+H2jXIG+KXkcB3Ei/kwNAHx4+c4Xk5qCTdnJHNfSniH4LadcJI9gpil7LDiL9OVP0wK8c8ReB73TL+W1ilWWWLhopR5Mg+mThvwNAHF5P0o5qxd2k9pN5d1DJBJ/dkQqf161CQf8AJoAbk0AnFLjvQFz3oAMkn3qWKQg4PNLb201zOsNtHJNMxwscalnP0A5rrrDwBfmIza1cw6VEAD5b/vbg56ARKeP+BEUAcqx4OM9ODToIZLqUR28ckznA2xoW5/CvcPCPwpW7VZYdLIhIBFzqzby3usK4H55r0TT/AIYrHCIrrWroRdPKtFECfktAHy7B4U1+YAx6TdBTx+8ATP8A30RUieE9cAO6yUEdczx8f+PV9Tj4T+H2zu+1M2PvO+c1A/wd8PyKVBmUk/wNjmgD5dk8Ma3tJFgSoOMrKjc/99VUuNF1W3yJtOu1x3EZI/MV9K3vwOsCN1hqMqOTjMmGBrBvPg94htQx0+9hYj+65Q/nQB88OHjk2urIw7MMGphny8gV674h8N+LrGInWLOa5ijXZmSMTAfzrk7i006YgT6b5RJwTbOYiPwOR+lAHGg0MxXGa6S48OW8nOm6mmSceVeJ5RB9N4yp/SsfVtJv9Nx9utpIkJ4kHzRt9HHB/OgCiXGO9VpMjnHFT84x1HtSbST/ACoAq7jS7jgUrpt75FISR60AG40ZOe9JnijOKAJo3I/KneY/rjFQhiMenWlzx9KAJfNPPJNJvPPWmA8mlzzQBIHIORn2opoPvRQBabYegFN2qR2oYEDoB3qPewGMDB9qAEIAGRinKTjkDJ/nTdxKn5RgU3PI7igCWTDbSAOaiKAduakGSo4HBoAPtxQA0L049qv6ZpF1qTsbdAIU4kmk4RPbPc+w5qzpemiWIXd6GW1JIjReGmPt6KO7V674F8EXeuCK41BfsemRDEUaLhf+Ajufc0AcRpOgpbyrFplo13eMcC4li3nPqkfQfU5/CvQ9A+GGqX8i3Gsstqh6tM3mSH6LnC17PoPhm00m2H2WCO1G3hiuXb3JrK17U10y48q4VHD/AHctt+pHrQAmieG9K0OFVtYAzgf6yQ7mJ/pWtNPFCgJfnONuM4rnn1qBYi00iQgDpuxge5rnrv4g+G7aQx/b4ZJPSM5/WgD0KO6SQkojZPqMVYjmTgbtuehORXntr4ztrzCWXlzkjI/fop/LOa2YNQujbhntJkA5yDx+YoA7SAK7c5IHUcGtBbOJ1HQ/jjNcZY69CSokkKY6sx/T610OnanFd7RHIrEjjBzQBaubDCkx5z2GQQK8b+JfhjVda161jtLW3uzL8i8eWQfdjxXtasf4iffBrC8UsYLD7bDkyW7rKODg4PP6UAeRWXwp8WyWbRtp7FR/y73XlvGfoGJH5YrF1P4I6t5bNL4clhkPO+zuMgf8AOR+VfS7XjjTxdLcSeWQDnPrXP3viDVLSN5YbpmyflRgCAKAPmif4PalGW/0HWBjqPIQ/qDSwfDhrMbpPDmsX7Y+7KSij8EAJH419Fx/EDUUG2aGCVidoAix9e9Tw+O9RkVikdoBnapSPP580AeG6J4e8VyyrZaPoUmmQSfIVt7XyQR6tJjc34mvW/D/AMM4/DttHe6zsnuE+cAqNit9e5+tdtoPiDVL7azFWUnoFAOK1/EM4l0a7SVFaPZhgehoA5G2nd0M0ojAP3dnPHqauRxvckGAMx6/3RWHdNGsEZii8uIYAC55q9a6x9jiO+SNYgOWJwKAOhisZ2zuRAcVMdNlOP3gA+nNc9H450pVIlvLckD5gHpkvxD0cZEM3mf7vIoA6M6YxPL5/ACkbT2zwRjbgNgflXD3vxL06ENIZ0UKec9T+FWtK+INjc4bcpjPGA3NAHZrYzSpKojEu1enr7Vx/iHwBoGv5N/pwt7nGDJEvlsPqK9O0pgLFJ8MFkUOOOcY4onuLOY7Z1GB0YigD5k8R/BK+gWSbRJ1vIhkGKTCuPp2NeeXGm6pomYpEmgZgBJBInyk55BU8H/69fapsFfe1nKkinnaTzWLrej2WowmDVbGKYY43p8wz1waAPie+0bS9RA/dLpN90LIpMDt/tJ1T6rx7Vyuq6Xd6Vc+TfQ7CeUdSGSQeqsOGFfWfir4P211FJJod0I3Cn9zcZKkAdN3UH3rxnxF4b1bw68lpqlgTaN8zQyjdG3qVPtn7wwaAPIygIwQMVWePYQMV1V9oYkRrjSC8gBJa1Y5lQDup/jH6+3eueddw7GgCmRxSd+BUjKVbDdPUU1upxkigAAzjinBR3A+lKikqDxknFOYAE446fnQAmBn7ooAGe35UN37+9BJ4HtQAuPpRSZOaKALLPgYAUE9+9Qux5xwCSOvNOkHfFJtUjPFADI2bgcH1HTNPA5BU5BPFRMozgjHrxUtrgA8e4oAnjUhTj7vTNa2iaYly32q9VxYxsFYKcNK3XYv9T2qDSNPfULjYDsiT55ZP7idz7nsBXsPw88Ix67qyNLGYdGscKqE/e77Qe5PUn3oA0/hx4HGqSRarrMOLZDi3t24BA6cdlFe+aZpcVlElxdIu7H7uLHC+5H9KTRrKGCD7VOqx2sAwgxxx/QVXuNZgktL3VtQlW00i0QvJcSjAVR3Hr/WgC3rd2sFpPdXLJFDEhdpCQAo/GvmHxx8WLQ3050O2W8us4F3cf6tP91e/wCNZPxk+LN544nbT9NR7Lw3E4McBGJLgjo8v9FHA9zXlDEE5wKANTV9c1HVpjJqN5LcEnoThR9AOBWej89O3AqLPHSgfd+vFADs5YYAB9elXbPW9S051+xahdwFeQI5mA/LOKolShG4YbbnB7VERk5xQB2C/EPxMYPJuNTe6gIwUuY0kBH1Iz+tdH4d+MusaLBb266ZpU0EOQBsdDg+4NeXEcncKKAPonSf2i0jGNR0Ekg8GCbPH/Aqsav8ftIv9PeBdJvI2bgk7Twfxr5v464pD1JoA+qtC+Png3T9MME9hq8m8ANGkKbR+b0snx+8BuCG8Oa0yjuRGP8A2evlXPFJ+FAH1Kfjf8NpP9Z4c1pSRg8Ifx/1lSn43fDbKsNH18FOQFRB/wCz18qn6UZ46UAfZGjfH34eKyoU1awUdGntt4/NWJp3iD45+Dp7J1sdQLhiSd0TKx/AivjYHmlzz06UAfQuqfG7TRHtsLa4lcfxSAKB9B3/ABrmNW+Mb3cIEWkxLNtw0jvnd747V5CTkkkDmk6Y4oA7T/hP9QjBW2trOM9mZCzD8zWfN4u1mcnN6ye0aha5zC4OevanLjPpQBovql5NnfdStn1aprXV9RtX8y3vZ0bpkPWWBxT8DPTmgD0DQviz4y0h1NvrM8igAbZGOCBXqnhf9py8jZI/FGjRXcOMGW2IWTP0PB/SvmroSacDxQB9+eDPH3gzxw8f9h6qsOodTaSN5UwPptP3vwJruxHL5ey4CzpnrjmvzLRtsisOGU5VgcEH2NfQXwf+OOsafGdK8Q3Mt9EqZt7iQbnUDqp9eO/WgD6a1PS51DPZN5kbEblP3l/xrnLwwXZ2X9skigFGicbuD3x61o6Z4mg13T4bzTDDLHN0ZHxg9cfXBp13BHfFbgpieMgnj72OaAPB/G/wt8mZrvQVKq3Kx5IKNnNeV+JvDryTt/aEQsr/AIAuduI5T/00A6H/AGh+Oa+7V06Ca1jYJhyoIP1FcR4r8E6dqsc0NzCFLDZkDkccEfnQB8GajYT2dw1veRGKZex5B9wehHuKzmUjg9a+gPiB8PLjRIniuYvtekFgIZUPzwk/3T2PqOhrx7XtCm00ozETWsuRDcquAxHVSP4WHp+VAGJESq9BnGRTmXO7nOOad5WVAI5HUU1gPm7HtQA0decfSmnnHsKew2cgnBpoA5oAB1HSilKjjAOe+aKAJH4zURYkdB+FTSKB3J9sVFxnnrQA05OOnIqe1SWS4ijgUvI7BFUfxE8YqFAOee1db4UsGSAXipmecmK3yM7R0dx79h+NAHQ6LpahILG33MgffcSKM+ZIPT2HQfnX0V4B0NrOzt/OGxCw+QdFHr9a5b4f+Fo9OtIp71B5hAYg9vau6udWFlmONVPuW4oA2vGXiTR/D+gTX+sXAh0y3wpCjLTN2RB/ET6fieK+P/ij8TdY8c3hSZjZaLG3+j6ZE/7tcdGf++/v0HYU34ueNrnxd4hYLOW0uzJjtolPy/7T49T6+lcAzdSf50AMZyTzimFue2aVzljmmqpYkJknk4oAGJxmrEKgRbn4A9fpVc1LuK25VuQSOvt6UARyytI5dvvHk0zcaXjdSMMGgB240mST+NJR9aAFy3IoJNA5PXr3oIwetABk/jQSelJ2pysQRhj6daAEyRijdRgY/CkoAdkk8YpeSfamjHqcjrTgBn3oAXJzS7iOh6jBpp6UcZ4NACjOaUE0hoH5UATKx6U8kg9c1GmNvXkdsVOOlAEb8KRTVY1Kyg00J+dADlJzVmymkguoZIiRIrDaR1rofCngHxH4osbi+0iw3WEHD3M0gijJ9Fzyx+ma9p+DXwOt3u01bxdMtz5JLQ6fBnYWHRnfjOM5Cjjpk9qAMv4Q+Jrjw9diC5VvsU8oMq9lHQke/rXukfia3g1GayvHVN+0QyHpyOD+orlL34ZxQsf3mIE3PyhBznjp157e1ZniXwrf/bbIW8jPcXEHUtlWKgYOTwOKAPefDd4bzSojI6tNH8jkd8dD+Iwau3UAuExnDKeDXi/wU1+7TWW0nVi6TMGRCwPz7PT29K9vxzmgDkNR02C8glt7yJXhOVZCOAK8i8X/AAusdO8O6pKk5ntpWBFvIvJGeMn1HY9vpXvupWvmBpB6cj8etZ93aRtEUnRXRlO8MMjHf+dAH59eKtAfRL9Yw5ltJeYZcYJ9VbtuHcfj0Nc++VPHHfJFfT3xT8FRadHcw3UZOmXbqIbjvCezH3HT3XivnPW9Ju9O1GSxuYmFwpACgZ8wH7rL6gjkYoAxiTnrn3pwPUd6dJG0cjo6sjqSGVhgqRwQR2NJgUAKMnHSilUc/WigCZ5FXOFJHeq4G5wTUjZGeTz1psa4yck0AWLK3e6uobeMfPIwQe3v+Fe9fDDQor27W6kj/wBDswI4cjg46HHv1/GvJfBdjJPdmSNWLsRbxYH8Tdf0/nX1h4S8Prp+i2VhH1yu845JPWgDrfDukR3EJubmMbOkY9fUmvIf2kdWHhq0+yWTbLjU4sLj+BeQxH8vxr3DUphA9lYW7Mkkp+UqucKtfJX7T2ux6r8TprSKQtFpdulofTf998fiwH4UAeQsO2OKgkbr/Snu47ZzUB69f0oAQn5abn8qOSD1pMdeaAHbhx/SnlyYwrYI7e3FRDg5FKcbQckk9R6UAOOe4pyoxxjGTxTI+XBJNWFbaAB0WgCvtI7A0hU+lT8HoCMc+tB2Yxz7UARBSMFlwD0z3pD3yKcVwe+KUjK5FAEfOOnegY6fpTtue5pMYPBoAUYOBj9KTjkDp2pcn15+lAHvQADg9vypaQjH1p+M4GcZ9aAE9SKSlHQ8mkAz+FAC96BQRSgfWgB6HaTj+VTo3PI4NVwDzU8aszYALE+lAE0cbzyiOJcu3AHWvevDvwj0u707SdUgt554J4Myi6cn94D8xCjA2+grhPhlocUs/wBsvVLx5wqDqfevpjQ7uS4RbSFB5KIEjVRjb6kfnQB0mgWNrBokVjFEgjVOkagKn0A6V1VjCIoNsSqo6YHQ+1Y+mRrGkapgp0yO2K27csiBeM4yB+NAEzor5DJuBA4x3rnNa0GO8udyMUjCOzBT/FjA2+ldA0g8vPOM4x3+lMEZYRbyeV+Y+ue1AHl1zZGO7htLtpLS8yTY3sY5QgZ5PpXoPhLxH/ammQtfBIrwMYZVB6SDrx2z1/Gp9c0u31TSpYpkwQMq2MFW7MPpXEWyTeH9bE82GilKLcgDIxjhz9eM49KAPU2GRg1n6kBGgZu59P0qeyJaNSsm9MZBzng9KfeQrNAQ4JxyMUAcpr2nW+r2E9hfoGhkXBzzhj0I9x1r5U+JXha5tvMs5i76jY5ktJx1mgHJTd6rjI/EV9bTBmHICleCfSuE+Jfh06pYQzWJMd/bkPBIeCCDxnP9aAPjPUrSL+xtMvlZ3uLtrjznZ927a64P1559aygPpjvXpHxXjkTT/D80sjO7x3bMrRJGYyJQCvyAA8g8kZ5rn/iB4dtvDusQWthJeSxPZ29yz3CqCGljEm0bRjgHFAHL/gKKMkEe1FADXIB6/XiiMjknpQ+Ks6TA1xfwRRkh3cAEDoO5/nQB7N8F9EWXUbFpV+W1iNyw9Xfp+QxX0XpLrFewKxPLBefrXmvwnsoo9NmuAPnlz+C9v0FdrPffZ3hkH3AQTntQB0fjnxDZeEvDuo6/ebS1pCTGveSQ8Ig+rYr8/tTvZr++uLu7kMlzcSNLK553MxyT+Zr3P9orxSt/pWnaVaSFrdrhpZCCcMVGAPwya8Dc5J5FADC316UwkZp35U04oAbmk4pSOvvTfx/CgAz3zzSk5JIPFJS49aADPOafG/J3fpUffg5ox36UAWQBsJHIwORSbuo9fWoVJXIDcH9aCT3NAErOMMp/ChSNvtjrUQHJzUi8UAIfvcDHNIRtxk08IWIxR5OMEkHigCMH0NOXPc+1Iop46UAHy9ec/SkYg5GPxp+AFYnOTUR60AL+NFGO1GDQAoxgUo/GlVD+NTW8DzzJFCpd3bCqO5oAYi7iFAJJ4AHU10Oi6c29mdSGAIbPYelX/D+hvHO2WiZ8Hc2cjHoD/Wum0nQzNcxwsT5e/wCc+ooA67wDp4Nl5anCdmx0/wAnivZPDduLZPutwMN2z61xPheyjtZFjQCNFXAX1/8Ar16PYQAMwHEaJnJ7+tAHR2B3Ic4ICk7gMAd8/wCfem6Vr+latJJHper6fezJzJHbXSSMi56sFJIH6U+3VmTYeVZWwPquBz2615N8OfAOsaVf+CH8Q2v2u2j0i7s54BDFC2nu4X5XZDmUOu5Ruzg855oA9wwgK5xwx2KP8KevzhCxBVT1H8Rryj4QaJrMGv3dz4it7lF0Cz/4R7Tp7jP+loszu06ZHIZPIXI6lT6V6tAoSQGQ/eb5M9QB2x9aAJZXwucZzgY+vBzXKeO4XXSZb+0QtJCpSYAZ3x9xg100zkBlXarBCfXvzmqtxGk2n3SOMh02gHrjH6UAc98OtbF/5MMb74Xti6nuCrAYP/fX6V3deW/CuwTS9e1LS33l7bM8RPTa/GB7V6lQBj3VsBJhedvzZNZup2puLK6iRFMrLmNWzjcBxkjp9a6KdDl25ycYzzWDrNzcWigWmlXd/vBL/Z5YU8v6+Y65/DNAHzR8YNHuNTsLNZrW2juo7aeQC1d5E8wTnIJcA5YA+3SvEtW1rVdVijTVNTvb1IsmNbiZpAnGOMnjgYr7H1Ww/tjU5LO5spbOSXTjJHFN5bFXE7ENmNmXn0z9a+V/iL4VufDuoxyyCD7FqHmS2zRTLJ91trqdpOCG4oA4c/WilIooAY4xW14MjDauZC2PKidxz36D+dYjmtvwb82q7QM5Q/zFAH0z8Oj5egq4+UOxGPwFal+bm7f7Pbxl35wF471X8Pwrb6TFEuBld3Xua7jwHbxzy3tzINx2Ki55HOc/yoA+TPjSkkGsWVvIhjaONyykYIbIrzYjLAdzxX0J+13psVv4j0C+iUKbq1kR8d2Rl5/I18+MRnmgBn1zTT+NOJpucetACY69fzptOPQ9c030oAOtJ1p4xyD0pI9oYbwSvegBBk8c460lLyOnQ0EgngED09KAHKh2hyRgkjrz/nmjA56/nQD8vf8ACl7c0ANAwaePck00HrwSe3tTvl2LgNnv/TFADy3ygDr3NMPPr1pTnHTpSckE4PHU0AH4mnYwOMjimk+lKuO+aAHnBA601lx3p4+96/hSsM+uetAEYH1p4Q8dacg7iui8F+FdT8X60mm6RGpfG6WaTiOBf7zH+Q6mgDO0HRdQ13U4dO0m1luryblY09O5J6ADuTxXt2g/BmextQZ5fOu3G2SRflVeOVXPb3716x8PPh1pPgjT9lmDcX0gHn3cnDykdgP4V/2fzzXZhgrYCBs88DigDxCL4bwaZiWNJHm3AbQpw1aUuk280kKqrQ3AA4x0IOOnpXrcczyYYnKkHbxkE1j6npkN5G0axgXDDlkGME/zoA4vTo5ILvALeXu2Ep1P+1n0616Xp4QwIwX5ygzgZAGf61zEWmEFoEO1kwFJ5OM/zNdJ4db92UlT5gwEaknGR6/zoA2rXGz5QdmcYA68549quxFgxZvvk8qOcDsKit9owM543kscfKOAfx9Kk85VSQ/d5G7PGBnv70AXCfnyzEHaAE6n04prufNUZ3ON3zdlx2qiJGl35Z0D7VyvDMPQf3R70qMfOJUKQBtGMlQe4HqR60ATHlzJliScZ68jt71W1C92bkjO4dJHHIyfp3/wqR977VLFcI25xx+nbio0iUq6rGvkrwu7o2QPzoAytLihtvFdtMoc3FzC6MxHpgjPoBjH1rsLW6huQ3kuGKkqw7giuemsVlvtKmiYiSB2JPZtwI3Y9u1bl3ZK9rJHbqI3YdVJUn6kc0ATXBBAwee2OazLySKON5pG/dxoSeC2ABknAHPHanzN5Z2/N8nAx1I+lVmfZksecDbzwnuew/PtQBwt3qUF14ps76xLyx/YBGP3TpyZ2ycOFOPfFeTftPWV1Npmj6jfGxWSCVrWKO2dydjgvlgwHPyjketez6w6XXieIoySn7EnIk3LxO/VgeRXjH7RC3SeFxJcQXGbnVklkuLlIUkcrAyKB5RJZQo+85DDgY6mgD5xPWikP40UAI6BuRXQeA4g/iGEE4G0k/z/AKVhMpHUfQ10XgGNn8SxKB8xjcdPagD6l0uMtpdqSgDCPcOPbpXZeAF2R3i5zkIR+ZrlfDcbLp9mCCCECkc8YFdX4TcQanJCQB5qHBB4yDn/ABoA8n/a8s/M8LaBeBB+5vZI2buA6Zx+a18quME859cV9hftYRKfhlAQB8mpQkfirivj1xzz/OgCNgOMU3pTjwKYwH+TQAhFBxn0o6HOTx70mP8APpQAuSM4J6c4pAC3fvingcAEDB4qRUzvLkgnnk0ARbBt680oUjFSqvPHPXvUioAvzZHXvQBV24xzSkcfpUu0HnFMKg+tADQMnHUnH4U4qe9OQDJ60u4ZJ9PegBjZx0pO9PODnkk5600Ad8kfWgBAKMcVJtXHfseaQJn8fQ0AIM5qXGQKaI/Xp9a6zwD4asfFGrpp95rcWlSNypmj3BwOoVsgA+xoAzvC/h+/8S6zDpmkx755DksfuxL3dj2Ar7B8A+DLfwvoFta28KI68uQMGRu7sT1Y/pwBU/wt8I6D4e0RRosYPmcvM53STMM4Zj/IcAV3DxqANxPofegDk/GmrP4e8KatrEcSztYW5n8pmwJMEDBPbr2rG8E+Ml146v8AbzpTWml26XUt/ptw89uVIZmQllUiRQhJHPGK6rxNoEHiPw/qGiXsk0VpfR+VJJBgOq5DcZBGePTvVLWfBlhq8mvs1xc2z63ZwWd59nKr+6iJ6ZU8srFGPoeMHmgCh8PPFU3iqyup7mwOm3NvIim1d9zCKSNZYZP+BI2fYg11qwAxkqdqLyW7isTwt4H0Twxq97e+HoGsI7y3jgmtlkLRHYzFXG7LBsMR1xjtXTKAVLfMF7kj73px79hQBmXNpmRbhSVJwDgDJ+n+PWmwthgQAoVPLOOc89AK0bjMYLCM4AKhO4yf5n1rNFrJCy7sMztlkVvugD17D+tAGmJS6Ex5WNhgs3U8d/8A61PjRnBZxtTdxn7xbHHHPTt9apwIUWNYfLwfusMntjgeta8dvtCYVnbtnGBn+poAZB8ykKD2PHOD7VZhiLZGRyM5HAJx/LPpTEj2xFnwqbhjJzu56n169BVxVER6E7DjcfvOSOOPTtQAwR8kAADIB9z6n19qI4AUO8nfyOP4B6nPepowygsMt6ADqfU9+PamSrwz8Z6AYyR+HSgA2BriKMFURgCefmfHP5cVo1gWwkn8RRsVIS3iIyTnrj/HpW/QBj3RHnzMzkEHbuB6DPQf1qtLErxtGyBo9vKFcg8cgg8EfzqaZXkZ5W+TJHynkjnpxTLoIkMoWV4gwI8xWGVY91yDyOvIP0oA467tYIvFltbWcFvaxNpwby4kCf8ALZs4AAAPvXjP7Rt+l3o0aC7Ny41AMd1tNCseImXbErjaqcfN8xLscgACvWbdHh8b2SPe3d639lOwmuigc/6QRj5VUY/CuB/akYt4P0vc7P8A8TAckk/8s39aAPlgiig0UAXo0DLlh+RrqPhuCPFdqFBwEcn6YGa5eSQQx7iDuPGD3rpPhMJrrxkkaKzu9pcALnvsz/SgD6t05CiKF6Ad1wasSzTW1xFcQY3RuGxnqB2qrojCTT7abJO+IEnOee/61cucCMDPcdqAOL/akf7Z8OkkRsKl5BKFPoQwI/AmvkaQYJx09fWvqT4vNJrPh260zLMVUywkdyOdv518tS5z05oAiPsOKax44GOOeetOb26U2gBvPYUDnseadigd6AEGehqYcKep/GojT1bHvigB6tl+nAHQ1IivIP3aM2Bzio1I3fNwKYW54PHoKAJCWGNwPtTBkhjjFN3H1pxAEa4bJJ5HpQA6QkHGOKizgf8A16t+aiW4/dK0xP8ArGOcD0x0psd26EHbHkY+bYCR74oAu6TpJ1KKSOCbbqAIMVs6YEq98PnAPsaW88P6vYqWutMuo1XGW2ZA/EU/SvEmp6beLc2c6LKOMtGpyPQgiuiuvin4lltTEstlArDDGK2UE0AcMylT8ysD6HilAOOn51Lc3M91MZbiVpJG5Lsck0sSEk55oARGOeRUiEZBxyDkU4p0BIpuDmgD1HwH8XNT0CaO3v0hnsiQGkCnzY/9rrz9K9rh+Llp5sKXJV1kTcsyMMFT6+9fIgU16Z8NPB9/4l06SRFZbcEqjsOGPsfT3oA+g7fx3aTKDEVOOxPB/H+tdFoXiOC6cxeeDMzZbBznjOBXgdx4T1nRGJCmZU4G4YAHr/8AWptrPqDyqUeSKZcbdrbd568D09zQB9Mtc7STkD1P+elLHcFYwFBAIyPf3+v8q4HwTrGoXEYtdSj33YACchU57nHU+1dutvI64diz9hj+nf6UATozPLudsqP4ugHb/JqZlWRdqn5NuemS2T1+vtUkNqEXYyl2J5y3SpygUbjIi7wFVUGT9B2HSgCBC4cqTsQffZj8x/2fbtmrUQV2C43qDkHpnnqartCqgZB5bPI3N+A7/U8VLFK2x8ptAHKZGfoT/OgCy8v8R28lVyrZOc9j/hSmYtvYBjhuvGF+nv71TlYL5PljeWON2eAPr0xTUIlkBLZAJw/OB/uigC+ZJCAAwTCAEKMkfU00FXlCLubIIwD/ADNVwDKXySETGMkgE49O5/lU+1Mszh2wcqp/iIHBx3oAuWMMcbuyAZIAz1x7fyqa9Z0tZDEQsmMKSucH6ViWWpSW+oxQXv8Arb2VliQEcKqk54+netG8kWa8jgzlIzlwehOOB7/T3FAFVkYqrKx2A8c9/rWZrN6llZTIkkYudp2hwZPm/wBoAgke2RW7FAtwpU5EYPBUbR9BWbr8NzZRxjSNAtdSDljN5t0INnTByVbOefTGKAPLtBmuE8YaSdQe3NxLps7YhRgMG4J6MzEH8a4T9qPUA2k6FZ5Yu88szHdkAKu3GP8AgVei6LbrdeKY7x7FbFIbCUeT9pWVQWuG5DLjIOOK8B/aI1P7b4+a0X/V6fbpCBsxgt87fXqKAPJgeowOfbpRTc80UASXh3S8jGBjrXc/ApgnxK035dwMU6kf9szXBy4LHnnNdB8PdXXQ/GOl37j93HLtkB/usNrfoc0AfVPhecBbu1UkeVcNsGeiHkf1ravMiLByD1xmsLVol03U7O+gizFK4huCDwAeh/PvXRTxgsRjPHBoA5LV7Tz1LAp909+/pXzN8RdCbRfEU6qv+jTkyRkdBnkr+f8AOvq3ywhIIBA5HzfmDVf4kfDWPxd4OdbJIxqaQ+fakcb5APun6jigD4vK49fpTQvpVqWFkZldGVlJUqeCCOCD71C64/xoAZjmjbk8ZpwxjmgcnHegBhHNLmpHAz34qM459KAAnnBOfrSDOCB3pemQCeevvSHGOKABOGBHUdMit7wd4efxHqrWyzJCiIXcseW9APrWEME+nrU9rPNbS+dbytG6dGU8igBLuCS3upYJlKyROUZc9CDUJH/66mlkaWYu7F3Y5JPUk+tIQNvp3yKAGIgxnjrVuwmksbuK6ttgmiOV3oHAOPQgg1AB29+9TIM4oAaVy7O2Mkliegr3z4NfAw6/YQa34tM0GnTAPb2MZKSTqeju3VVPUAcn2rz34N+GIPFnxD0nTL1DJZbjPcKO8aDdg+xOAfrX3jbRKFGAAAMAAYAHpQBxlj8KPBFvAIo/DOm7emWi3N+Zya5/xH8AfCGp7X0+xWxkByViZlV/bg17AiduKkVSPegD5g174MeDvD19Hda0NVh0yMhpVNz8rj+6Djdj6HNerXk62PhG7bwbpdvJJb2LtpsESfumcIdihR97nt3P1rv9c0iy1vS5rDUoVlt5VwQRyp7MD2I7GvncNrXw/wDFcuiwTy3MZbMEUxysq4yNpP3T2oA6v4Y/2nrkWpL4jddQtkjtzb3DwsjiRkJlQkwxKQCAcAEqTtJPFZfjnwI9orX+iYIHXcNz/wDAR3+tdd4d8X3WtMIm02eOdR8wDBlX8c/zrppIzIuJVV+Mc5ZR/jQB5h4Jdb2xHkgiWP5JDv59yT/n616taNGsKxnbhV+aU9AB79q851TS/wCyPE8U9uxeK8OGQNtG/sAB2/IV0viK3ubzwV4htIl8+7n064hjQAfMWjYBVHuSBmgDqsgAmNR5ZI/iAz6c/wCFQR3Ed3Ebu2nt54mBCSxOGjIHBwRkHBGMDuDXneiXutt8HU03QtJ1e18RWmlwabHHcWhgMczRrGZVd+CqnJLDpgcVb+FXh/V/DEGsaFqGnWtvYRzR3GntaStNbhHjAkjQuA27ehYggffOKAO6CZYRpls8s5PzEf0Fch4h1a5sfHHg3Tre6jjsb83/ANqXaGWQRQqyAE88Mc8de/FdmrAIxQAB2xnaMdPy9fWs7WvD+i6zBbjxBpNpqPlljCt3Gr+XnAO0dicDOPQUAcL8SfFd74ZvGWCUyjVLAWmjxeQHzqXmbQGODwRIjAHj5G/H0DT45LaG3XUH825ih2M+PmkfA3PtHAyecdBmqr6NpYXT7RdPtxbaY4ltIo4lVbVwCFKk8IQCenrV632iLMQDEjqpyD/wI0AWLZTjdKcEjkSEc8dABTrq3LW8/lfMSADknLdvwA54HpTRJtmVTIThCoEY4Hqff61PpvmS3L7AY4IyAdxyxOOnt1+v50AYVrpM1lrh1a4ijM3lskPmOcRr0A9BnvjNT6C0l/qFyzzPIN5Z1wUVO3A6n6nFN+IWux6db21hCnnajekiCEZzgdSfbkVvaFY/2fpkMLD98QGlPHLkc9PyoAvqAoAUAAcACua8b6nJb6ZPb2qyGR4zudATtHTAxkkn0AJp/iXxFDp7i1jkxO3DMBnZmsNHadWllBwhwN5xn3AoA5fRGTSrSe7MF7FaWlhiSa9ge23MJJJGwHG7bgj5sV8ea1fy6pql3fXBzLcytK34nNfS/wC0P4hbTPBbWUM4W41CUW52ZyYwMvz+Q/GvlxiGXOaAKTCims3zYz3ooAkbpmiP73TIpCKRS3HOBnNAH1R8LtYTxT8P4IZ5t97aD7PPv+9lRlG+hGPyNeg2rO8CM/Py4JB79Oa+Yfgf4o/sLxWtndSbbDUtsMhJxtk/5Zt+ZwfrX09DGEkcKCAT0z60AVrmPDZILBsgkkda63wtcrc6PGuTvgPlkdwOornvKjxkqvJx6/nVjQrn7BfsCG8p22uO2Ox/CgD53/aY8D/2D4nXxBYRY03VnJlAHEVzjLD6MBu+u6vE2B6A8V+hfjPw3Y+KvDl7o+pqWtbpNpZfvRsOVdfcHB/Svg/xd4dvvC3iG+0fVY9t3bPs3D7si9nX1VhyP/rUAYRB5ximrwc9MVKcgN7jn3ppUDGBkZySaAGPxwetNGfpSn5voPzNKAccYXHWgBnejuacw9QKTGOB1NACDPJ4penejbgfzpuD1oAenJ56VKuQPXNNtojJMiAxqWZVBdgqjJ6knoPU1Pd20tpdT203lmWBzG5jkV1yCQSrKSGHHBBIPagBFUFc5AOcbe596VeDx1qNRjjtU0aZIXBJ9AM0Ae7/ALI8EcnjfWZXGZItPGz23SAH+VfXMK4A7n3r5B/ZXnew8azNICIb6L7NnHUjLfpX2DGvTtQA9PvY/T0qUCkRcdeTTqACvL/ivorz63pmpQRB3WJ0IJGOOckfQnvXqFYnjDSZdX0dobUoLhGDpv6NjqD7EUAc94L0q00zw7ax2qBTKokdyudxPckdTXI3/ijUYvijbaTbXVw1idRWxutNuLNVxGYdy3CMFLMu/Hzs6g/dCcZrpPD+rnTQtjqe+2EbeXCZFIEWP4D6+x6YrqXm3Q581khPOQeo+lAHN+NbL7To80gl8t4l3eYQMrjnr/QVH4U1RbvToUmbfchMbVGD+I7fWrniLVLe006dsKJSAqiRss7dlAxgH6V5++otHpra1pkkjm3bbqNvG2Cpz98evAwTk/hQB67aSma3KtMMKdpUfdz2AHenXHyARxgyMw4LHjPv/wDWFcZ4Z8TW2pt5lrcIrMAWVW+ZT2BzV641UMWjglJVRgsgzubv854P0HSgDblmBlUq/mFeMlefw5AUUDi4LB1Uk4GFDs3qc9MfpWDHdB5Y4tpeQNuYFSwU9sKMD8TmtVXMStv2W6P13qPMcfTqPyoAmYIP4JMjONwBJPrjHf1xSSzqrIszu0mOFbL9vSq32nCu0hYoxOE2lAQP9nqc+pqk0t88kbNBi5nG23tQ23Pqz45Cgf8A6qANG5kkytpaKTqVzyiMeI0B5kfB+6MjjjJIFdPZ2yWlusUeSByWbqx7k+5qh4f0gaXDI80nn31wQ08x/iI6KPRRnAH+NU/Fd+6xrYWpxJPxLIGx5ad8H+8eg/E+lAGNAsWq+JbnW5NzRQL9mtgFxmMH5jzzy2fwxXQ3OsAHy4wEJGdxOfyArJgMdvEsUUcaxAKABjA/Pr+VRlyWZBwzf3AM9fU/4UAZk9n9r1X7QwJjXHJ4LEHOR/8AXqy0hIJyAzDuTz+X+NSSvHCu2MADpj7xPOeT/wDXrhPip4uHhfwldXykLfS/urRCRku3Gceijn8KAPnz44+JV1/xvPHbzeZY6ev2WIgYG4f6wj2Ld/avPFbk/SkmkaR2ZyWZiSzHqSTyaYOoFAFYnDZ96KQD94R6migCVmPPGaZk56ZxT3HGeMUwcZINAEsLsCDkqfUda+tfhL4q/wCEo8LwyzMf7QtCtvcDd1YD5X99wGfrmvkVWHrmvUvgj4k0/SNYFtcLcR3l46QxyrIXSUtIirGYvujALnzCcjsOxAPqFACoB3ZJ6YqdEPm8KvI/OsTTb95b1UlRIkkgM6RID+723EkXU8nIQH65xxW7AykDB3Y45OQPqKANvSrzzI1t5c7wPkLdx6V558d/huPG2hfa9NiQeILFSbduhnj7wsfzK+h4711rMdqlWVWRuCOP0rXsL+O7HkyMFuB26bvp7+1AH53yxvFI8boyOhKurLtZSOCCD0I6YqEk8jHFfUv7QXwmk1h5/E/hmAHUQu69s0GDcgf8tE/28dR3+vX5dIwffOCD60AQkHvSc+nNSkD1oCZwMjP1oAZyB92m8nt045qUjH/1qZjPXA9aAGkEdjQwJyQCo7CpFPA6ZpW5OOMUARqCD0x0qQZHGMbcdBShQQSB06kGlwMUACnv71PGScHsOtRKvOK9b/Z9+HT+NPEwvr+P/iQaa6tcMek8vVYR+hPoPrQB9JfBDwbB4b8A6Ot1ax/2nNF9ondlBZGfnaD2wMCvTYl2qB6etVJZYbS2ee4kjhgiXc7McBQKdpjTyxvcTnasxDxxEYMa4GAffufSgCnrniC20k7HV5Jj0RBnNZcHi5t48+2UIe4b7v19qz/H2k3CT/2hAsslvtPmhW+5+HfPr2rkILgyMkKxS8nIhjwzN6e2fzoA9mtLqK6QtE6tjhgDnFTAgsR3FZfh/TzZWxeQMssoXcjEHYAMAZHWr80R3GaFV+0BdoLZwR1wf88UAZviDQbfWI8yqhk27cOMq464YfWuNexm0e58p0u0hJ+VUO5T77uwHpXeWWoCdxBcRm2u8ZMLMDn3Ujg/z9qtTwx3ETRTorxt1VhQB43r1vBqV1ulgZdnCEy9z/sd/Wnw6XJYabbCwmEsVsGDNgITu5IMQGXGfWu81DwXZTBmsJHs5m/jA3/Xqc/maoWvhzWdPkxby2k0Y+beSUduemAP1zQB4T4s0K7sNWjv9AknttQmYlrORBBEP9oE+v8AdPrW1omta3NKkN/atZXCfK6yKWDfQgYH516hr/hXUdSeJjaxMyjJkEo3A/iP60aV4W1O2QrJbqy44Es+7B9e+ePpQBm6ZPcwjf5Y2IpkKxkrvY93I/QVJZ3GoXt6Z5wlnCowoUh2Ix37L+JrUvfB+qXcOFvbe1BOWXBfP17fzrMk8LtYFzeX8FwSNq+YxVFPc7ehoAY2sx2sv2fT4Zr7UJgFjSME7mzwWcAgDucfia7/AELSRYRCW4Imv5FHmynnH+yue386o+D9HOnwSXErhnn+6oTaFQdPr60ni7xfpvhqBhczRteFcpBuwfq3oP8AIoAueJtbj0ayLL5b3cnEMTNjcfU+wriPt7lpHmnBdyXcqMEknufbt6V5fdeL9Q13XJpxMjTSsqqVXIRQeg9BXR6Lp+p3Th7mf5Gb7pG0AD36nNAHYW1/57jks2Mjjoc/nV1JxFIwSNpJG4LHgCsizij02zbYyhskNJk9M1k33iWKK1ka22ytkhcvgk/nmgC94k1+DSrZnuAHlBJjUnv/AJ9a+Uvij4wufFWuZcgWtrlIkU/LnPLfj/Suh+JfiRR5sfms97MmzAfPl+pPP4CvKN2DnI4xQAZOcUoyCTjp1ppPJ5pVPUeooAgTIfkdKKOrHkdaKAL8gTbtxwOlV1AxjHXipJXyuR0qBj0HHvigBHTaCR6UKSuDz9RTWYhc5zkEYphY4OOmcYoA96+BPjhWuJdA1iYma4bzLa5lIZmYD/VsxOSf7vpyK9zglkjYMDHMme4wwr4WilZJEeM7WQghl6gjofrX058I/iAniawFlqEqprduuZBnYJ1/56Ljv0yPx6UAewxTLKrGPPupGCDVeQMhJXcpHTnkfSs53VwvmKWGCMoTn86imnuY0L2/+lpjlJGw/wCff8RQB0tj4ggMotNTlWK4JwkrDar+mewP6V5T8aPhHaazLPq2kRLZao53O4/1M5x0cD7pP94fjWZ8QdWEtr5Qt57eb7oEnykfj0NUPhz8VdQ0WRNL1ZjqGnj5FSVsPGP9lvT2OaAPBtW0u90bUJrHU7WS2uo+GjcdvUHoR71SHSvsnxZ4T0Dx1o2+2EUiBdyq+Q8BPdSOR+or528W/DHV9EkdrT/S7fsMYfH16H/PFAHAsD12kdulRnPHSrdzBcWx8u6ili2n7roRiq23cRjBJoAQcgjoOpoHNSInU9qTaFwGIGaAEAqRUyOK6fwt8P8AxR4oYf2Jod3PESMzuvlRD6u+B+Wa9y8C/s620DJc+NL8XhGD9gsSVjPs8hwzfRcfWgDyP4WfDTVvH+phLRTa6RCwF1qDr8qeqp/efHboO+K+2fCXh7TvDOh2mk6Lbrb2Nsu1V6sxPJZj3YnkmptK0+3sLG3srG3jtbSBQkUES7URfQCtJdoAUkZI6Z5NAGTf3C3V9bwMyrbK245+87Dpx6fWt1LiJkDl1UH1OKow2NvDObhY1RiOWK8/nXJa5avrErLIZFjyf3fmHbj3wP8ACgD0AgMpBwQR+dcNH8P5F8Rx6i2v3/2KKcTx2CoioMHO1mAyy+xqXw1cT6IFtbh7i4s2b5SVyLf2B67frnFdrn8qAGTyxwRNLM6pGoyzMcAVTsdWsr59ltNuY9FKkE/nWPrIuLu9KuQLdDlArY2+rN7+1LHbApkSyE5zuBwfwoA25LSNrlZiDkHPAHX19anlmihj3zSLGnq52j9ao2lzKI1SSIsMcu7gZqlq0dpf3EEsyxM0GSjEEkE9fw/OgDajuYJP9XNG3+6wNS1hoyxj92Y1weW2kf0oe4YcNIcDvt6/40AbTOq43Mq59TioZL23jBLyrgenP8qwbx22sdxQsCWk+7gdPwqkHRXUFmVQOMnsKAOguNYgj3iPLlepPArGl1Vnk83yzJs4GVAX8O5qqbgAKflUDkDb0qlNciTP70uc9Tn9AKALdz4juyATcx28QUs7FR0+vPXtXmn/AAis2tandahqE9wtvNKzIpJZ2Hrk9Pxrp9W1KzsF869kjIH3VK7jn2HrXB6r4y1TV7g22jWz7cY2Beg9XboKAO1tV0jQ0WONYIwiHcWb29awda8e2qhobTzLiXaBtiU4z6ZryPxB4vttPldNU1FtSulOPsdk3yRkdmk6fXGa8/1rxjqupBo4mSxtW48q3GMj3Y8mgD1XxV46RGJ1TUNmGBFpA2+T8ccD8TXmGs+Nby7V4rFDawngtu3SMPc9B+Fcmzc9MnvUZdu+KAJXkLsWclmPJY80hYgYIwMZHvULMaASeOAOtAEu4+nanZ9BUIJzT1JI9qAGBvn6d6KQEh2HrRQBK7dcc1GzDPT606XIOASe/WoyMAHJB70ABII6YxSEjb2/CkJxSUASFlL5UBRnoOas2N5LZXUVzazPDcRHfHJGcMjdiDVMEhgehzmk3Y/KgD6T+HvxOGrWEcN/cWxvkOHt5XEbP/tRk8Nn+71Br0O11zS7qQow8m4HVJV2uPzr4rVyK7HQfF2uWluqJMl/bJwba4+dl/3T98D6GgD6sv7W21G1aK7jE0ZHG4AY+h7VxV/4JtijfYojcc7hGxBK/wC62OK4LQPiPaMwVru60qccGK4zNAf+BAZH4iu8svGBKCW4tvtMPUz2bGdR+KdPpQBVF/rugwQR/ZJGaJsrIGEjKv1FdFpvjaHUYRDfRlmx8waIj8weKfZa/pWogeROiN2EhCtn8TU11Yi6Tc0KyKD97PP6f40AMu7G1vMq5ZIiPuMoVaq23wz8K35DTW0UjOeQqgE/jxWmlowg2yruI+6QR09D3NENuFXdGOAeSpKBT/vE8/hQBd0v4R+Do2+bw9buPWVt38q7DRfBvh7Rir6boWl2rr/HHbLu/wC+iM1zVlczxgBbjCjujEfrWhHfTPhVmkbI654/n+tAHZSTwp/rpk47Fsn8qrf2xaKSI1d8dWxtFcqWds5Ab3DcfiTwanibAxGsZPquOPywKANW41WeZzuuUhh7JEMsR/OoLfy4tQW6RpFuVyAS5Jwe22oAwTgBd/qFGf1/nU8RKcE7P9kZGf6UAa893c3G3oI8dC3B+vrUTLL5QYcqp5wcfkKpib5kYSKMcjDcfh60wXpul/c7RGD94EE//WoAtIzFioR1GOsp+X8BWho9zcR211b3chZACYH2ndjup+h6e1YhYxspZcA9cjpVXUNWutPQyx2wkiVSSRKSQvrzQB0XmxsiNuIUjhWHP4imtLhl/eZXOSScZFcjo3iS21SJX87bcsOYmOwPj/az+grfS6Vk2x+WW77Dn9aANL7RHIjGYiNjwBuBz/hSCQjIU4LfxZyTWVPEPLKbN/bnnJP86z7G0v4EIn1K4mjHJLIuSPTigDoCxY4MmVXnB5xTVnK4JcZbjauMD2yev1qks4CsRkAcKrHArB1bxno+jSol5dne2cBF3fUjvQB010/7vlvlBzt3DJP8qy3nZVBdVHJ2xoQc/rXHX/xG09gTY217cZ6YjIJPb/8AXWDJ4q13Uk/0O2Wyi/vIwdse7H5U/GgD0HU9Wg06J59Ruo7ZccR+YGb6DB5Ncbe+L7zUp/snh2zMS8nzpMAhf72Oij6mvNte8WaBo0sjX1/JrOpk/wCotZPMUN/tT9B9FzXB+IfFWs6zbm3vrmPRtJYn/RIQQz/7yj53+rYFAHceJPGGiadNKL++bWr4H5orN/lz6NN0x7LmuA8SeL9Z1uEwzSJpmlt0tLfKIw/2h95z7muYW5jgLfZFxgYV5FBYfQdFP0qrJKzyF5GZnJ5Zjkn60APZ41GIwCOmW/oKjZ8nJOT05NML+lN3cUAPJ9xTc5IFIW5pM80AOz7ijjsRSbs0obk5oAcMeo6U/PU8VGDTwevFAEbY8wnjrRSP/rG+tFMCwigfMcE57jNMKA5xx6VIo4PXFGMUgKzDjj0pGQoygspyA3ykEcjP5+3apWHyjg1AwweKAE79eKRvTdkUYOeMmlII6jjHGaAEwexp6EqwIbBHQ0wdelKo447+1AHU6xcaYtjo8mnO9081uTepdMGaOYORgEAFQV2kdfxqtp13HBN5thfXmmT54KMSv5rg/oa58MVJHOP51Mr9KAPRbXxFrDgfbbOw1+JRxJEuZB75TDA/Va6Dw74xs57uCC11q80uZ3VCmoDzIkyccOMn8CB9a8himZHBQsrg8MpwR+Na1v4hvFlga9S31BYWDKl5HuIwf74w/b1oA+hNM8T3j6Wsz232pg7K7xAOFAYjnb908Zwa3LHxNptyyrNNJDMMZEoHGRkcfTFfNtjrGlLqM11LZ3llJIxcyWl25YMTn1HHPrXY23jf55Z0fSNSaVVLxX9zLG7MqhAxZ1HzbVH8ePagD32K5gcIYpFYtnbtcAnHX64yOnTNSscAGQ+WjEAdixJ46nJr5+ufFerqYJF8JQpFbs7K9jeySqN4XPKM3HyircHxKVYRBfWl1asssc/7yKVyGRtynO7OM+1AH0CsscKNI4CRqMl3I6dz9Ku284leNUIO5gN2QRz3/wD114e/xMtL+yuLWbWdJEV1C8Egngu1IVgVPIB7H3rSg+IwjEIg1nwm4jChd01wvQcfex6UAep6RqP9oWCXPltEXaRcYyBtdkz75259s1aN7bxOI/OMk2QCq4JGRnkdRx6147B4ouRZLaWepeGzCrMfk1F1I3MWPJPqxqidSFrfvqMmo6BDcFI0eRtUc5CKFHAJzwOaAPeXuYmZUYqjNng/ebHXHfiqdvb2Fg0k1siRlz8zlyAST7nGSeK8jbxzaSS2U7+IPChltDKYwZbn/looVsnHPAFXLjxlFfWghn13wgYvNimz9qmBzG4dfwyo7UAesrcLlndgCcnLdeOpPoBXI6trkuuyyWGnQma0b5GlBBDnpgd2/CuR1P4hQpazm48QeF9joyslq9zI7hgQVCj6n0rh7f4lXF/bJpNs8ehabbQndeW87pM0aqAFHBJZuOARz1OKAO4TwfqtyjtAFaG1mkitmBZcGNypfHTkr0Ndjb61qWl2cP2+I3V0oBeOIhXK9N46bq+XdT8QW2oajcXctld7ppGl41CRRknJwMHHrXR6P8TLnQzb/YrV72JbcwYvLp3O3eX2nK54JOMEcGgD6YsfENlcwiR5DCWO0JOhQ5xnHPU4B6U65162Qn78yg5+VCM9hz068V4LF8UdXvxa3KeFtLhhtZjMs8l08MYYo0fJcgNwx6Zqnq/xFnure5t9U115rWeMq1pYSuyodwIwwjQbgQCDk0Ae83Wsam6bf7OFkhHDXDL36cHp9OteZ+Idb8M2s81zq+v2MkgUrstcXEp9RtXAH4tXjLa7p8eqw3q2N5dyQSrKjXV+5JKnI3DB7+9PPiPSokBsvDNrazDOZluXlck9/wB4GA/ACgD0bW/Ggs5ri28NeHnvfJCn7fenbCqsoZSUGFBwRwzV594k1/UtWyviDXpbmMfcttPA8gH042oPwDVQ1vxFa6zePcX+mzuzEHaL5goIAGQNuATjPFV5dY0x7G3tW0iTyoHd1xfNnL4zn5f9kUAQLqDQhzptutouNpkH7yT/AL7I4/DFZ8pLlnYksTksxySfetGbUrT+zbi0s7EwfaGRnd7kycISQAMD1rMJBQnI96AGZwCM+9NYjdwc/UYpNwIwcUgK56j86AE/GjnikZlx1HFKCpHLc9hQAH3o5pNy460bl7t+lADh9aAOv5U5GTbyR75FNLpzj+VACr3wf0qVfr+lRBlz1p4dM9/yoAY4/eHmihiGYkUUAf/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest CT demonstrates the postoperative change in location of mediastinal organs, with the heart abutting the chest wall. Blind chest tube or needle placement into the postpneumonectomy space may puncture the heart or great vessels.",
"    <div class=\"footnotes\">",
"     LV: left ventricle, RV: right ventricle, LA: left artium, RA: right artium, a: descending aorta, e: esophagus.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Irwin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Postpneumonectomy shift of the liver",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <p>",
"     Chest CT demonstrates the postoperative change in location of the liver, showing the potential risk of hepatic injury with blind chest tube or needle placement into the postpneumonectomy space. The liver (closed arrow) abuts the chest wall; the open arrow denotes fluid in the postpneumonectomy space.",
"    </p>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Irwin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Postpneumonectomy shift of the spleen",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 231px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADnAWgDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5qcHBwKTac9eM55qeTpmoXyRQA/p71DMnzFgOtOLYGATyKR23RqTngf1oArc57UoLeg9KVqTp3oAQHGOlIvfoOCc4/SjNJkHGR+NAE27IyPofemuAMEHJqPJU8UpJIzigB3UY6D2o3OvIOM0owFx60N0HvzQBJaTGKQnqCMEetST3BLMFxg8ZHeqqjuBzTlViwVASxOAAM5oAdlmYAnjtT4IXnbbEpY98dvrWpp+jM5VrnOSciNev4mvTPCXga71BEeWH7PZR8s+3GO/TqaAPOrXQjO6mYlmOAI04/M16Fo3gy6vj9q1Ax20CKEaV1SP5R0HGPz616XoHw+tL1fJ0uV0z9+5nhO0jvhTXsXg3wHoGgwq32db29bhri4G859FB4UfQUAeF6B4Ls7qFW0rRL/VwvW4dxDDjp94jJ/AV01r8KILmUSasLeyiz8sdsTvB9WY/4dq901SRbaFm3xxhhsAPf0ryjxR4hktLiRobHUVkHCy7wwYepHbvQBLZ/BTRd2+PWNSII4WN1AB/KuT8X+HG8OSMhvry4sFB3RtM0ecgq2QhGSVJXP8AdJHQmuo0f4orawRJqFnsZshXkdUXj1PavMPit8UYNesQltBtuGzvK8qB2AOB9aAOUi07U/EuqajYeFNPvb6WZNs6WrBIhFkHa+cAjIBGSBkDArol+GXxTnLTTW+rkuvluf7WjDlOTjmX/ab/AL6Pqab8PPjVrXhbw+mk2+i6bcQREsjndG+WOSXIyGPvx2rudL+M2u6gIppFtYBuO4JASq+zZbJHv70AedS+GfEaa5Ho+qQa9a3d0CJDdXhKSJtKkhgxVhh2B5P32B+8a2de+GGvWWpNp9stxcSskQG25LK8Y5RDkjIUqMDoCAR0rZ+IXxS1fUtKfTNT0mzjtJHDC7h3blKnIwCflJ6dTkEjvXpPwj8RabeQs7XkT3EqD52cktjtz0/OgD528TeGPFOlQs2uW2qrG7CV2lZ5EdhkByckFhuPzHn5j6muc827uncve3MxkiMDZmZi0edxjPPKk8lehPOK+8dRuils5hi+0KOHUDII7ivMPEnw80zxXOZ7Fo7CWTdJG9vGApI4xjI/OgD5B1jw+07l0UxTED5j90joMjtXK3VtLbSmOdCj9ee/uK+rPEfgTVvDenySajpv9p20Y/18B+ZV9T/hXlup+GrfVoJZdOT7RbKNzJ/FH6nNAHj+D7dcU+PNamr6LPp7k4Lx9Txyv1/xrLB49RQAj53E8UnahutHtmgBO+KcM+1NFLnjNAC4496WkB4NH49OaAFNLzSZozQA6gUmaUc9wKAHDJOBUm1gSAOOlIhAHUZ9aeDzyeOuaAAZ44GKKXPOe1FADm7+n1pjAlSeabLk98568dKYX+YYPIoAR+TSYyp9qc2GGUGB6elOiThixwOmPWgCAjrSY61JMNoA70wdc+nNADX4wBikIoJ5zml+Xack5z+lADQKXpj+VBORQDQA7/PNKw4xx0/Okq/aWT3Tk9I1HzN3+n1oAr2dpJczbUHA6segrufDHhiS7cJaoSCDumI5I9v8K1PBHhKfWbyG2toH8hcbggySSeB9TX2H4A8Faf4S0spDCkt66gSy4yc/3R6AZ/GgD5w8NeDEs7iKa6QuVwQmCfzrrdV1OHSZBPrV/DaWkaHaFGG/3R6+1T/HTx9a+C7l9PsLZJNVmXcikYEKnPJ4r5Y1nV77Wr6S81S5kubhySWft7AdBQB7jqvxss7CILon2yWRXyGICBh6knk/lWfF+0FrT3KvNHLHEp+WO3ZP13DJNeHEnHfino20/KSCfT/P0oA9o174/a5dx7dMtI7eUjDT3D+a5+gwFFec6t438RarI8l5qsxY8HZ8n8q57oCetN5+brz6CgCy91cykGW4mf6uTW54S+03mqxQIFmDcFX6H61z8MbSOqICWPAAFe8/DHwilhbJdyxeZOQGyTjGe35H9KANbTPBVjd2wMSvBcrw2DkZzXWeH/By2yMk0QkBPJHRsGug8NWAhmVmQygvjnAIwTzke2K9D0/SmdQ8wVQ2CQowAfUUAcJb+CLG406G1vLcFGj7jp1wR71xuqfCCS2uGm0S7e2c/OgJ+UEe+e9fQsNtHHGihRlRjNRXFnC4clByPTP+elAHhGl614h8OSW51uW7QwOYt0TExDqCTH0PArv/AAh4k0+VmuPOgmkl2LI8aBBkkndjtx2q5r1tA0QE0fmoV8wgjIx3IrhpfDtijtJayGGU/MzL3UE8jn0/lQB7fvQru3KV9c8V5X8Q/h1YX9xPqfhuRdP10AkoBiK4PUhh0BOeorN8W6L4isdOW90a+kurNzvIiIVwMDrjg9K85HxP8QWF08F3cSSIchre4UHj2bHB4AzQBlahb2N/qBs9asvsGooTHJg4XI6lT3zzXmnizwgttNJLYsNmSAR91iPX0r2S51DS/G8JjkCw6qufKLZ5PPAPQn2rnr+zurO2aS7TfZ5IlLjlT0OB69KAPBJ4HhkKSqUcdjUZWu+13SUWSaOdN0St8j9xnuDXKXmmS2qmTBlh6bh1H1FAGZtx3H4UEDHvVgQZAZcHr1/nUOCrEEYINADMcHml204UY/zigBuOev605cAjIB9jSUvcUAJip4UVkXrkk5+lReuBketSodsY5xx6d6AHvz1xjpSYBxgU/g7uwoVSxxgkmgBu3pRS5yaKAHtjGKhfG/kEqDzzT5WY88VC5JPOPTAoAWEndtA5IqQnah5qvkghh1FSFyw+tABI2TnqPQ1CemCB1696VicDpmmEn2oAUc9+9BHftSEnvxRn1oAXoetKMcfSm5ODzUlvDJcTLFEMs3THagC1p1m13Kc7hCnMjDqPYe9djounyXVzBBaply2xE7f570+7tLJEtrbSJbZxb2vzzxLIv2mYknG1l4IztyeoXJI4FezeHtO8Py6gmo+FdOvY41RYzKbGSSOMbnMjlRj59vlqGY7eWJYkUAelfDrwxb+DPDcF60Ym1KbiEdSzHgnHfrXDfGD4yz+D7abw94evEuvEjEm8vOHjss/wL2aTHXPC+5rnvid8a7yytb6y02J7PWbgeVCwUqbCAOwBXPId4/LOMfKS3fAr5vaVmLszEluSScknuSaALWqajealfz3mo3M91eTNulnncs7n1JNVFYgjJpH3BiGzuHr1pvNAEzEEcHP1pmT26mmgHHanAHIxigB5znNSRoXbaKYoJA6VseH7J7u7RcoAT/EwH86AO4+GvhmKe5We5hZ2HI9jXv8AoumyebHBCoYBQWXtz245/CsLwF4dnjsrV9hiJ+YbO46cn1r2rw5oEdlGruoDAYwPX1oANF0byIkl3KGJznHBX3Fb1rG8cW18ZB4x6VKAAOAMUtABRRRQBnajYJPE4xyVKr7E9/zrxPxwl9oVzKI+EUeYhweR0xn+le+1z/jPw3D4i0iW3IVLgDMchHQ+h9jQB85+EPijdaDrstk4F3YXRAMLE4Vs5yOeD2pfFDaV4kmuI/K8ifafLbgdz19+a878WaXJpXiSa32ylsnlQfkPOD9Km0bVpJZmS7JEighucg+4oAzL+K60a/K7ivOcdM4J/wAK9n+G+r2fjLTp9L1Mj7a6lQzkBZh1w3ow7HvXnHiaFLq2WTh3KnLLyMCue8OaxPoWsQ3sRPyPubb6dqAPVfHXw2utP0+aexhea0K7mVRloyPw6V4v9xwfT39a++9CNrfaXa30DRzQ3MYlR1wQwYA/1r49+NugR+HviHqdtbIEtZCs8aAYAVxkj8DmgDzPVrKO2xcQLiNj8wHTJ9PSsS4QE7l6g4Oe/pXWOn2mxltyV3Y+XA/GuOfeTtbqP0oAYBkUHrQQQKTJoACOeDQetIc9O9HNADvUZ4qaPBQH0/Wq/OakjfB5GQaAJhgk9cmg4A49Ka2SMjhB6UzJ3cHI9elAEq4zzRSKT+dFACtjnP41C/U45qVhznAzUT4z+PpQAw+1CnkikIHHSkwPTNACNzRyxAByegoI6cUh+gzQAlL0AzSYx2pVAwenAoATsa6bTLJrSIbzi5lHzkHO0dlz/OsvQrZZbvzXAKQ4bB7t2H9a6eKI8tjJx1PegDZ8Pacs91GrthRksfYDmvQNf8dxeDPBdrbWiE3+qAyNCDx5S8Jn0Hf3zXJaQi2di8kpwGGWwMnb0Az+NeceLdWk1rXrm6di0a4ihB/hRRgADt0oAzbmeW8nlnuJN8zks7N3NQU5F3MOmKVoztzgcUAR5Ock804dqDGVcrgZHoc0oQnGF5PtQA5FyMg4pwH5UscRZwhXDZxg8Yq3b2Zd8bfmzgAd6AIUjYkfKTn0rtfAGjy3urW6FCyhuw5+lRabood0jC7z9OPevoD4NeDYYL3dPDK5jIfnhd393645oA9f8F6T9nsh58G1dgVQTwQfauspFUIoVQAB0AGKWgAooooAKKKKACiiigDzz4l+BNK1a2uNVS38vVET76NjzAAeCOhNeBaxoqSzwIsYW5PyqFGCwPbjvzX1XrF0jWckZAy4Pysuc/lXidjaQzeOYfNwYbT94+PUEnP58flQB5vr2mCyt7yFCjtbFHfHoewrg54v3rLtOCMqfWvZpdIkuJ7iSXP+ksyuAOPmOQfwyK8v16zNvKyMu1oWI5oA9m/Zq8TXs2h654cFyUms4/tljvG4KpY7157btvH+0aoftIWK348P60VVJLu3eCTHTchz/wCzGuC+EOsL4f8AiLol5MQttLIbWck4ASQFcn2BIP4V7h8cNKjfwDBbouGs77y1J/uurHPt2oA+UYD5cyux5yQSa5/X7X7LqUgXiNwHX3zXT3kWOCpHGc9M+1ZniiHzLGyuiOVLQtnr6j+tAHO4+TGPpzUTKAQAR0qRBkbcdKbLwR9KAI6CPlB3DOcFecj3oPWkx/KgBe/vThk9s03APal6nJxQA5jk+gpV6nvxTQKei7nAwOaAJF57UUIBz0ooAST7vQ81EevSpn56ZzUbAZ4zQBGc5xg5pPQ47U8/r9aYaAEz32mkJHUA4pW7UnGP6UAN/Ol7Yxx1pf8AGrWmw+bdxqRkA7m+goA6DRrXy7WOPoxO5s+prptM0576baqsUXjj61mWEEkjjYQFUjc5Pc9vc19BfD7wkI7GKOJR5roTJI45Pc49DQB4v8RXfRLBbRmkinuF3IuOcAV5UT6A16v+0wyJ8VLuzi4S0trePHX5jGGP/oVeUmgCSNtg3YPHGKl35wCpODkY4qurEe9TqQ/I6gdKAFG0ZOD70EAgYBz6U48HBpRyB1oAt2drI4SdxkZwCfWuj0WwW8MIGd4PT+VZWjQPcIFXAAyR7mvR/CNrDbQmXyw7MqgFhkA55IHWgDf8FaWI54kxl5W2bsfdPoa+kPAOlmysfMdAjnggdG9/rXCeFdHZL6CUOJP3absqBjPQjsP617DZxiKBUGcD1oAmooooAKKKKACiiigAqnqVwYLV3UZboAf51cOe3Ws7ULfzFk3qZQ21VRSQRyDyfQkUAcfeXL3UrhgVgOEWQnHmc/dHPDc/jWNqWnLp4ljABkuGO4uMs0f4dOgA/GtbWLuDSEdvlur3czRbVxHGfr3wOveuE1fWLoyTyFgXY5PGMADgAdhgcfWgC3qUS28Kp8rxxBsnOTtOOPw9a8s8eWYaQSqMFwFkwBgkV3+patHJEQw/gHIOMjGSPXiuHvWW+Dg52qCBgf55oA83dnRMjh88EDHI6GvpPXPEI8T+AL7zXBu/slpeHj7rJKqufxBr5/1W0aK4k+XGGzj612vgfUj/AGLfW8j5Mlq0BbHJ5GB+GKAOZ8R2DW15D9mQjzFI6Zxz6etclfxtNoupw/eaLbcL6/Kef0Nej+N0BsrWTo4Ubj0wa4vT4Fe/hiZSY7mN4D77lIH60AedAnqKJDlhwc4oKlVw33l4P1phIJBHPGKAEyM0HtxQTz1oagAz6A5pc8dDSA80ooAUGnKe+ab/ACp+GOGweeBQBIrcjg0UifnRQA9uM9DkEcjP4/Wonwc84/Cnufeo29RmgBp+ppv4mnH60h9fWgBpHHWjGe/FHej69RQABR61taDCRHLOfdR+H/66xeneuosk8rTo0BO5lDH8aAOw+G+mDU/ElnFIN0KSeaw7YAz/AIV9feA4Y00e7nCFt0vkqAOcDA/mf0r5y+ClmsS3l9LztUAD6da+hvBN/Fa+DJr24KpBDcTzStngKuWJP5UAfFvxzvPt3xc8WTbsgXzxD6IAn/stcIatajdvfXtxdTEmS4leZiTySzE/1qr0Pr7UAJ360v40A980Drx3oAk81jjdzTg7YGDz9KjIwORgg4OetHYc/X/CgDo/DerR2Myi4jBHTcOoHevU/Cd1bahepJbB5LXIDoDgpn+Y968OjYYAzzXQ+Eddl0TVYLmJyoVvTPHoaAPtbSfLhhiUSKYicJjhiCB68mu906YNCi4KjoueM15T4K8QafqHh+0dJV+0hvnU4zyM5Htmu8sGecgs42dflYYP5UAdNRUMchPyvwcDkHvSiZO5waAJSQBk9KKzp7xFmIZv4eFB68+1Q3V6I0GHyVwCfUA88UAa9FZq3f7yXyvmfG4Rg4ya0RwOTzQAtYfiC6u1DwWyhQyj5zyTknt9BW0d24dMd65zxXf40yZYGAkBKkqevB+XP49qAPLvEmokSJEjk4AQqWAx3247Z45rkrq8/es7sNqNuBPIB65I7irHiK5BnuJc5GAVDDockY/Dp/8ArrlWuCeCQyuwU5OACTnP4f1oATVb9iGTJEhcuQO2R/k1WsLjKSJkLuATPXAz+tVNQ3XEgEXzErhCT3Oc/jTILaWKGaRSuQoIJPzIM9frQBtX2nRy26mXAkwQ5BztB6fjis7wlEx1aW3BJTYxP0I4/HOKsWN5JcxDzTlE5bccA5P+fzr0L4GaDFqXi7VruZSYLaAbc9d7khT+AVqAOK8aaLdGWG2ZXWMQ+ax/z75/KvO45GgmhlGA8Thh74INfXfxG0SGWZ/LjGZbfH4LwB718kanEYrq5TI3JIaAOT8WW40/xVqH2V8IJvPhYf3Ww4I/P9Kyby5uLyUPczvM4GAznJx1rofF2JjYzj7xi8pv+Anj9DWBdSySCGOR2cRJsTcc7V/uj0GSfzoAr7c7uentTSCOhqTbwMc0jcZ9aAGEHOc0D3P6UvekAxzQAopwpSF2qVbJOcrj7vPHPegcigB6DnOT+VFKn1ooAVgBnPWoiKlcEdvyNRN97gfrQA0imnGacfpTeeDj9aADHQYpDjijJzxx9DQc9cfrQA5E3uq8/MwXj3rsoYlLYAwi+3auOhBaaMYHLAc/WvWde1Y6/qlvMtt9nEaeQELbuMjBzz+I6DjaBzkA9I+Hqiw8Lx5OzfCXJI9Sa0vHHiddC/Z1EcMqC51d54VXGSA0pz9PlrmtTneztorZS4EkKRKP+A9v1rzr4sa3LcWmmaWSPJtWd0UHjGAo/UE0AecSAA4FMxg05zycKB7ZpvJPA6+9AAAMHnBHb1oGMj69aQZzgil9OKAHE5Yk9TRimjr0pcn0oAUcVZ2hWKghsHGR0P0quOMfqPSpVJzkjAoA6/wb4uudBvIyHLRBgcH+Gvq34MfEK18TstjOYI7wKWRoxjf7Yr4mLdsVueEfE+peFNYi1LSJfLmjOSOzD0oA/RpoMkYY8DH+FQTWJlV/3zBz0bHQenvWB8M/G+n+OvDMGp2MiiUDbcQkjdG/oRXVRPvBwc4YigDkPFGn3tlZ3N3BKZIhhig4I964K18YMZgrZ5yrDsMEc/lXqfizVLew0W8MpVj5ZGwnGc18k6ldub0i2eQBQfmVsE+n+FAH1B4PvoLtw7kK3zMnI5BJ/wD18etdVHcJL8yk8du596+UbXxPquhywPBOCgJDAdcHJyPwJ/KvQfCnxU897e18tmnYFAzgDHPOc/hQB6l4o1I29t5cDBZiyjgZIBPzfpz9cV5rrtzeiSeOOYTNE/lpu6SZySy+4B/nUOm65NqWszpdojcjcQ/KLnOc57YH6V21zpKlg6Rqx2lRv6qCSA2exHSgDwHxPIyyhQ2R5hGCev4+tc8Zt7M+ScjbjI6dR+ma7L4kabNBPM5RgqE4GPT6d/b0rzfzXCsW5Ugnj19B+VAHTW88JKO+wgYY5457Go9TnRZJGDBUZfnVvT1H6Vys11J5gK5B4xg8dO9Qy3ss0ewkk9cnk/SgDsfDiG9Ro1UiM5zgdf8AI7+9fQ3wI0lLTwnLqbKPtGpTsxP/AEzRiiD9GP8AwKvHvhlpobRNRvcqwgiLFSerduvbsa+l/DljFpHh3T7Ndqx29uqk9BkDk/nk0AZXiqRJpzDt3eUm1iOxbHH5AV8geMrdbbxPqtuqgFJTw3H619PQaidXsIb51KC+kaQDvs3/ACA+4UD8q+aPic5/4TvWGXhRcEEfgKAOD1lTJZMvVlO5f8/SubmaRvL813YIgRN5J2r2A9sk11EzqjqWUlQwBGO1Yuv20trqDWz+YybVMDOTxEckY9utAGdgE88CiRMKPWm/MpwM9OaV2JGKAIyAWpCKX8KTP4UAKBzThTfwp6ZzxmgB4GeTRSj6d6KAJXzgqp4zmoHH1BrRktxgYJ3H361BLbMwLDg+9AFEgk4pv1qQqR1zTSPc0ANOTjJo5H0p23HXNBBHXNAD7MD7Xb5xjzVz/wB9CvZNB0SYzWbSx4ecxTR7WDDy5CSrcdOAeOoxzXjlsCJ4WHJ8wYAPPBHavpvwlaefHpsf2pLjyhbqs0QVYpYUyo8sdWCklWY4+agB3iDTHuLrQlhXMpnK4UEngcmvHfjXpT6L47nsJc7UgjdCB1VxuB/Wvpfw8kb/ABA8ORShTGJLgbG75gfAP5GvHv2sbJYPF2hXewpJc6UEdSO8cjKP0I/KgDwxl5+U+4HcU/YQ3OevWljGR0OPWpGJ5yxPOaAIVQEgZ570NGAMg8mplHTnNNYjoS2BQBBtpCOlSvjnBOaREyOc0AEYAGTjmnDk+pyOnrTG4AAJI96TPTGc5oAkbOPekVjjqKYRxgZyaXaMHPXNAHSeD/Fus+EdTN5od7JbSMNsiryrj3HQ17Lo/wC0zq8FvFHqeiWczR/8tIGKbj6kHvXzsvXvUintk0AfQesfE9/GV0bia4S0tnhKiCJjuR+CAQe+RnPpXN6fqNpaQTLJbPPcyucE8YwOh98mvLdPfbIxXOSOCDXuvws8LxXDW76g4nuZ+TG33VByAvPfHNAFAaVqWseVcPCd92GMMSrtAQcbsenFdTYeALyC0hmmlCXzSbggyDGuBjP1wDivaoLLRdNtlht2in1KSIAIMO2O49uD0rStbeCNkMoR50ZIwTwu7A4HfjPfmgDzjwr4UvbeZpZoWEYHlbyv3ueMfqT+Femw2E0CtE7icKNscpPJyMBT+BrVaCGWHymcsN2w+Wcc88HHtVWKA2Fk9ushkMcY8ot94qOACe57flQB5l8SNCe406O7SylkjKkP5bAeWw5DYP3geenNfO00DJOys2MOQR1CnP8ALpX2LJayXmhSfaYjGxUlUbHyAgc8fzr5R8VRw2uvagrbkXdviAGejdD6d6AOVukeEgSDkcAjow56e1RxqS6gOM9AfUVNNG2SQCUOfqPoKhZWA+YKSTn5eMGgD1v4OaksV61lJta2lUK6/wAJGST+gFe5+OfEcdh4aggLqLnUEMY9FQD5yfwO3juwr5f+Gcsr64EQNkkcr0X39q9z8VeGL68VtaupCtrY2wEA9gwLsR6Y/wAaAI5NSgtrSJR0Cq5AxwBwPoK+dPFt2dQ1rU7skMJLlmz27fpxXrt55p0Z7hLdgnlEpk/cGcDPrXh9yhVn5PBOcnv3zQBnXitMcopYuOigk59BWR4oMq6haiZZEcWsYxICD37HpW1I5RVKsyEZIKnBH4isHxP5pv4DO8rubaM7pGLFhzzk9RQBlk8daQ/rTQaPxoADwe1FHrzSCgBR+dPQE5IBIAyT6UwdakQc9eKAJATlu1FKF4PJooAmubkMcJnH8/eqzSsScseevNK6dTmmED1oAQtxg80mQMZNLj0pPrgf1oARn5yT+NN3e9KQCPekIoAnscNeW4YgKZFzn0zX1R4OVrKzt4nhuBLHbJIZLt8yg5JCYydq4IbapwM/N8xOPlOFtk0bk42sG9ehr6Z+FUkUemymQRkHDRsAAevegDfg1NNI8SeGdSum279USFy3RVdTHn/x6uY/bKtPs+qeFnJyWhulyT28xWH/AKFWX8QbtykNlcqysLliCDyoHI/U1R/ao1+31/xF4duLWXzE/ssO2D91mc5GOxBHNAHiiPxycClPP8R5PSm4HqMUAKTyefagB7NtOc/hUZfJGR+FDsTwCMelMcYPByPWgBXILHFOVvmGemMU3aNoO4ZzjHf605OCCeKAEfgkZz703vzT25OTwOlNyQeCRng49KAFDDnAH484pxYbRzzimgE9MGkIJz0oAMjjPSnL82QMZ96aRzzipYRgGgDovBNgl7q22QAwxq0rlugCjNGq+LNQujtgvJYoIifL8pipx25HtWnpJgsvhnrt2D/p91eQWMeOqREFnP47QPxNcvp2mz394lvbJksRk9lBPWgD6l+G7y6T4Ks50ka51OWNd8h5AJXhQfVQR+P0o1vxP4i0hTeXFq0cAKkeaQSD6kds5A9q5rQtTGn6raaHpkjtZWiBd56yMOSfY9a2/i5qD/YLKODbPG8AEsinGwlshWHc89aAPQPhX42k121mjcKnkMu45A2qOSOn416jEyuxXbuC8A5z15/wrwX4G6fPDpV2bGaOK7uJRiYjcIyU+U474I6V7hp9u1hZKk9xJPLEmGmkILSdyxA6cnpQA2WFbeOBZZWIUbFYjjOO4/D8zXx/8QXSbxdqK27qVBOCeMncf8e9fUXxA1qLRNEnZZt10W3xxE5YgcH8j618oX18b6e6WBDLPcS72dVB3MTkKo9c4FAGSchxu3K6fdJOMGoZwNrtuUpnrnpX1j8N/hhpGlaDbT61p0V1q86rLM1wu4xEjIjAPHy9PzqH4r/DLR9Y0C9vNPtI7PUoYiyPCNofGOCOnQdaAPJv2ctOF54mbdGSpjcsSudqjg/TOQM/7VfQnxDBbwpPYwyeS94yWqEDoCQWH/fAauJ/Z10EaXoN7cSLieVxH06AFjx7En9K3dc1X+1dau0iK/YdOPkF89ZT/rDntjhfruoA5vXbIyaXLaWkASIlIiTjnGOn4V826tFGmrX0MRG1d455xg19M6zfpBam+ZwttDGZDJ/fyMAD9K+altpH06W7mDAyoSGbuA2Sf1xQBgSLvEQf5T0P51i+NIzDrzQlWUxQxJhh/s9vbmujt4mlurbdyGdRj0Jbmsf4lwNb+PdciYFdlyVUEH7uBjGe1AHL5AoJAI6UuKTFABmkJ4pQOvT24oA47UAFPU4INJj6U5Rg5GM+9AEiuOR3NFKFx6c0UADk+gPaoWzkmpX74pmC3CjJoAJAoOFB+pPtURFSYLEDHU4+lIFyxGM498UAR7WOAB2zRz6DNSu2dvGMKB69P85ppyv3gQT04oAYAe4Fe+fBxn1TRrgYwkEakuvUEYH9K8G49ec17b+z1qqJ/aukudrS7ZAT3XoRQBP8W4Ht9dsZH3BHt9457g4J/lXnnxO0y707WrdbwMfMtVkQn+6SelemfGjUFa/0sAbpYIGUKee/H8jWj8dfDBu/hloGu2zed/ZsFuzyDq1vcKAP++ZAB/wKgD5ywV5xxTecVJJkHB5pp/OgBuOcAg0mGJ4HNO5pKAFFABJGO9Han5GF2A57+9ADADjI7UFSpwQKcpx2zTwrEbgcA8e+KAIx2pcEgcUu3DYApyc54AyPzoAYVYYwKfGGGcgU8DpUiI8rqiKSzcACgDS0bzbu2m0/zVjinKvlskKVPWup0mw/4R57qVb6OeeRQiBEIBGevNY9no8otS6htyjkgVoW0LxN5lwpIA2HI+5z2oA9Q+Gtk0pF+WSTqzl+Cp6fyOPxqh8UdVF06WtmA0Q+UbRt4Hr6DJ4o8BRTC9ubeSZxbzW+cp0IJ6/0r1LwN8MbPV9Dt9VvpVmkuE3DPO9cnH9PyoA4X4YeJLvR7a3O/AU7ZEP8eOhB7dq7DXPjX/ZgmgtYPPuIiwD7SF54HJ/D2r0uw8DaZA+I7ZFiK7HUjqMZx+Z/SuZ8S/DrTpYLiS1t4459pfBXIJXk/wBKAPn/AFvxrqerea1/5nmvGY2KORuQ9VIx34/KvePhB8LLXSrXS9f1pS+r7BNHF/BDlflGO5APX1+lZeh/B1Be6bPfgzebGslxJ/cOSQoHsMCvdFAVQo6AYFAC02RFkjZHGVYEEeop1ZviLU49H0e4vJWwUXCD1Y9BQB514t15fAnhjUriwlD6rfTm3sYgMhGJOXweOAc8jBKjsao6Pozad4Stbbzgbicl5ud27PJB9fr+IrkfGul6q+uaVDewhZ75tkKEEmFT1Y/oMda76SO9iaOJYBBaW7IyzNzJKRweOwHqexoA4b4qTvpvw5gtriQnVLiVVx/sg4wPXjFcFrmnvp+jm0mKnySIkHGVGAzfqDWp8QdRXUfiHJI+TbacoChvm3SBcgfyP4Vka5DIllcXF3lpZVHfOwHn8zyT9aAOIDmNoGIC7SDx7Gsb4nsZPHusy8kTSiYEnsyKav3QdxBGikyMBtUckkngVmfEXd/wl95vG1wkIYe/lLmgDmuaDQaCaADn0oyeD0pB1NHY0AOU47A8d6UGm9zTl60AWByAfaiiFhjFFACMq45bGaYcK2Uc5B+lLJ/nimEgNnAPsaAGscsSST+NI2M8ZqRipP3ByOAM1GR7HH0oAQnJ5JpD6c8e9Bpc0AGOR1rb8MajNpWrQXFvKYyTsYnpg/8A18Vijp6mnr14PHJNAHeeKJ7maeGe7YtIydc9Vz1r6G+HFsvjb9na60WQq11Fa3Onk/xAqfMh/wDZa+ZFum1Czt2dgWjXy2HfIFe1fsv+Jf7O8Z3GiTE/ZtUjUoeyzR5I/Ndw/AUAfOGCygtkHuKQp3zn8a6L4gaW+h+Ndb051CiG7k2qvI2liw/QiueJUt8ufrQBGQe+eKQingc88/hSKRnJzQAmAD1NJ244pxGcYP5igDGDnFAE9pay3KzGBGbyYjNJjjagxkn8xTQuDwTj2roPBGiDX7zULFJpYZv7Pmnj2MoDugDBXz1U4OQOeh5waw0UMAR1xnBoADgqBtwQME9c+9OigkllCRI8jscBUUsSfYCtnw14futdvUt7VSQzBS2OBk/oK+tvhT8F9K0WGPUNYtRNfqQ0BbpGf72PX60AfI114b1Oyuo4NRs5rOWQblWZSpIrrPBfhlLu88mEM9w/yFz2z2HpXtfx8+Huqyyrrlg5uYYBzEqY8tfX8/Wsn9m3To7zxVctcIN1spfaVxtY8d+/JoA9L8JfCrT7e0WPUYXIKhs5AJPP5f8A1hTPih8NdHuPDMkml2k1vdW6/KYsuHAPRhyemcEfjXrVIQGBDAEHgg96APj3wZGVvzps+9RslVQDtKEAHaD+dfSPwjkguPh1oslqSIvKIA7gq7DFeK/tA6SfD/iuHUNMHkR3S+eWQY2Sfd4x0zgV6h8D9Xe/8LvHPbx28kE+dsX3WWTkOPqc/iDQB6YOlMlQOMYBzxn0p+PbrRQAEZI9qKKKACuatU/t7X3vJk3adp0my1yvEsv8Ug9Qp4B9c+lbepTNFb7I22zSny4zjgMehNcr8RPE1t4B8GNLbCL7Ww8iyhb+OQj7xx2HLMeM9M5IoA8/+JfjWNPiXYQLGs9ro2c7WB3SuuHxj0GF9jurM1/4giaN3sIDNNIcwxSLjYFPLyenbA74ryPSJ7q61SYrKWJ3SSzty3JyW+pP55rS1GZ3RYrE+Sh5kkJwV+p7nt7UALHtkvZ57uQz3LkvI/YFup+p44ql4x1AM8NhGd5UAyAdAT6++KqT6kunrvtwfMYERhuoOfv/AOBNc9KxQPKXBmk55OT7mgAtbc3+pW9uuGDyKnHpn+Vcx4uuYrzxPqk9vxCZ2WPAAG1flHT2Fdhbz/2JoF5qzAefMptbRT13sCGf/gIz+JFedMBuIyfxoAZ+NBp2SVC5+XOcUhxQAmOe9Ljg8479etJnmjtQAuKUU2nCgCWMYdTnjPaimp95frRQBIeDndgUwgnvzT3DYJGKiYHJ6UAIevFKoySCeaaSQeKXFACmNu2D9DSYYLntnGfelzgDH40rfMf4eB2GKAGLkHP5U7O3AHFIPu4PXP4UhyTk8k0AaWj3IjuvLc4jk4z6Hsa6fSry5sL6C6sZngvIWEkUinBVgcgj8a4/T5LRDcfb4nlUwSCHY2CsuPkY+oz1FereGovB1zJ5euzxQSJZo3mWt40qO5IzjnIdV65HLZCqcZIBQ+PITUvEFl4nt0WOPWLZGnjH8FwihXB9M/eFeY5OeteuCwn8WeALiJEL3lmqvtxnaw6n8cV5KFK53DBB5BHSgBNxzSrjOM89qbzz/ShM57ZHNAD1Unp0PX3FOCkH3oGQ3PB7ClXIAyRQA+MshVo2KsOhU4NXNLs5dQv7WztlzNPII0Huaq9lbIJbkgZ+Xnv/APWrsPhPYjUfiBo0DDgzDvjqQP60AfXvwd8DaV4P8JWE9xDCdQnVZHmkUblJHAX8K9Jik3jJRl+tZgkP2sWiIhtYgio6nlWGcqfwH61oqW85l2/IBnd6k/4UAG1biB4541ZWBR0YAgg9iPpXnPhnwHJ4P8ez32lKJdFvgRs/5aWzHJIJ/iTPQ9R0PYn0iIFVAdg0gA3MBjPvillcxxO4VnKqTtXqfYUAOorktM8e6NcREahcR6dOkphkjuJAArA4+96H1OK5/wCI3xP0/RII4NIu7W8uJgwZonEgj446HGeaAMT4stYa/wCI49Ougr29pA0sjpgkEcjP4/1ry34X+NpPDnj+Ke4lX+y7rFnIqjCIpYbWA7bT/M1NY6rLPout6pe5kuZ2Ee9h8wOfXt06V5zInmBlYDJwevfgYz/nrQB98odw3BgynkEelLXh/wACviXDcWkHhnxDcLFewARWc8hwJkHAQkn746e4969woAKR2VEZnICqMknsKR3VASzAAdST0ri/GvjOx03GnxuJ7ub5REjAls54PtxzQBdu/EVo+sukdzELTToXuryZvuwouQST+B/AE9q+XPin40n8Z+IDfOZI7CMNHZ2zsP3cfckdN7YBP0AydtdD8S9eks9Gk0S3ZUlvJ/tt+8Zxv7JD7ooxwep/XzrSbUXUj3l1gQo3G4/eI7fTFAGjpObTSASdsly+9iMZIH3R+Oc1JqNzDBYsJABEGzHEP427k+oz/KmXN4sameclUH+rhGAzY4H0I/lXOXl1LfTmWV1VVHRRwg7YoAgmmeeZ7m5YsT1z1J9Km06ym1bUEt4htYjczfwqB1PsMVWBaV1UBgoIVEHX8fWtHxhd/wDCM6JHo1uQNWu4994+fmhjPRPYt1+lAHM+NdXi1DUEt7A506zBjg/2yfvP+JH5YrmWPzGnFjjHGMVG2c9qADv3pev1pmTjtS5Oe350AONHQ9vwpcHaxx278UznHagB1O5BPrTcHGT0py53dvxoAlj++QDkAZHvRTYiQ/TrRQBaPQj1/nUEyDkqB0qV+WPTioZCOMc+tAERHGetB+Y8DPtQ2OSD36d6bQApPQ0n1zijODmg4xz0oAFb5gSOlLgnk0IOeOfag44AoAT6113w91bw/p+pOPFGnfabVoiiSxnDRknJJGDu4yBjBGeCOo5MEg8cGnOqlNyDHsaAPYPAHi6y06/0q8YCBnAhvm42uOm4j1HU1vfGT4NXVpHea94btzLFEfMvbOMZKKefNT1XHJ9K8Gs5/JYqwzG3DD1r7I/Zx8dr4l8Ox6LfyZ1fSoQscjNk3Fv0B+q8KfwPrQB8aFe4xjtQgxz/ADr6j+MfwBN7cz6z4ChjWeQ+ZPpJYIrMTy0LEgL1JKHj09K+bta0e+0PUZLHWbK4sL1OsNwmxvqM9R7igDPOcg8Z4FKBwKewzgAc00CgBydhXoHwZt3m8Yq0eQ6RZDD+El1AP5muChRpHVEUuzcBQMk177+z5o66QbvUL6Fft9yuLdHYKI1Q79xJOMkgAA/WgD6yjtI0uXmA5Y7sY79z+g/X1qzUVpOtzawzx52Sorrn0IzXnGu+JNVudau7KzuTbwQyNHiJRuIU4J3Hvxn8QKAPTMDOcc1W1KVoNPuZY43kdI2ZUQ4LHHQVzHgfXrm/vLzT76XzZYEDoxTDbckHcRwe3Yd6seO/EcOkaTewQTf8TVrffBEvDHcSoIJGOoP5UAfO3xBufst5HNHC1pDP8h2EuBID8x56nn6VVs9IE11FLoDvqrgbmlnj2CI91IY4J9xmr/ihW1S3gukmZPIdm+ePfvbqSfQ55P1FdL4b8S6Y9hDBIEhk/jkaMhWwevr+dAF7T/DmnJ4dOn6kkbXDSiWVwcAuwz06YHYc1yGufDOZJDLp4d4cgqxHHUZ79q9FlhaJYifKZ2YO5QghcDPU9OPQVesriUx+Y8iPgAkn7q5JOenpQB4HL4P1ESOFhkLZOCOuc9a2fH+teNvDPw2ktrvVJ/s1zKlpH5rBpFK/OVVs5xtUV69Lqtnbr5l9PArglRuYLnOfx7143+0Hq2na14egvIpbmW4sJhFCu0pEu4neSG5Y4VQO1AHpcWtSXnh6w1K+1GS7a8t0uhFH8qgyLuCt2PzE8dTiqh8JatY283iXXgIpnBKxt96LHIZucKMZ+X1xmu/+E3gZPCvhnTor9hcXsUY2BvmFuDzsB7kZI3dccDjr5Z8bfiWutXDeH9Acy2aMVmkTnzmHp/s/z6+lAHlWvG41fV3mG9I7iRjGzHJKZ5Yjr75PWr11Jb6bp0BcFEx+4hx8zj++fr69ulEzQ6JElzqOHv5V+S1HVR2Z27fSuVvLqW6d7q6cu55OAOnt6UAJc3El3J5szYK9STwKrtIPL4UKmehHX602YhotrEqgztTFdL4Z02xt7JvEnicvFots22NAPmupOdqL689aALGiR23hfQz4r1qJZZHOzTLR+DcSY+8R/dXqTXlOp3tzqF9PeXsrTXc7mSWRurE1reL/ABDeeKNXa/vdkSAbLe3Q/JBGOiKP5nv1rAb3FAEWD6VGfvYqU+uOO1QsOTQAZOaOeKQdaXHPv7UALk+tKM8n8KTA9OKAOKAHYPX2pwpoHzYNOUe2aAJBk4opUAzniigBZDycg/lTJDk9OlSyDB4PHvUUnBxmgCM4xSu25iwUKCeijgUhHJHOaQbgQecjnrQAoIGCeR6U3PGKU5z70NgFtpyuTgkY4oAQduOKWgc4pfwoAVTgnj86ccHOzPPtTMjtTgTk444oAaTXQeGPEN54e1NbvTbiSCQcB4yVYe49D/OsQgsTmkKsMgjKng+9AH2B4L+OiXFrGPEFurBk3JLGpSSQdCcEBTk+mK9JuL3wl4x08WesQ2k6GNZWtNSiCvGD0PPT8DXxKfHF7cw6fHewpP8AZIJ4CVIj89ZERQHIHYRryOT6ivRdH8QR+J9KubSwvIN81rHbSWN6/wC9YoXKvvIAP3yMDI4HSgDb8dfCvwzpniUWaW9xZJMDJEbdmZCvtk/1rz7VPBmn2oVrbz7iMybd0hKt9MDvXaDUNTMj2moy3kLR2b2y28m6SPdtwuzAOOccio9KleR9Rk1CSRXcsIlijkZScfKp+XIGaAOu+AXw88O6joOqNq2mH+1WneK3nkYsIl2DBUA43A5JzXReBvgld2uqpeeLNQhuLaGXellb5KTYJ2+YSBx0JUDnoTVPwf4kfR9PSx0vzxeLOGA+yyFZwf4WJUAccZr1jWPFyWVoWi03UzcnHlxvZyYbnnkDA4zzQB04AUAAAAcACuA8TeDrt9U+1aMqSRXLkzxSS7PLZmyXzg7l9uo7ZzgZl78S5kiu99tPbMAfKIs5jsO4D5yVweD2xSx+Podcju9MtmuZZ98c1rNDBIrSRo6s+7gAMFB789MZ6gHceGfD1toMMoidpriYgyysME4zgAdgMn8zWJ8U/Cc/ijRIjprCPVLSTzIW3Y3A/eT05469x261wOpfFvVNTv5k0D7Na2eD9maS2llll/2mG0BRjtyfeuqtfiDdXOht9is3udWZWe3DW0ipKqthmK9Rxnv1oA8KuNC16HUBptzZTLdqpZYmfbwTkksT1OKHtbjTL8Wmo21zDbyIBNG53ZGCCc9OOtenfFeQ+K4bDUNEtdTV7USxmRraRFJK5UHg5GRz+NZVyv2uxVBZSXcqxH7OZ7eQKxyAARgZGKAMbw9PqVnapFY2dzeWsabUZZQoCnpjPTp0rU0qw1TxFqC2UUtwuQ2YbmYRxxgHIzt5atDVoYDpLaZpdjdrJNHIiH7HInuMErx0657V1sHibTdJgvD4e0O5hupRvEktrKxkfI4bjOMH1oAi0D4URRSJc6rdiOfO5orJdoz6F2yT+lcz+0h4Ws7D4X+RomnN5lzqdv58qhpXCjcSzMckKPwAzWl4l+JepaciyJKIIplYRedYyBjL821QNpyvA57c1514l8Savq4kn8S67d2enSxOqwxrKqyk8qvlhB8vTJIzigDp/ib8UX1tLnQPB8jDT4xsutQ3bRIOQUUkfd45bv8ATr4veaza6NG1vovzXBO5rtlzgkdEz/6FVjVNThvke0trm1tdMRWMcSCUlm2nYXPl+uM+lY9ulvAXd721y8MkYfbKfmZCFwNnHJ60AZzSM7F5w0kjdd/U+5NDzkI6Fmk384x39q19F8P3OtSumnslwoVstGJAoOOC7MoULnGSSOKmvfEOgeDx5egeTrmuoxzqEikW1sen7tT/AKw+54470AWbLRrDQ9PGs+NHkit3BNpYKczXTem3+FenJ4rhfGPim+8T36TXirBbQL5dtZRZ8q2T0UevqTyazNY1O91fUJr7U7mW7vJT88shyT6D2HsKolyTk5oAQsKARjPIFIx98/SkzxigAZs+vsKiJ5PFPphPJoAQEcUoPA7UAnA96M5HegBc9aM/X8qAeaXJoAUVImM96jB5qVDQBIuPf8qKUZooAkdAQfXr0qCRcDt+VFFADXR4iFcFSwU44PBGR+mKj/GiigBGzj72QR0pMHHXmiigBPTmlwcdfxoooAUE9yD+FO24AycZ9qKKAHnegznIpQ4Y45GT09KKKAGsSrnDVNYxXN3KwtVLvDG8zYYKVRBlmB9h+NFFAHW+FfEXiO5knh068u5WgiaaX96OI1xkncfft+VdNeeIvEenRWM+pQWTJdxebbvJEjF0454OR1HX1oooAtWOv+IJ44lt7GAeaYipV8bvNDFOC2PmCP8ATHOMitbS/FHieeFtSgHm2k1tNcfK4XbHCyq7YJBABZcAcn0oooAr65qHiBLy2TWZ2j+2Wu6CHcCGRlG1zgnBwwPPPNd38LNDdQsevE6SdPs31Bp4CJHlSX5UY4zxgHjr2PWiigDivEcOqeH9cuNNuyianY3DHdG25XDAMrZ4+XaQQOvPOMVQk1XWLGcTvOqXca4WQH5o+c/LiiigC5L4/v7uGNb+3trhYstH8pAUngkc98Zph+I2oSC3SZLcLGd6jyi+MZwclsmiigDYg+JZ5Zr+a2ckE/ZbYKT05OW54FUtW8fW1yHxd65OT/CJlgU8AYO3JxRRQBkXXjjUJgzWccFo5484bpJgMEY3tnHfpXOXU7XDyXFxNJNKeWdzlj+JoooAqyTlAqdydqg84zzXRJ4fTR9Dj8Q+LGMenSNtghiO+SdsZC8cKMdyRRRQBynirxtqWtWpsISNO0RT8mn2p2xker4+8frxXJM3JGcY9qKKAGElc8+1P2jB+lFFADGUZ4PUZ6UnIzg+1FFACdqiI5JoooAAM9D0oPbn9KKKAHdCeaAO2aKKAHrycZqSMZzzzRRQBKPc/pRRRQB//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest CT scan demonstrates the postoperative change in location of the spleen (arrow) and illustrates the potential risk of splenic injury with blind chest tube or needle placement into the postpneumonectomy space.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard Irwin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24711=[""].join("\n");
var outline_f24_8_24711=null;
var title_f24_8_24712="Treatment of basal cell carcinomas at high risk for recurrence";
var content_f24_8_24712=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of basal cell carcinomas at high risk for recurrence",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/8/24712/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/8/24712/contributors\">",
"     Sumaira Z Aasi, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/8/24712/contributors\">",
"     Timothy K Chartier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/8/24712/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/8/24712/contributors\">",
"     June K Robinson, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/8/24712/contributors\">",
"     Robert S Stern, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/8/24712/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/8/24712/contributors\">",
"     Abena O Ofori, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/8/24712/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 17, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H7225556\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Basal cell carcinoma (BCC) is a common skin cancer that arises from the basal layer of epidermis and its appendages. Treatment of BCC is indicated due to the locally invasive, aggressive, and destructive effects of BCC on skin and surrounding tissues (",
"    <a class=\"graphic graphic_picture graphicRef68274 graphicRef81632 \" href=\"UTD.htm?6/30/6632\">",
"     picture 1A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Tumor characteristics such as size, location, and pathology influence the likelihood for deep tumor invasion and recurrence of BCC after treatment. Lesions at high risk for recurrence may benefit from removal with Mohs micrographic surgery, a procedure that allows for the assessment of all margins of excised tissue. Alternative therapies include conventional surgical excision and radiation therapy. Electrodessication and curettage (ED&amp;C), cryosurgery, and topical 5-fluorouracil or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     imiquimod",
"    </a>",
"    are not recommended for the management of these BCCs (",
"    <a class=\"graphic graphic_table graphicRef70043 graphicRef56173 \" href=\"UTD.htm?38/5/39005\">",
"     table 1A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The treatment of BCCs with clinical or pathological features associated with increased risk for recurrence will be reviewed here. The risk factors, clinical manifestations, and prognosis of BCC, as well as the management of less aggressive BCCs, are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=see_link\">",
"     \"Epidemiology and clinical features of basal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link\">",
"     \"Treatment and prognosis of basal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329758\">",
"    <span class=\"h1\">",
"     FEATURES ASSOCIATED WITH HIGH RISK FOR RECURRENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain clinical and pathological features of BCC are associated with an elevated risk for recurrence after treatment. Recurrent BCC may reappear months to years after initial treatment, leading to local tissue destruction, morbidity, increased risk for metastasis, and the need for retreatment (",
"    <a class=\"graphic graphic_picture graphicRef68274 graphicRef81632 \" href=\"UTD.htm?6/30/6632\">",
"     picture 1A-B",
"    </a>",
"    ). (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H40#H40\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Local recurrence'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H13999098#H13999098\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Metastasis'",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    The following characteristics have been proposed as factors associated with increased risk for tumor recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Location and size",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Greater than or equal to 6 mm in diameter in high-risk areas (eg, central face, nose, lips, eyelids, eyebrows, periorbital skin, chin, mandible, ears, preauricular and postauricular areas, temples, hands, feet)",
"     </li>",
"     <li>",
"      Over 10 mm in diameter in other areas of the head and neck",
"     </li>",
"     <li>",
"      Over 20 mm in diameter in all other areas (excluding hands and feet)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Aggressive pathological features",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Morpheaform, sclerosing, or mixed infiltrative (",
"      <a class=\"graphic graphic_picture graphicRef56527 \" href=\"UTD.htm?0/33/533\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Micronodular",
"     </li>",
"     <li>",
"      Basosquamous (keratinizing)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Recurrent lesions",
"      </strong>",
"     </li>",
"     <li>",
"      <strong>",
"       Lesions in sites of prior radiation therapy",
"      </strong>",
"     </li>",
"     <li>",
"      <strong>",
"       Lesions with poorly defined borders",
"      </strong>",
"     </li>",
"     <li>",
"      <strong>",
"       Lesions in immunocompromised patients &ndash;",
"      </strong>",
"      In one retrospective study of 24 patients with chronic lymphocytic leukemia (CLL) and their matched controls, BCCs were more likely to recur in the patients with CLL [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Perineural invasion",
"      </strong>",
"      &ndash; Perineural invasion (tumor growth in or around nerves) occurs in up to 10 percent of BCCs and has been categorized as another histopathologic feature associated with an elevated risk for lesion recurrence [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/5\">",
"       5",
"      </a>",
"      ]. Perineural invasion is most commonly detected in histologically aggressive BCCs and in recurrent lesions [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The designation of tumor location and size as important determinants for the selection of appropriate treatment is based upon the following factors:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Lesions in high risk areas are more likely to have histologically aggressive subtypes.",
"     </li>",
"     <li>",
"      Many high-risk areas on the face represent embryologic cleavage planes; these sites provide relatively little resistance to tumor invasion.",
"     </li>",
"     <li>",
"      High risk sites often have a high density of hair follicles and sebaceous glands; the physical presence of these structures makes eradication of tumors with electrodesiccation and curettage (ED&amp;C) less reliable.",
"     </li>",
"     <li>",
"      Involvement of critical structures or cosmetically sensitive areas makes complete tumor removal without cosmetic or functional impairment difficult.",
"     </li>",
"     <li>",
"      Large tumors may have extensive subclinical growth, requiring wider excisional margins for disease clearance, and accounting for lower rates of response to destructive therapies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329774\">",
"    <span class=\"h1\">",
"     APPROACH TO TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mohs surgery is an effective treatment for BCC at high risk for recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12329758\">",
"     'Features associated with high risk for recurrence'",
"    </a>",
"    above.) Other options for the treatment of these lesions include surgical excision and radiation therapy. Conventional surgical excision has lower cure rates than Mohs surgery and provides pathological assessment of only a small fraction of the excisional margin, but is faster, less expensive, and more widely available than Mohs surgery. In older patients with high-risk BCC who are not surgical candidates, radiation therapy may be used for management. Disadvantages of radiation therapy include the need for multiple clinic visits, high cost, and potential risk for long term adverse effects. (See",
"    <a class=\"local\" href=\"#H12329838\">",
"     'Radiation therapy'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Electrodesiccation and curettage can achieve high cure rates for primary BCCs at low risk for recurrence, but should",
"    <strong>",
"     not",
"    </strong>",
"    be used for the treatment of most lesions with more aggressive clinical or pathologic features [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/11-13\">",
"     11-13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H12#H12\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Electrodesiccation and curettage (ED&amp;C)'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329803\">",
"    <span class=\"h2\">",
"     Mohs surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mohs micrographic surgery (Mohs surgery) is a specialized surgical technique performed by dermatologic surgeons that optimizes control of the tumor margins, while minimizing the amount of normal tissue that must be resected [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/14\">",
"     14",
"    </a>",
"    ]. In contrast to routine histopathologic processing of a conventional surgical excision specimen, which permits evaluation of less than 1 percent of the excised tissue margins, Mohs surgery allows for histological evaluation of 100 percent of the margins. Mohs surgery is performed in the outpatient setting under local anesthesia [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/15\">",
"     15",
"    </a>",
"    ]. The techniques used to perform Mohs surgery are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/63/17400?source=see_link\">",
"     \"Mohs surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329817\">",
"    <span class=\"h3\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mohs surgery results in five-year cure rates of about 98 to 99 percent for primary BCCs and 95 percent for recurrent BCCs (",
"    <a class=\"graphic graphic_table graphicRef70043 graphicRef56173 \" href=\"UTD.htm?38/5/39005\">",
"     table 1A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mohs surgery was compared to conventional surgical excision in a prospective trial in which 408 primary facial BCCs with features associated with increased risk for recurrence (size &gt;1 cm, location in high-risk facial site, or aggressive histopathologic growth pattern) and 204 recurrent facial BCCs were randomly assigned to Mohs surgery or conventional surgical excision [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. While this trial suggested that the ultimate cure rates were similar with conventional excision and Mohs excision, several design flaws in the study prevented any definitive conclusions on comparative efficacy. In general, more aggressive BCCs appeared to benefit from Mohs surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/16\">",
"     16",
"    </a>",
"    ]. Additionally, the rates of incomplete excision with conventional techniques for primary and recurrent BCCs were 18 and 32 percent, respectively. Mohs surgery improved the cure rate with the initial procedure, and thus, was able to avoid the unnecessary morbidity and disfigurement associated with repeat surgery.",
"   </p>",
"   <p>",
"    The recurrence rate after Mohs surgery appears to be higher for lesions with histologic evidence for perineural invasion. In a series of 3020 patients with BCC (including 78 patients with BCCs with perineural invasion), five-year recurrence rates for patients with or without perineural invasion were 8 and 2 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/6\">",
"     6",
"    </a>",
"    ]. Adjuvant radiation therapy has been suggested for patients with perineural invasion, but it remains unclear whether this provides additional benefit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329824\">",
"    <span class=\"h3\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mohs surgery is indicated for primary BCCs with features that increase risk for recurrence (see",
"    <a class=\"local\" href=\"#H12329758\">",
"     'Features associated with high risk for recurrence'",
"    </a>",
"    above). The tissue-sparing effect of Mohs surgery is also useful in cosmetically sensitive or functionally critical areas [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/15\">",
"     15",
"    </a>",
"    ]. Recurrent BCCs, especially those located in high-risk sites, are candidates for Mohs surgery, particularly because recurrent tumors tend to develop more aggressive histologic subtypes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/17\">",
"     17",
"    </a>",
"    ]. Mohs surgery is",
"    <strong>",
"     not",
"    </strong>",
"    indicated for small primary BCCs located on the trunk or extremities that lack aggressive clinical or pathological features because other procedures have similar efficacy and are less time-consuming and less costly. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link\">",
"     \"Treatment and prognosis of basal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/63/17400?source=see_link&amp;anchor=H1574000248#H1574000248\">",
"     \"Mohs surgery\", section on 'Indications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Criteria for the appropriate use of Mohs surgery have been developed by a panel of clinicians from the American Academy of Dermatology, the American College of Mohs Surgery, the American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329831\">",
"    <span class=\"h3\">",
"     Advantages and disadvantages",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary benefit of Mohs surgery is the precision with which tumors can be excised, resulting in excellent long-term cure rates for high-risk tumors (",
"    <a class=\"graphic graphic_table graphicRef70043 graphicRef56173 \" href=\"UTD.htm?38/5/39005\">",
"     table 1A-B",
"    </a>",
"    ). Another major advantage is the ability of Mohs surgery to spare normal tissue, thus allowing preservation of vital structures, simplifying repair (and hence, the cost of the repair) of the surgical wound, and improving the cosmetic results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/63/17400?source=see_link&amp;anchor=H9483386#H9483386\">",
"     \"Mohs surgery\", section on 'Advantages and disadvantages'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A typical Mohs surgery procedure lasts two to four hours and more complicated cases can take longer. Reconstruction following Mohs surgery can add another hour to the procedure. A significant amount of the total time is spent with the histologic preparation and analysis; during this time, patients are temporarily bandaged and may await the final results in a waiting room. A small minority of patients may find it difficult to tolerate a procedure of this length.",
"   </p>",
"   <p>",
"    Mohs surgery is more expensive than standard surgical excision. Whether Mohs surgery is cost-effective is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/19\">",
"     19",
"    </a>",
"    ]. One study in the United States concluded that Mohs surgery was cost-effective because of the much lower rates of local disease recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/20\">",
"     20",
"    </a>",
"    ]. In contrast, a subsequent analysis in the Netherlands concluded that Mohs surgery was not cost effective, based upon the low rates of recurrence seen in a randomized trial [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/21\">",
"     21",
"    </a>",
"    ]. However, these results are difficult to interpret since the study was limited to a follow-up period of 30 months for primary BCCs and 18 months for recurrent lesions. In addition, cost determination and accounting for surgery differs considerably among countries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1031894\">",
"    <span class=\"h2\">",
"     Surgical excision",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conventional surgical excision with postoperative margin assessment is commonly used for BCCs with a low likelihood for recurrence and is effective for the treatment of select higher risk lesions. &nbsp;",
"   </p>",
"   <p>",
"    Although cure rates for lesions with a low-risk of recurrence can exceed 95 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/22-25\">",
"     22-25",
"    </a>",
"    ], the efficacy of conventional excision is less consistent in the management of BCCs with clinical or pathological features associated with a high risk for recurrence (see",
"    <a class=\"local\" href=\"#H12329758\">",
"     'Features associated with high risk for recurrence'",
"    </a>",
"    above). Examples of reported cure rates for conventional excision in tumors that are large, located in high-sites, or recurrent include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Primary BCCs &gt;15, &gt;20, or &gt;30 mm in diameter; 88, 83, and 77 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/7,23\">",
"       7,23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Tumors located on higher risk areas of the face and head (ie, lips, nose, paranasal or periocular region, ears, scalp); 57 to 82 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/7,22,23,25\">",
"       7,22,23,25",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Recurrent tumors; 83 to 92 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/7,9\">",
"       7,9",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, when Mohs surgery is available, it is our preferred treatment for BCCs with features associated with a high risk for recurrence. However, other factors such as the availability or cost of Mohs surgery, practicality of Mohs surgery, patient tolerance for the Mohs procedure, and patient preference may lead to the selection of conventional surgical excision over Mohs surgery.",
"   </p>",
"   <p>",
"    Postoperative margin assessment should be performed on all excised tissue specimens. Conventional surgical excision is discussed in greater detail separately. (See",
"    <a class=\"local\" href=\"#H12329774\">",
"     'Approach to treatment'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H16554092#H16554092\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Surgical excision'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20395114\">",
"    <span class=\"h2\">",
"     Staged excision with circumferential margin assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Staged excision with circumferential margin assessment, sometimes referred to as &ldquo;slow Mohs,&rdquo; involves complete assessment of tissue margins utilizing formalin-fixed tissue, rather than the rapidly processed frozen sections used in standard Mohs surgery. This procedure is performed without the equipment and technician expertise required for frozen tissue processing. Although staged excision with circumferential margin assessment was associated with a 97 percent five-year clinical cure rate in a series of 1090 BCCs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/26\">",
"     26",
"    </a>",
"    ] and a 99 percent five-year clinical cure rate in a separate series of 287 periocular BCCs [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/27\">",
"     27",
"    </a>",
"    ], the time required to attain pathology results from formalin-fixed tissue specimens delays wound closure for days and leads to the need for repeat office visits. Thus, the procedure is less desirable than Mohs surgery for some patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329838\">",
"    <span class=\"h2\">",
"     Radiation therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation therapy (RT) is an important treatment option for BCCs. RT is usually administered in a fractionated schedule that requires four or more treatments. Fractionation limits treatment-related side effects in normal tissues, but the frequent visits are problematic for many patients.",
"   </p>",
"   <p>",
"    The major advantages of RT are the relative sparing of cosmetically and functionally important structures, its noninvasive and painless nature, and its utility for many patients who are not candidates for surgical intervention or for whom it is difficult to attain histologic clearance. In addition, the relative sparing of normal healthy tissue can offer superior cosmetic results for tumors located on or around the lips, nose, and eyelids. However, these favorable cosmetic results may deteriorate with time [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/28-30\">",
"     28-30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unlike surgical excision or Mohs surgery, RT does not provide histologic control of the tumor margin. RT is considerably more expensive than other treatments and is associated with a number of short-term and long-term side effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H4#H4\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Approach to treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329845\">",
"    <span class=\"h3\">",
"     Results",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most large series report overall five-year cure rates of 91 to 93 percent for previously untreated BCCs, with rates as high as 96 percent for smaller BCCs at low risk for recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/31-33\">",
"     31-33",
"    </a>",
"    ]. For patients with recurrent BCCs, the reported cure rates are somewhat lower, generally between 86 and 91 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/31-34\">",
"     31-34",
"    </a>",
"    ]. BCCs that recur following RT may behave more aggressively than those recurring after surgical procedures, with higher rates of second recurrence and distant metastasis [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although early reports suggested a poor outcome with RT alone for larger or more deeply invasive tumors (ie, those involving cartilage, bone,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    muscle), series using modern RT techniques suggest excellent control rates with good cosmesis and functional outcomes. In several reports, three to five-year locoregional control rates were 86 to 91 percent for large",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    locally advanced BCCs with RT [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/28,31,33,36-38\">",
"     28,31,33,36-38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329852\">",
"    <span class=\"h3\">",
"     Short-term effects of RT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Short-term cutaneous side effects of RT include erythema and edema, scaling, vesicles, bullae, erosions, ulceration, pain, and occasionally infection. Healing generally occurs within three to four weeks following the final treatment, but symptoms may persist for months in severe cases.",
"   </p>",
"   <p>",
"    Other less common short-term side effects include a &ldquo;comedo reaction&rdquo;, which is a benign condition characterized by the appearance of large, open comedones at the periphery of the treated area in certain sites (nose, cheeks, ears), the shedding of nails, and, even more rarely, gangrene.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329859\">",
"    <span class=\"h3\">",
"     Long-term complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delayed effects of radiation within the treatment field include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Permanent alopecia usually occurs within the treatment field. Patients should be advised of this prior to treatment, and pretreatment counseling is essential.",
"     </li>",
"     <li>",
"      Chronic radiation dermatitis generally appears months to years following therapy and is characterized by permanently mottled areas of hypopigmentation and hyperpigmentation, a dry, hyperkeratotic, atrophic, shiny epidermis, telangiectasias, and dermal fibrosis.",
"     </li>",
"     <li>",
"      Severe dermal and subcutaneous fibrosis is an uncommon consequence of RT for cutaneous malignancies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/46/17129?source=see_link\">",
"       \"Clinical manifestations and treatment of radiation-induced fibrosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Delayed radiation necrosis may develop months to years following RT, and is marked by spontaneous breakdown of the skin within the treatment field, with erythema, erosions or ulcerations, crusting, and discomfort. Radiation necrosis is usually precipitated by trauma, infection, or exposure to cold or sunshine, and is secondary to poor vascularity and atrophy of the previously irradiated area.",
"     </li>",
"     <li>",
"      Irradiation of cartilaginous and bony structures such as the ear and nose may result in chondroradionecrosis or osteoradionecrosis, although this is uncommon using modern techniques [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Radiation-induced cutaneous malignancies (both BCCs and squamous cell cancers) most often develop within irradiated sites that are also exposed to solar radiation (eg, the head, neck, and upper extremities) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/40,41\">",
"       40,41",
"      </a>",
"      ]. These secondary cancers can occur from 5 to 65 years following RT and are thought to behave aggressively, with a higher likelihood of subclinical extension than other skin cancers.",
"     </li>",
"     <li>",
"      Risk factors for secondary cancers after RT include higher radiation doses, larger radiation fields, sun-exposed sites, fair skin, and early age of radiation exposure. Increased fractionation with a smaller dose per fraction reduces this risk. Although some investigators think that the risk of radiation-induced cutaneous malignancy is much smaller using modern treatment protocols, RT continues to be avoided in young people, and in those with genetic susceptibility to radiation-induced malignancies (",
"      <a class=\"graphic graphic_table graphicRef57649 \" href=\"UTD.htm?4/20/4427\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/42,43\">",
"       42,43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other secondary malignancies are rare, but fibrosarcomas and melanomas have been reported.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Incidental radiation exposure to other tissues can also result in delayed complications, such as cataracts, infertility, and thyroid cancer. These are uncommon events that should be avoided with proper shielding during therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329866\">",
"    <span class=\"h3\">",
"     Patient selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;RT is particularly useful for patients who are unable to tolerate outpatient surgery and for elderly patients with large tumors and a limited life expectancy, in whom long-term adverse effects are of lesser concern. RT is generally avoided in patients younger than 60 years of age because of the late effects of radiation.",
"   </p>",
"   <p>",
"    RT is generally avoided for tumors located on the trunk and extremities because of their greater tendency to develop delayed skin changes [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/39\">",
"     39",
"    </a>",
"    ]. These areas are subject to greater trauma and tension than skin on the head and neck and are more prone to break down and ulcerate as a result of the atrophy and poor vascularity of irradiated tissue.",
"   </p>",
"   <p>",
"    RT should be considered a treatment of last resort for previously irradiated recurrent BCCs because of the risk of cumulative radiation toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/44\">",
"     44",
"    </a>",
"    ]. RT should never be used in patients with basal cell nevus syndrome (BCNS), where RT may induce numerous skin cancers that are difficult to manage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/5/44121?source=see_link&amp;anchor=H8#H8\">",
"     \"Nevoid basal cell carcinoma syndrome\", section on 'Risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1032209\">",
"    <span class=\"h2\">",
"     Other therapies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Successful treatment of BCCs with features associated with a high risk for recurrence with photodynamic therapy has been reported in uncontrolled studies [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/45-48\">",
"     45-48",
"    </a>",
"    ]. In addition,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     imiquimod",
"    </a>",
"    has been reported to be effective in small numbers of such lesions, including the successful treatment of 15 patients with primary nodular BCCs of the eyelid in a randomized trial that compared imiquimod to radiation therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/49-54\">",
"     49-54",
"    </a>",
"    ]. However, cure rates associated with these interventions for some lesions with high-risk features appear to be much lower than for Mohs surgery, and we cannot recommend the routine use of these therapies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H21#H21\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Photodynamic therapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H20#H20\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Imiquimod'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329873\">",
"    <span class=\"h1\">",
"     METASTATIC DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the effectiveness of surgery for the treatment of BCC, experience with systemic chemotherapy for these tumors is limited.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/59/18357?source=see_link\">",
"     Vismodegib",
"    </a>",
"    (an orally administered inhibitor of the hedgehog pathway) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/55\">",
"     55",
"    </a>",
"    ], platinum-based regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/56\">",
"     56",
"    </a>",
"    ], and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"     cetuximab",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24712/abstract/57\">",
"     57",
"    </a>",
"    ] have been utilized for the treatment of metastatic disease. Metastatic BCC and systemic therapy for BCC are discussed in greater detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H13999098#H13999098\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Metastasis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/45/15063?source=see_link&amp;anchor=H19784616#H19784616\">",
"     \"Evaluation for locoregional and distant metastases in cutaneous squamous cell and basal cell carcinoma\", section on 'Basal cell carcinoma'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/61/14293?source=see_link\">",
"     \"Systemic treatment of advanced cutaneous squamous and basal cell carcinomas\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12329880\">",
"    <span class=\"h1\">",
"     PROGNOSIS AND FOLLOW-UP",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prognosis and post-therapeutic management of patients with BCC is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H36#H36\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Prognosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=see_link&amp;anchor=H39#H39\">",
"     \"Treatment and prognosis of basal cell carcinoma\", section on 'Follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H260624\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatments that provide histologic confirmation of tumor removal are preferred in the management of BCCs with clinical or pathological features associated with an elevated risk for recurrence. Electrodesiccation and curettage (ED&amp;C), cryosurgery, and topical therapy are not recommended for the treatment of these lesions. (See",
"      <a class=\"local\" href=\"#H12329758\">",
"       'Features associated with high risk for recurrence'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12329774\">",
"       'Approach to treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Mohs micrographic surgery (Mohs surgery) is a procedure that utilizes frozen tissue sections to assess 100 percent of excised tissue margins. Advantages of Mohs surgery include rapid assurance of complete tumor removal and a tissue-sparing effect. Disadvantages include the time, cost, and expertise required to perform this procedure. (See",
"      <a class=\"local\" href=\"#H12329803\">",
"       'Mohs surgery'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/63/17400?source=see_link\">",
"       \"Mohs surgery\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Conventional surgical excision is commonly used for the treatment of low-risk BCC and can be used for the management of some high-risk lesions. Less than 1 percent of the tissue margin is examined after conventional surgical excision, contributing to cure rates that are lower compared to Mohs surgery. (See",
"      <a class=\"local\" href=\"#H1031894\">",
"       'Surgical excision'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with BCCs at high risk for recurrence, we recommend excision using either Mohs surgery or a conventional surgical approach to completely resect the tumor (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Mohs surgery may be particularly advantageous in cosmetically and functionally critical areas. (See",
"      <a class=\"local\" href=\"#H12329803\">",
"       'Mohs surgery'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H1031894\">",
"       'Surgical excision'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Radiation therapy is effective for the treatment of BCCs at high risk for recurrence; however, cure rates are lower than Mohs surgery and there is the potential for long-term local adverse effects. For older patients with high-risk lesions who are not candidates for surgical excision, radiation therapy is a reasonable alternative. (See",
"      <a class=\"local\" href=\"#H12329838\">",
"       'Radiation therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/1\">",
"      Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 2002; 138:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/2\">",
"      Walling HW, Fosko SW, Geraminejad PA, et al. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev 2004; 23:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/3\">",
"      Miller SJ, Alam M, Andersen J, et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2010; 8:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/4\">",
"      Mehrany K, Weenig RH, Pittelkow MR, et al. High recurrence rates of Basal cell carcinoma after mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol 2004; 140:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/5\">",
"      Brown CI, Perry AE. Incidence of perineural invasion in histologically aggressive types of basal cell carcinoma. Am J Dermatopathol 2000; 22:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/6\">",
"      Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia III. Perineural invasion. J Am Acad Dermatol 2005; 53:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/7\">",
"      Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989; 15:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/8\">",
"      Leibovitch I, Huilgol SC, Selva D, et al. Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 2005; 53:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/9\">",
"      Smeets NW, Krekels GA, Ostertag JU, et al. Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004; 364:1766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/10\">",
"      Mosterd K, Krekels GA, Nieman FH, et al. Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. Lancet Oncol 2008; 9:1149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/11\">",
"      Salasche SJ. Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma. J Am Acad Dermatol 1983; 8:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/12\">",
"      Suhge d'Aubermont PC, Bennett RG. Failure of curettage and electrodesiccation for removal of basal cell carcinoma. Arch Dermatol 1984; 120:1456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/13\">",
"      Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. J Dermatol Surg Oncol 1991; 17:720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/14\">",
"      Muller FM, Dawe RS, Moseley H, Fleming CJ. Randomized comparison of Mohs micrographic surgery and surgical excision for small nodular basal cell carcinoma: tissue-sparing outcome. Dermatol Surg 2009; 35:1349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/15\">",
"      Drake LA, Dinehart SM, Goltz RW, et al. Guidelines of care for Mohs micrographic surgery. American Academy of Dermatology. J Am Acad Dermatol 1995; 33:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/16\">",
"      Feldman S, Pearce DJ, Williford PM. Surgical decision making for basal-cell carcinoma of the face. Lancet Oncol 2008; 9:1119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/17\">",
"      Boulinguez S, Grison-Tabone C, Lamant L, et al. Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions. Br J Dermatol 2004; 151:623.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/18\">",
"      Ad Hoc Task Force, Connolly SM, Baker DR, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol 2012; 67:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/19\">",
"      Chren MM. Determining the value of surgical therapies for basal cell carcinoma. Arch Dermatol 2006; 142:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/20\">",
"      Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol 1998; 39:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/21\">",
"      Essers BA, Dirksen CD, Nieman FH, et al. Cost-effectiveness of Mohs Micrographic Surgery vs Surgical Excision for Basal Cell Carcinoma of the Face. Arch Dermatol 2006; 142:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/22\">",
"      Dubin N, Kopf AW. Multivariate risk score for recurrence of cutaneous basal cell carcinomas. Arch Dermatol 1983; 119:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/23\">",
"      Silverman MK, Kopf AW, Bart RS, et al. Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision. J Dermatol Surg Oncol 1992; 18:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/24\">",
"      Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987; 123:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/25\">",
"      Bart RS, Schrager D, Kopf AW, et al. Scalpel excision of basal cell carcinomas. Arch Dermatol 1978; 114:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/26\">",
"      Lawrence CM, Haniffa M, Dahl MG. Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data. Br J Dermatol 2009; 160:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/27\">",
"      Morris DS, Elzaridi E, Clarke L, et al. Periocular basal cell carcinoma: 5-year outcome following Slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure. Br J Ophthalmol 2009; 93:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/28\">",
"      Lovett RD, Perez CA, Shapiro SJ, Garcia DM. External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 1990; 19:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/29\">",
"      Petit JY, Avril MF, Margulis A, et al. Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face. Plast Reconstr Surg 2000; 105:2544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/30\">",
"      Avril MF, Auperin A, Margulis A, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 1997; 76:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/31\">",
"      Silverman MK, Kopf AW, Gladstein AH, et al. Recurrence rates of treated basal cell carcinomas. Part 4: X-ray therapy. J Dermatol Surg Oncol 1992; 18:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/32\">",
"      Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989; 15:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/33\">",
"      Locke J, Karimpour S, Young G, et al. Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys 2001; 51:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/34\">",
"      Wilder RB, Shimm DS, Kittelson JM, et al. Recurrent basal cell carcinoma treated with radiation therapy. Arch Dermatol 1991; 127:1668.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/35\">",
"      Fleming ID, Amonette R, Monaghan T, Fleming MD. Principles of management of basal and squamous cell carcinoma of the skin. Cancer 1995; 75:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/36\">",
"      Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys 2004; 60:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/37\">",
"      Caccialanza M, Piccinno R, Beretta M, Gnecchi L. Results and side effects of dermatologic radiotherapy: a retrospective study of irradiated cutaneous epithelial neoplasms. J Am Acad Dermatol 1999; 41:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/38\">",
"      Griep C, Davelaar J, Scholten AN, et al. Electron beam therapy is not inferior to superficial x-ray therapy in the treatment of skin carcinoma. Int J Radiat Oncol Biol Phys 1995; 32:1347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/39\">",
"      Petrovich Z, Kuisk H, Langholz B, et al. Treatment of carcinoma of the skin with bone and/or cartilage involvement. Am J Clin Oncol 1988; 11:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/40\">",
"      Lichter MD, Karagas MR, Mott LA, et al. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. Arch Dermatol 2000; 136:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/41\">",
"      Karagas MR, McDonald JA, Greenberg ER, et al. Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group. J Natl Cancer Inst 1996; 88:1848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/42\">",
"      Goldschmidt H, Breneman JC, Breneman DL. Ionizing radiation therapy in dermatology. J Am Acad Dermatol 1994; 30:157.",
"     </a>",
"    </li>",
"    <li>",
"     Malkinson FD. Radiobiology of the skin. In: Fitzpatrick's Dermatology in General Medicine, 5th ed, Freedberg IM, et al (Eds), McGraw-Hill, New York 1999. Vol 1, p.1514.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/44\">",
"      Chao CK, Gerber RM, Perez CA. Reirradiation of recurrent skin cancer of the face. A successful salvage modality. Cancer 1995; 75:2351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/45\">",
"      Vinciullo C, Elliott T, Francis D, et al. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol 2005; 152:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/46\">",
"      Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol 2003; 149:1242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/47\">",
"      Love WE, Bernhard JD, Bordeaux JS. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review. Arch Dermatol 2009; 145:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/48\">",
"      Farhadi M, Kamrava SK, Behzadi AH, et al. The efficacy of photodynamic therapy in treatment of recurrent squamous cell and basal cell carcinoma. J Drugs Dermatol 2010; 9:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/49\">",
"      Garcia-Martin E, Gil-Arribas LM, Idoipe M, et al. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma. Br J Ophthalmol 2011; 95:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/50\">",
"      Carneiro RC, de Macedo EM, Matayoshi S. Imiquimod 5% cream for the treatment of periocular Basal cell carcinoma. Ophthal Plast Reconstr Surg 2010; 26:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/51\">",
"      Blasi MA, Giammaria D, Balestrazzi E. Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma. Am J Ophthalmol 2005; 140:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/52\">",
"      Amini S, Viera MH, Valins W, Berman B. Nonsurgical innovations in the treatment of nonmelanoma skin cancer. J Clin Aesthet Dermatol 2010; 3:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/53\">",
"      Lepp&auml;l&auml; J, Kaarniranta K, Uusitalo H, Kontkanen M. Imiquimod in the treatment of eyelid basal cell carcinoma. Acta Ophthalmol Scand 2007; 85:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/54\">",
"      Choontanom R, Thanos S, Busse H, Stupp T. Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study. Graefes Arch Clin Exp Ophthalmol 2007; 245:1217.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.accessdata.fda.gov/drugsatfda_docs/label/2012/203388lbl.pdf (Accessed on January 31, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/56\">",
"      Moeholt K, Aagaard H, Pfeiffer P, Hansen O. Platinum-based cytotoxic therapy in basal cell carcinoma--a review of the literature. Acta Oncol 1996; 35:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24712/abstract/57\">",
"      Caron J, Dereure O, Kerob D, et al. Metastatic basal cell carcinoma: report of two cases treated with cetuximab. Br J Dermatol 2009; 161:702.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13724 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-5368725AE9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24712=[""].join("\n");
var outline_f24_8_24712=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H260624\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7225556\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12329758\">",
"      FEATURES ASSOCIATED WITH HIGH RISK FOR RECURRENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12329774\">",
"      APPROACH TO TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12329803\">",
"      Mohs surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12329817\">",
"      - Efficacy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12329824\">",
"      - Indications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12329831\">",
"      - Advantages and disadvantages",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1031894\">",
"      Surgical excision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20395114\">",
"      Staged excision with circumferential margin assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12329838\">",
"      Radiation therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12329845\">",
"      - Results",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12329852\">",
"      - Short-term effects of RT",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12329859\">",
"      - Long-term complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12329866\">",
"      - Patient selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1032209\">",
"      Other therapies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12329873\">",
"      METASTATIC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12329880\">",
"      PROGNOSIS AND FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H260624\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13724\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13724|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/13/43217\" title=\"picture 1A\">",
"      Large basal cell carcinoma on nose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/28/44483\" title=\"picture 1B\">",
"      Large basal cell carcinoma on ear",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/33/533\" title=\"picture 2\">",
"      Infiltrative basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13724|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/27/31164\" title=\"table 1A\">",
"      Treatment summary I BCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/37/31324\" title=\"table 1B\">",
"      Treatment summary II BCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?4/20/4427\" title=\"table 2\">",
"      Radiation sensitivity syndromes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/46/17129?source=related_link\">",
"      Clinical manifestations and treatment of radiation-induced fibrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/39/14970?source=related_link\">",
"      Epidemiology and clinical features of basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/45/15063?source=related_link\">",
"      Evaluation for locoregional and distant metastases in cutaneous squamous cell and basal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/63/17400?source=related_link\">",
"      Mohs surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/5/44121?source=related_link\">",
"      Nevoid basal cell carcinoma syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/61/14293?source=related_link\">",
"      Systemic treatment of advanced cutaneous squamous and basal cell carcinomas",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13690?source=related_link\">",
"      Treatment and prognosis of basal cell carcinoma",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_8_24713="Postpartum and postabortion contraception";
var content_f24_8_24713=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Postpartum and postabortion contraception",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/8/24713/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/8/24713/contributors\">",
"     Andrew M Kaunitz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/8/24713/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/8/24713/contributors\">",
"     Mimi Zieman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?24/8/24713/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?24/8/24713/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?24/8/24713/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The method of contraception initiated after a birth, miscarriage, or pregnancy termination depends upon patient preferences and medical history, anatomic and hormonal factors, and whether or not the woman is breastfeeding.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     POSTPARTUM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimally, contraceptive plans should be initially reviewed as part of prenatal care, revisited before the woman leaves the hospital and implemented by three weeks postpartum. Many, if not most, women resume sexual relations by six weeks postpartum, which is the most common time for a postpartum office visit [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/1\">",
"     1",
"    </a>",
"    ]. In women who are not breastfeeding, studies using urinary pregnanediol levels to measure ovulation reported the mean day of first ovulation ranged from 45 to 94 days postpartum (earliest ovulation reported 25 days after delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/2\">",
"     2",
"    </a>",
"    ]) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/3\">",
"     3",
"    </a>",
"    ]. As many as 60 percent of these ovulations were potentially fertile. Since the first ovulation often occurred before the first menses, return of menses cannot be used as a marker for need to initiate contraception.",
"   </p>",
"   <p>",
"    In a 2004-2006 survey of 43,887 postpartum sexually active women in the United States, 88 percent reported they were using at least one method of contraception [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/4\">",
"     4",
"    </a>",
"    ]. Of these women, 61.7 percent reported using a method defined as highly effective, 20.0 percent used a method defined as moderately effective, and 6.4 percent used less effective methods.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Sterilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sterilization can be performed after a vaginal or cesarean delivery, postabortion, or as an interval procedure unrelated to pregnancy. Ideally, postpartum procedures are performed immediately after delivery or within 24 hours [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/5-9\">",
"     5-9",
"    </a>",
"    ]. Delaying the procedure for more than seven days after birth increases the risk of infection and the difficulty due to uterine involution. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15018?source=see_link\">",
"     \"Surgical sterilization of women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the United States, the modified Pomeroy technique is the most common sterilization procedure performed following childbirth (cesarean or vaginal birth). In the United States Collaborative Review of Sterilization (CREST) study, it was highly effective, with a 10-year failure rate of less than 1 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The Filshie clip is a small titanium clip with soft Silastic&reg; lining approved for use postpartum, as well as for interval sterilizations, but appears to be less effective than the modified Pomeroy procedure. A systematic review of studies of postpartum sterilization with the titanium clip evaluated 10 observational trials and 3 reports from a single randomized trial [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/11\">",
"     11",
"    </a>",
"    ]. Based on data from the only randomized trial identified, the risk of pregnancy was significantly increased at 24 months in women who underwent clip sterilization postpartum (cumulative rate 1.7 compared with 0.4 in controls who underwent partial salpingectomy by the modified Pomeroy technique [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/12\">",
"     12",
"    </a>",
"    ]). The authors recommended against routine use of the titanium clip during the postpartum period.",
"   </p>",
"   <p>",
"    Few data address the efficacy of tubal sterilization following pregnancy termination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Barrier methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diaphragm and cervical cap come in different sizes and need to be fitted. Fitting cannot be performed properly until pregnancy-related cervical changes have regressed, which takes about six weeks after a delivery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/38/20070?source=see_link\">",
"     \"Barrier contraception: Diaphragm\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other barrier methods (male condom, female condom, contraceptive sponge) can be used as soon as coitus is resumed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/62/30696?source=see_link\">",
"     \"Male condoms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5334?source=see_link\">",
"     \"Female condoms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39306?source=see_link&amp;anchor=H34#H34\">",
"     \"Overview of contraception\", section on 'Sponge'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Progestin only pills, injections, implants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postpartum women are at increased risk of venous thrombosis compared to women remote from pregnancy. Progestin contraceptives have little effect on coagulation factors, blood pressure, or lipid levels. Large epidemiologic studies have not identified an increased risk of stroke, myocardial infarction, or venous thromboembolism with use of progestin contraceptives. Thus, these drugs represent an appropriate contraceptive choice for",
"    <span class=\"nowrap\">",
"     postpartum/postabortal",
"    </span>",
"    women who have no contraindications to their use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/52/9031?source=see_link\">",
"     \"Progestin-only pills (minipills) for contraception\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34522?source=see_link\">",
"     \"Depot medroxyprogesterone acetate for contraception\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/27/3512?source=see_link\">",
"     \"Etonogestrel contraceptive implant\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Progestin-only pills, depot",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    (DMPA) injections, and progestin implants (eg, Implanon) can be initiated immediately postpartum if this is the best option for contraception (",
"    <a class=\"graphic graphic_table graphicRef82680 \" href=\"UTD.htm?20/51/21311\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/13,14\">",
"     13,14",
"    </a>",
"    ], and should be initiated within three weeks to maximize effectiveness since ovulation can occur as early as 25 days after birth [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/2,15-18\">",
"     2,15-18",
"    </a>",
"    ]. (Of note, the manufacturer of Implanon recommends that it be inserted three to four weeks postpartum and within five days of an abortion. Labeling for DMPA and progestin-only pills suggests starting six weeks postpartum in breastfeeding women).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Intrauterine contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women with no contraindications to IUC use, post-placental (within 10 minutes of placental delivery) IUC insertion is convenient and ensures that the woman is not pregnant. In particular, insertion at this time may benefit patients who are unable or unwilling to return for later insertion, and who do not have other options for effective contraception. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32058?source=see_link&amp;anchor=H23833369#H23833369\">",
"     \"Overview of intrauterine contraception\", section on 'Contraindications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The TCu380A is the best studied type of intrauterine contraception (IUC) for post-placental insertion. There are two doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    -releasing IUCs (52 mg released initially at 20",
"    <span class=\"nowrap\">",
"     mcg/day",
"    </span>",
"    [LNg20] and 13.5 mg released initially at 14",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    [LNg14]). There is less information on use of the levonorgestrel-releasing IUC immediately postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/19-22\">",
"     19-22",
"    </a>",
"    ], and there are concerns that its drug release sleeve may be damaged by modifications in insertion technique that are needed for the post-placental insertion. Nevertheless, the World Health Organization (WHO) and Centers for Disease Control (CDC) support use of the levonorgestrel-releasing IUC in postabortal women and postpartum non-breastfeeding women (",
"    <a class=\"graphic graphic_table graphicRef82680 \" href=\"UTD.htm?20/51/21311\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32058?source=see_link\">",
"     \"Overview of intrauterine contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An IUC may be placed after vaginal or abdominal delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/23-29\">",
"     23-29",
"    </a>",
"    ]. The major drawback is an increased expulsion rate [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/30-32\">",
"     30-32",
"    </a>",
"    ], which in some studies is lower with insertion after cesarean delivery than after vaginal birth [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/26,33,34\">",
"     26,33,34",
"    </a>",
"    ], and when the insertion is performed by more experienced operators [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/30\">",
"     30",
"    </a>",
"    ]. In the only randomized trial of immediate (within 10 minutes of placental delivery) versus delayed (interval) insertion (six to eight weeks postpartum) of the LNg20 after vaginal delivery, expulsion rates were 24 and 4.4 percent, respectively (P = 0.008) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/20\">",
"     20",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Several studies, but not all, have reported that immediate IUC insertion within minutes of placental delivery results in a significantly lower expulsion rate than insertion hours after placental delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/34\">",
"     34",
"    </a>",
"    ]. As an example, a pooled analysis of data from nine sites worldwide found the cumulative expulsion rate over six months was 9.5 percent when insertion was performed within 10 minutes of placental delivery versus 29 to 37 percent when insertion was performed 2 to 72 hours after placental delivery [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/35\">",
"     35",
"    </a>",
"    ]. Others have reported similar findings, but actual expulsion rates vary among studies due to factors such as length of follow-up, patient age, parity, and provider experience [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There is consistent evidence that the lowest IUC expulsion rates are after interval insertion (ie, at least four weeks after delivery) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/34\">",
"     34",
"    </a>",
"    ]. In one study, for example, expulsion rates within 12 months of immediate, early postpartum, and interval insertion were 14.3, 18.6, and 3.8 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/36\">",
"     36",
"    </a>",
"    ]. Rates of adverse effects such as pain, bleeding, infection, and perforation were the same regardless of the timing of insertion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/34,37\">",
"     34,37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based on these data, delaying insertion until four or more weeks postpartum when the uterus has nearly completely involuted may be the best approach for many women postpartum. However, for parturients who wish to have an IUC inserted, but are reluctant or unable to return for insertion (or will not have insurance coverage later) and understand that expulsion rates with immediate postpartum insertion are higher, immediate postpartum insertion of an IUC can be appropriate. In this setting, the disadvantage of higher expulsion rates must be weighed against the advantage of immediate and prolonged contraceptive coverage. Many postpartum women who express a desire for an IUC may have difficulty obtaining one at their postpartum follow-up visit [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The procedure for insertion of an IUC postpartum is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/29/34265?source=see_link&amp;anchor=H17#H17\">",
"     \"Insertion and removal of an intrauterine contraceptive device\", section on 'Postabortion or postpartum placement'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5865405\">",
"    <span class=\"h2\">",
"     Estrogen-progestin contraceptives",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of venous thromboembolism (VTE) is elevated in postpartum women; the risk declines rapidly in the first 21 days postpartum and returns to baseline levels after 6 weeks postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/39\">",
"     39",
"    </a>",
"    ], although VTEs have been reported as long as 10 to 12 weeks postpartum. Estrogen-progestin contraceptives are also associated with an increased risk of VTE. These risks need to be balanced against the risk of unintended pregnancy when deciding when to initiate combined hormonal contraception postpartum. Various approaches have been proposed:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Product labeling for estrogen-progestin contraceptives (eg, pill, patch, ring) recommends waiting at least four weeks after delivery before initiating these methods to allow resolution of most pregnancy-related changes in coagulation factors. The usual contraindications to use of estrogen-progestin contraception apply (",
"      <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"       table 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Because ovulation can occur as early as 25 to 26 days after delivery, the WHO and CDC recommend initiating estrogen-progestin contraceptives at &ge;21 days postpartum in non-breastfeeding women, but only in women without additional risk factors for postpartum VTE (",
"      <a class=\"graphic graphic_table graphicRef82680 \" href=\"UTD.htm?20/51/21311\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/40,41\">",
"       40,41",
"      </a>",
"      ]. These risk factors include age &ge;35 years, previous thromboembolism, thrombophilia, immobility, transfusion at delivery, body mass index (BMI) &ge;30",
"      <span class=\"nowrap\">",
"       kg/m",
"       <sup>",
"        2",
"       </sup>",
"       ,",
"      </span>",
"      postpartum hemorrhage, recent cesarean delivery, preeclampsia, or smoking. &nbsp;",
"      <br/>",
"      <br/>",
"      Non-breastfeeding women with additional risk factors for postpartum VTE can initiate estrogen-progestin contraceptives at six weeks postpartum when the risk of VTE is lower, if they meet the standard criteria for use of combined hormonal contraception that apply to nonpregnant women. Although transfusion at delivery, postpartum hemorrhage, recent cesarean delivery, preeclampsia, age &ge;35 years, and BMI &ge;30 are risk factors for VTE after delivery, they are not significant contraindications to use of estrogen-progestin contraceptives after the postpartum period. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=see_link\">",
"       \"Risks and side effects associated with estrogen-progestin contraceptives\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      We agree with this approach, which allows postpartum women at low risk of VTE to begin estrogen-progestin contraception after the period of greatest risk of VTE but before ovulation resumes. Although there is evidence that the risk of VTE remains increased three to six weeks postpartum, and possibly even longer, there is no direct evidence that initiation of contraception during this period further increases the risk of VTE, which continues to fall over time.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Lactation as a contraceptive method",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who breastfeed have a delay in resumption of ovulation postpartum due to prolactin-induced inhibition of pulsatile gonadotropin-releasing hormone release from the hypothalamus. The degree to which breastfeeding suppresses ovulation is modulated by the intensity of the breastfeeding, the basal nutritional status of the mother, and the body mass index of the mother. While breastfeeding is associated with subfertility, anovulation is likely only when specific conditions are met:",
"   </p>",
"   <p>",
"    &nbsp;(1) The woman is less than six months postpartum",
"   </p>",
"   <p>",
"    &nbsp;(2) She is breastfeeding exclusively (ie, not providing food or other liquid to the infant)",
"   </p>",
"   <p>",
"    &nbsp;(3) She is amenorrheic",
"   </p>",
"   <p>",
"    Under these conditions, there is 98 percent protection from pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/42\">",
"     42",
"    </a>",
"    ]. If these conditions are not met, the risk of unintended pregnancy while breastfeeding is high [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/42-45\">",
"     42-45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Contraceptive choices during lactation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Barrier methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonhormonal methods of contraception (barrier contraception, copper IUC) are preferred in nursing mothers because they do not have systemic effects. There are theoretic concerns that hormonal contraception may interfere with lactation and that the transfer of hormones into milk may pose a risk to the infant.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Intrauterine contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;Breastfeeding women can safely use either the TCu380A IUC or the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/47/25336?source=see_link\">",
"     levonorgestrel",
"    </a>",
"    -releasing IUC. WHO suggests insertion of the levonorgestrel releasing intrauterine device at four to six weeks postpartum in breastfeeding women; the CDC does not have this restriction in the absence of puerperal sepsis (",
"    <a class=\"graphic graphic_table graphicRef82680 \" href=\"UTD.htm?20/51/21311\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"     table 2",
"    </a>",
"    ). There is no evidence of an effect on the quantity or quality of breast milk. Although one trial found that women randomly assigned to immediate postpartum insertion were less likely to be breastfeeding at six weeks to six months after delivery than those in whom insertion was delayed, the number of breastfeeding women was small, precluding a clear conclusion about the effect of early insertion on breastfeeding duration [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Intrauterine contraception'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Progestin only methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;If hormonal methods are to be used, progestin contraceptives are the preferred method for breastfeeding women because these drugs do not appear to affect milk volume or composition, or to cause deleterious effects in the infant [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/47\">",
"     47",
"    </a>",
"    ]. However, the timing of initiation of therapy (immediately versus six weeks postpartum) is somewhat controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/48\">",
"     48",
"    </a>",
"    ]. Because falling progesterone levels trigger lactogenesis, early initiation of progestin contraceptives theoretically could interfere with this process, particularly if an injectable contraceptive is given in the first 72 hours after delivery. In addition, the immature metabolism of neonates could theoretically lead to accumulation of progesterone and its metabolites in the infant [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/49\">",
"     49",
"    </a>",
"    ]. However, there are data that early initiation of progestin contraception does not impair, and may increase lactation, and is not harmful to the neonate [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/47,50-56\">",
"     47,50-56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CDC Medical Eligibility Criteria provide the least restrictive guidance and indicate that progestin-only hormonal methods, including progestin-only pills, depot",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     medroxyprogesterone acetate",
"    </a>",
"    injections and implants, are safe for postpartum women, including women who are breastfeeding, and can be initiated immediately postpartum (",
"    <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/40,57\">",
"     40,57",
"    </a>",
"    ]. We agree with the CDC recommendations.",
"   </p>",
"   <p>",
"    In contrast, manufacturers' package inserts recommend starting progestin contraceptives six weeks postpartum if the mother is exclusively breastfeeding, and three weeks postpartum if she is supplementing with formula. The WHO and the American College of Obstetricians and Gynecologists (ACOG) also suggest that breastfeeding women initiate oral, injectable, or implantable progestin contraceptives six weeks postpartum (",
"    <a class=\"graphic graphic_table graphicRef82680 \" href=\"UTD.htm?20/51/21311\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/13,58\">",
"     13,58",
"    </a>",
"    ]. Even if the clinician usually chooses to wait three to six weeks before initiating hormonal contraception, in certain clinical situations, including concerns about patient follow-up or when an unintended pregnancy would be associated with elevated risks, it may be appropriate to start progestin contraception earlier. In fact, many experts believe the real maternal risks of unintended pregnancy outweigh the theoretical risks to the infant and thus endorse DMPA use immediately postpartum regardless of breastfeeding status [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/1,48\">",
"     1,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Estrogen-progestin contraceptives",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estrogen-progestin contraceptives (pills, patch, ring) may suppress milk production in the early postpartum period [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Clinical trials examining the effect of estrogen-progestin contraceptives on milk supply and infant growth have reported mixed results. A review of the literature concluded that the data were of such poor quality that no evidence-based recommendation could be made regarding use of estrogen-progestin contraceptives in lactating women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/61\">",
"     61",
"    </a>",
"    ]. A review limited to eight controlled trials (four randomized, four observational) did not find any adverse infant health outcomes in children of mothers who used estrogen-progestin contraceptive pills while breastfeeding, although one study reported lower average infant weights in the first year of life in the infants of these women [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/62\">",
"     62",
"    </a>",
"    ]. A subsequent randomized trial found no difference in outcome (breastfeeding continuation, infant growth) at eight weeks postpartum between women who initiated progestin-only pills and those who initiated combined hormonal contraception two weeks postpartum [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/63\">",
"     63",
"    </a>",
"    ]. At six months postpartum, there was no difference between groups in breastfeeding continuation; infant growth was not reassessed.",
"   </p>",
"   <p>",
"    Recommendations of major organizations vary:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The CDC recommends delaying initiation of estrogen-progestin contraceptives until 30 days postpartum if the woman has no additional risk factors for VTE (",
"      <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"       table 2",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/40\">",
"       40",
"      </a>",
"      ]. Women with additional risk factors for VTE can initiate estrogen-progestin contraceptives at six weeks postpartum if they meet the standard criteria for use of combined hormonal contraception that apply to nonpregnant women. We agree with this recommendation.",
"     </li>",
"     <li>",
"      ACOG recommends delaying the initiation of estrogen-progestin contraceptives until at least four weeks postpartum, and then only if lactation is well-established [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      WHO prefers delaying the initiation of estrogen-progestin contraceptives until six months postpartum (",
"      <a class=\"graphic graphic_table graphicRef82680 \" href=\"UTD.htm?20/51/21311\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/58\">",
"       58",
"      </a>",
"      ]. Between six weeks and six months, WHO states that the theoretical or proven risks usually outweigh the advantages of initiating these drugs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H276839832\">",
"    <span class=\"h2\">",
"     Postpartum contraception and depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;World Health Organization and Centers of Disease Control and Prevention medical eligibility criteria for contraceptive use do not restrict the use of any type of contraception in women with a past or current history of depression (",
"    <a class=\"graphic graphic_table graphicRef61848 \" href=\"UTD.htm?1/1/1052\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"     table 2",
"    </a>",
"    ); however, data on the effect of these drugs on postpartum depression are limited [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/57,64\">",
"     57,64",
"    </a>",
"    ]. There are no data on the effect of low dose estrogen on prevention or treatment of postpartum depression; there are some data that high dose estrogen has a beneficial effect in postpartum women with severe depression [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. Whether progestins have an effect on postpartum depression is less clear. A randomized trial of healthy postpartum women assigned to the injectable progestin norethisterone enanthate or a placebo within 48 hours postdelivery reported higher depression scores six weeks postpartum in the progestin group [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/67\">",
"     67",
"    </a>",
"    ], while a retrospective study did not observe a difference in depression scores among postpartum women given DMPA in the immediate postpartum period compared with controls. In this same study, the percentage of women with postpartum depression was higher in controls than in those women who receive immediate postpartum DMPA [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/68\">",
"     68",
"    </a>",
"    ]. Some experts recommend avoiding DMPA immediately postpartum in women with a history of severe postpartum depression [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     POSTABORTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contraception should be discussed with women who undergo spontaneous or induced abortion. The mean day of first ovulation postabortion has been reported to range from 21 to 29 days after the event, with a range of 6 to 103 days postabortion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/70,71\">",
"     70,71",
"    </a>",
"    ], thus immediate contraception is important (if desired) and should be initiated the day the miscarriage or pregnancy termination is completed.",
"   </p>",
"   <p>",
"    Long-acting reversible contraceptives (LARC) are a good choice for women who undergo pregnancy termination. In one study, the use of LARC (DMPA or IUD) in this patient population significantly reduced the rate of repeat pregnancy termination within two years compared with women using shorter-acting methods (primarily oral contraceptive pills): 6.5 versus 14.5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H837486\">",
"    <span class=\"h2\">",
"     Barrier contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diaphragm and cervical cap come in different sizes and need to be fitted. Fitting cannot be performed properly until pregnancy-related cervical changes have regressed, which takes about two weeks after an abortion or miscarriage. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/38/20070?source=see_link\">",
"     \"Barrier contraception: Diaphragm\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other barrier methods (male condom, female condom, contraceptive sponge) can be used as soon as coitus is resumed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/62/30696?source=see_link\">",
"     \"Male condoms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5334?source=see_link\">",
"     \"Female condoms\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39306?source=see_link&amp;anchor=H34#H34\">",
"     \"Overview of contraception\", section on 'Sponge'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H837493\">",
"    <span class=\"h2\">",
"     Hormonal contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estrogen-progestin contraceptives and progestin-only contraceptives can be initiated immediately after miscarriage or pregnancy termination (",
"    <a class=\"graphic graphic_table graphicRef82680 \" href=\"UTD.htm?20/51/21311\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39306?source=see_link\">",
"     \"Overview of contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H837478\">",
"    <span class=\"h2\">",
"     Intrauterine contraception",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intrauterine contraception can be inserted immediately after miscarriage or pregnancy termination (",
"    <a class=\"graphic graphic_table graphicRef82680 \" href=\"UTD.htm?20/51/21311\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"     table 2",
"    </a>",
"    ). As in postpartum women, postabortion IUC insertion is convenient and ensures that the woman is not pregnant. Insertion at this time may benefit patients who are unable or unwilling to return for later insertion, and who do not have other options for effective contraception. A series including 865 women who underwent first trimester surgical abortion at a New York City family planning clinic observed that 21.4 percent became pregnant again in the 12 months after the abortion and one-half of these women had a repeat abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/73\">",
"     73",
"    </a>",
"    ]. Postabortal IUC insertion decreases the rate of repeat abortion by over 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. In one study, the rates of repeat abortion after immediate IUC insertion versus controls who chose non-IUC contraception on the day of the abortion were 34.6 and 91.3 abortions per 1000 woman-years, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/74\">",
"     74",
"    </a>",
"    ]. These studies highlight the need for providing immediate, effective contraception that the patient will use correctly and consistently postabortion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32777?source=see_link\">",
"     \"Counseling women considering combined hormonal contraception\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Systematic reviews of postabortion IUC insertion studies have concluded that immediate insertion is a safe, effective, and practical procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. Most studies have not reported an increased risk of expulsion associated with immediate postabortion IUC insertion compared with insertion at other times, but the risk of expulsion appears to be greater for insertions following second- versus first-trimester abortion and for later versus earlier first-trimester abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/77\">",
"     77",
"    </a>",
"    ]. In the largest randomized trial of immediate versus delayed postabortion (first trimester) insertion of contemporary IUCs (Mirena&reg; or ParaGard&reg;), the expulsion rates at six months after immediate and delayed insertion were 5.0 and 2.7 percent, respectively, which were not statistically different (95% CI of difference -1.0 to 5.8) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/78\">",
"     78",
"    </a>",
"    ]. Eighteen of the 19 expulsions were detected because the woman was symptomatic, which is reassuring. Of note, the use of IUDs at six months was significantly greater in the immediate group: 92.3 versus 76.6 percent.",
"   </p>",
"   <p>",
"    Since expulsion rates are higher after second trimester than after first trimester procedures, this should be considered when deciding to place an IUC at this time (",
"    <a class=\"graphic graphic_table graphicRef82680 \" href=\"UTD.htm?20/51/21311\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"     table 2",
"    </a>",
"    ). However, if a woman desires an IUC immediately after a second trimester abortion and is unlikely to return for interval insertion, postabortion insertion is a reasonable option since the absolute rate of expulsion with modern IUCs is low [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/38,79-84\">",
"     38,79-84",
"    </a>",
"    ]. Placement of the IUC with ultrasound guidance may minimize the risk of expulsion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32058?source=see_link\">",
"     \"Overview of intrauterine contraception\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/29/34265?source=see_link\">",
"     \"Insertion and removal of an intrauterine contraceptive device\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Both copper and progestin releasing devices have been used immediately after first trimester surgical abortion (",
"    <a class=\"graphic graphic_table graphicRef82680 \" href=\"UTD.htm?20/51/21311\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/80,81,85\">",
"     80,81,85",
"    </a>",
"    ]. A randomized trial comparing the LNg20 with a copper device (Nova T) in this setting reported lower pregnancy and discontinuation rates with the LNg20 [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/80,81\">",
"     80,81",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Few studies have evaluated insertion immediately following medical abortion; in one such study the rate of expulsion was 4 percent",
"    <span class=\"nowrap\">",
"     (4/97)",
"    </span>",
"    in the first three months after insertion [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/86\">",
"     86",
"    </a>",
"    ]. An expert panel proposed clinical guidelines for this circumstance [",
"    <a class=\"abstract\" href=\"UTD.htm?24/8/24713/abstract/87\">",
"     87",
"    </a>",
"    ]. The panel advocated IUC insertion within 14 days of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/45/1753?source=see_link\">",
"     mifepristone",
"    </a>",
"    use if ultrasound examination confirms that the abortion is complete and if there is no heavy bleeding or infection. In patients who are more than 14 days post medical abortion, the IUC can be inserted with the next menses.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2733308\">",
"    <span class=\"h1\">",
"     EXCLUDING PREGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;As discussed above, a major advantage of starting contraception soon after delivery or abortion is initiation of the method before resumption of ovulation. For women who delay and present for contraception after having unprotected sexual activity, a new pregnancy should be excluded by menstrual history or laboratory testing. It is important to remember that HCG levels will typically take two to four weeks, but sometimes longer, to resolve after delivery or abortion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/30/39402?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of postpartum care\", section on 'Reproductive hormones'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/49/2841?source=see_link&amp;anchor=H4112405#H4112405\">",
"     \"Spontaneous abortion: Management\", section on 'Resolution of positive hCG'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/60/9157?source=see_link\">",
"       \"Patient information: Birth control; which method is right for me? (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H837264\">",
"    <span class=\"h2\">",
"     Postpartum",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest performing postpartum sterilization procedures immediately after delivery or within 24 hours rather than later (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Delaying the procedure for more than seven days after birth increases the risk of infection and the difficulty due to uterine involution. The modified Pomeroy technique is the procedure of choice in this setting. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Sterilization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diaphragm and cervical cap come in different sizes and need to be fitted. Fitting cannot be performed properly until pregnancy-related cervical changes have regressed, which takes about six weeks after a delivery. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Barrier methods'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In non-breastfeeding women, progestin-only pills, depot",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"       medroxyprogesterone acetate",
"      </a>",
"      (DMPA) injections, and progestin implants (eg, Implanon) may be initiated immediately postpartum, and should be initiated within three weeks to maximize effectiveness since ovulation can occur as early as 25 days after birth. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Progestin only pills, injections, implants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The TCu380A is the only type of intrauterine contraception (IUC) approved for post-placental insertion in the United States. It may be placed immediately after a vaginal or abdominal delivery, but expulsion rates are higher than with placement four or more weeks postpartum. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Intrauterine contraception'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For non-breastfeeding women with no risk factors for venous thromboembolism (other than the postpartum state) who desire to use an estrogen-progestin contraceptive, we suggest waiting at least three weeks after delivery (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Additional risk factors for postpartum venous thromboembolism include age &ge;35 years, previous thromboembolism, thrombophilia, immobility, transfusion at delivery, body mass index (BMI) &ge;30, postpartum hemorrhage, recent cesarean delivery, preeclampsia, and smoking (",
"      <a class=\"graphic graphic_table graphicRef74890 \" href=\"UTD.htm?12/13/12506\">",
"       table 2",
"      </a>",
"      ).",
"      <br/>",
"      <br/>",
"      Non-breastfeeding women with additional risk factors for postpartum venous thromboembolism can initiate estrogen-progestin contraceptives at six weeks postpartum if they meet the standard criteria for use of combined hormonal contraception that apply to nonpregnant women. Although transfusion at delivery, postpartum hemorrhage, recent cesarean delivery, preeclampsia, age &ge;35 years, and BMI &ge;30 are risk factors for venous thromboembolism after delivery, they are not significant contraindications to use of estrogen-progestin contraceptives after the postpartum period. (See",
"      <a class=\"local\" href=\"#H5865405\">",
"       'Estrogen-progestin contraceptives'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H837256\">",
"    <span class=\"h2\">",
"     Breastfeeding women",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In breastfeeding women, nonhormonal methods of contraception (barrier contraception, copper intrauterine contraception) have the advantage of being nonsystemic. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Contraceptive choices during lactation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In breastfeeding women, progestin-only contraception can be initiated immediately if this is the best option for contraceptive protection. We agree with the CDC recommendation that estrogen-progestin contraceptives should be delayed until one month postpartum in women without additional risk factors for venous thromboembolism and until six weeks postpartum in women with additional risk factors (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Additional risk factors postpartum include transfusion at delivery, postpartum hemorrhage, recent cesarean delivery, preeclampsia, age &ge;35 years, and BMI &ge;30. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Contraceptive choices during lactation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H837248\">",
"    <span class=\"h2\">",
"     Postabortion",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ovulation can occur two weeks after a first trimester abortion, thus immediate contraception is important (if desired) and can be initiated the day of the abortion. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Postabortion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diaphragm and cervical cap cannot be fitted optimally until pregnancy-related cervical changes have regressed, which takes about two weeks after an abortion or miscarriage. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Barrier methods'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/1\">",
"      Speroff L, Mishell DR Jr. The postpartum visit: it's time for a change in order to optimally initiate contraception. Contraception 2008; 78:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/2\">",
"      Gray RH, Campbell OM, Zacur HA, et al. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays. J Clin Endocrinol Metab 1987; 64:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/3\">",
"      Jackson E, Glasier A. Return of ovulation and menses in postpartum nonlactating women: a systematic review. Obstet Gynecol 2011; 117:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/4\">",
"      Centers for Disease Control and Prevention (CDC). Contraceptive use among postpartum women - 12 states and New York City, 2004-2006. MMWR Morb Mortal Wkly Rep 2009; 58:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/5\">",
"      WHITACRE FE, LOEB WM, LOEB L. The time for postpartum sterilization; report of 150 cases; bacteriologic studies on the postpartum uterus. Am J Obstet Gynecol 1946; 52:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/6\">",
"      Rozier JR. Immediate postpartum tubal ligation. An intraumbilical approach. Am J Obstet Gynecol 1973; 117:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/7\">",
"      Lu T, Chun D. A long term follow-up study of 1,055 cases of postpartum tubal ligation. J Obstet Gynaecol Br Emp 1967; 74:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/8\">",
"      Black WP, Sclare AB. Sterilization by tubal ligation--a follow-up study. J Obstet Gynaecol Br Commonw 1968; 75:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/9\">",
"      Green LR, Laros RK Jr. Postpartum sterilization. Clin Obstet Gynecol 1980; 23:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/10\">",
"      Peterson HB, Xia Z, Hughes JM, et al. The risk of pregnancy after tubal sterilization: findings from the U.S. Collaborative Review of Sterilization. Am J Obstet Gynecol 1996; 174:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/11\">",
"      Rodriguez MI, Edelman AB, Kapp N. Postpartum sterilization with the titanium clip: a systematic review. Obstet Gynecol 2011; 118:143.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Food and Drug Administration. Premarket Approval of Femcare Ltd Filshie Clip Mark VI System. 1996. Available at: www.accessdata.fda.gov/cdrh_docs/pdf/p920046.pdf. Accessed February 13, 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/13\">",
"      ACOG Committee on Practice Bulletins-Gynecology. ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions. Obstet Gynecol 2006; 107:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/14\">",
"      Brito MB, Ferriani RA, Quintana SM, et al. Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study. Contraception 2009; 80:519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/15\">",
"      Reyes FI, Winter JS, Faiman C. Postpartum disappearance of chorionic gonadotropin from the maternal and neonatal circulations. Am J Obstet Gynecol 1985; 153:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/16\">",
"      Cronin TJ. Influence of lactation upon ovulation. Lancet 1968; 2:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/17\">",
"      Said S, Johansson ED, Gemzel C. Return of ovulation during the postpartum period. Acta Obstet Gynecol Scand 1974; 53:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/18\">",
"      Guillebaud J. Postpartum contraception. Unnecessary before three weeks. BMJ 1993; 307:1560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/19\">",
"      Hayes JL, Cwiak C, Goedken P, Zieman M. A pilot clinical trial of ultrasound-guided postplacental insertion of a levonorgestrel intrauterine device. Contraception 2007; 76:292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/20\">",
"      Chen BA, Reeves MF, Hayes JL, et al. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial. Obstet Gynecol 2010; 116:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/21\">",
"      Dahlke JD, Terpstra ER, Ramseyer AM, et al. Postpartum insertion of levonorgestrel--intrauterine system at three time periods: a prospective randomized pilot study. Contraception 2011; 84:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/22\">",
"      Stuart GS, Bryant AG, O'Neill E, Doherty IA. Feasibility of postpartum placement of the levonorgestrel intrauterine system more than 6 h after vaginal birth. Contraception 2012; 85:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/23\">",
"      Chi IC, Farr G. Postpartum IUD contraception--a review of an international experience. Adv Contracept 1989; 5:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/24\">",
"      Xu JX, Connell C, Chi IC. Immediate postpartum intrauterine device insertion--a report on the Chinese experience. Adv Contracept 1992; 8:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/25\">",
"      Parikh V, Gandhi AS. Safety of copper T as contraceptive after caesarean section. J Indian Med Assoc 1989; 87:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/26\">",
"      Lara R, S&aacute;nchez RA, Aznar R. [Application of intrauterine device through the incision of the cesarean section]. Ginecol Obstet Mex 1989; 57:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/27\">",
"      Chi IC, Ji G, Siemens AJ, Waszak CS. IUD insertion at cesarean section--the Chinese experience. Adv Contracept 1986; 2:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/28\">",
"      Van Kets H, Thiery M, Van der Pas H. IUD insertion during cesarean section. Adv Contracept 1985; 1:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/29\">",
"      &Ccedil;elen , Sucak A, Yldz Y, Danman N. Immediate postplacental insertion of an intrauterine contraceptive device during cesarean section. Contraception 2011; 84:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/30\">",
"      Grimes D, Schulz K, Van Vliet H, Stanwood N. Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev 2003; :CD003036.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/31\">",
"      Xu JX, Rivera R, Dunson TR, et al. A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China. Contraception 1996; 54:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/32\">",
"      Celen S, M&ouml;r&ouml;y P, Sucak A, et al. Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices. Contraception 2004; 69:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/33\">",
"      Chi IC, Zhou SW, Balogh S, NG K. Post-cesarean section insertion of intrauterine devices. Am J Public Health 1984; 74:1281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/34\">",
"      Kapp N, Curtis KM. Intrauterine device insertion during the postpartum period: a systematic review. Contraception 2009; 80:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/35\">",
"      Chi IC, Wilkens L, Rogers S. Expulsions in immediate postpartum insertions of Lippes Loop D and Copper T IUDs and their counterpart Delta devices--an epidemiological analysis. Contraception 1985; 32:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/36\">",
"      Erolu K, Akkuzu G, Vural G, et al. Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up. Contraception 2006; 74:376.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/37\">",
"      Grimes D, Schulz K, van Vliet H, Stanwood N. Immediate post-partum insertion of intrauterine devices: a Cochrane review. Hum Reprod 2002; 17:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/38\">",
"      Ogburn JA, Espey E, Stonehocker J. Barriers to intrauterine device insertion in postpartum women. Contraception 2005; 72:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/39\">",
"      Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period: a systematic review. Obstet Gynecol 2011; 117:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/40\">",
"      Centers for Disease Control and Prevention (CDC). Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period. MMWR Morb Mortal Wkly Rep 2011; 60:878.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Combined hormonal contraceptive use during the postpartum period. 26 January 2010, Geneva, Switzerland file://whqlibdoc.who.int/hq/2010/WHO_RHR_10.15_eng.pdf (Accessed on July 29, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/42\">",
"      Kennedy KI, Rivera R, McNeilly AS. Consensus statement on the use of breastfeeding as a family planning method. Contraception 1989; 39:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/43\">",
"      Shaaban OM, Glasier AF. Pregnancy during breastfeeding in rural Egypt. Contraception 2008; 77:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/44\">",
"      Israngkura B, Kennedy KI, Leelapatana B, Cohen HS. Breastfeeding and return to ovulation in Bangkok. Int J Gynaecol Obstet 1989; 30:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/45\">",
"      Van der Wijden C, Kleijnen J, Van den Berk T. Lactational amenorrhea for family planning. Cochrane Database Syst Rev 2003; :CD001329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/46\">",
"      Hohmann HL, Reeves MF, Chen BA, et al. Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial. Contraception 2012; 85:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/47\">",
"      Kapp N, Curtis K, Nanda K. Progestogen-only contraceptive use among breastfeeding women: a systematic review. Contraception 2010; 82:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/48\">",
"      Rodriguez MI, Kaunitz AM. An evidence-based approach to postpartum use of depot medroxyprogesterone acetate in breastfeeding women. Contraception 2009; 80:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/49\">",
"      Kennedy KI, Short RV, Tully MR. Premature introduction of progestin-only contraceptive methods during lactation. Contraception 1997; 55:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/50\">",
"      Halderman LD, Nelson AL. Impact of early postpartum administration of progestin-only hormonal contraceptives compared with nonhormonal contraceptives on short-term breast-feeding patterns. Am J Obstet Gynecol 2002; 186:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/51\">",
"      Koetsawang S. The effects of contraceptive methods on the quality and quantity of breast milk. Int J Gynaecol Obstet 1987; 25 Suppl:115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/52\">",
"      Effects of hormonal contraceptives on breast milk composition and infant growth. World Health Organization (WHO) Task Force on Oral Contraceptives. Stud Fam Plann 1988; 19:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/53\">",
"      Truitt ST, Fraser AB, Grimes DA, et al. Hormonal contraception during lactation. systematic review of randomized controlled trials. Contraception 2003; 68:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/54\">",
"      McCann MF, Potter LS. Progestin-only oral contraception: a comprehensive review. Contraception 1994; 50:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/55\">",
"      Taneepanichskul S, Reinprayoon D, Thaithumyanon P, et al. Effects of the etonogestrel-releasing implant Implanon and a nonmedicated intrauterine device on the growth of breast-fed infants. Contraception 2006; 73:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/56\">",
"      Gurtcheff SE, Turok DK, Stoddard G, et al. Lactogenesis after early postpartum use of the contraceptive implant: a randomized controlled trial. Obstet Gynecol 2011; 117:1114.",
"     </a>",
"    </li>",
"    <li>",
"     CDC. U S. Medical Eligibility Criteria for Contraceptive Use, 2010. file://www.cdc.gov/Mmwr/preview/mmwrhtml/rr59e0528a1.htm (Accessed on August 16, 2010).",
"    </li>",
"    <li>",
"     www.who.int/topics/contraception/en/. (Accessed February 6, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/59\">",
"      Booker DE, Pahl IR. Control of postpartum breast engorgement with oral contraceptives. Am J Obstet Gynecol 1967; 98:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/60\">",
"      Tankeyoon M, Dusitsin N, Chalapati S, et al. Effects of hormonal contraceptives on milk volume and infant growth. WHO Special Programme of Research, Development and Research Training in Human Reproduction Task force on oral contraceptives. Contraception 1984; 30:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/61\">",
"      Truitt ST, Fraser AB, Grimes DA, et al. Combined hormonal versus nonhormonal versus progestin-only contraception in lactation. Cochrane Database Syst Rev 2003; :CD003988.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/62\">",
"      Kapp N, Curtis KM. Combined oral contraceptive use among breastfeeding women: a systematic review. Contraception 2010; 82:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/63\">",
"      Espey E, Ogburn T, Leeman L, et al. Effect of progestin compared with combined oral contraceptive pills on lactation: a randomized controlled trial. Obstet Gynecol 2012; 119:5.",
"     </a>",
"    </li>",
"    <li>",
"     World Health Organization. Medical eligibility criteria for contraceptive use. 2009. file://whqlibdoc.who.int/publications/2009/9789241563888_eng.pdf (Accessed on August 16, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/65\">",
"      Gregoire AJ, Kumar R, Everitt B, et al. Transdermal oestrogen for treatment of severe postnatal depression. Lancet 1996; 347:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/66\">",
"      Ahokas A, Kaukoranta J, Wahlbeck K, Aito M. Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry 2001; 62:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/67\">",
"      Lawrie TA, Hofmeyr GJ, De Jager M, et al. A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones. Br J Obstet Gynaecol 1998; 105:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/68\">",
"      Tsai R, Schaffir J. Effect of depot medroxyprogesterone acetate on postpartum depression. Contraception 2010; 82:174.",
"     </a>",
"    </li>",
"    <li>",
"     Goldberg, AB., Grimes, DA. Injectable contraceptives. In: Contraceptive Technology, 19 th edition, Hatcher, RA, Trussell, J, Nelson, AL, et al. (Eds), Ardent Media, 2007. p.162.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/70\">",
"      Stoddard A, Eisenberg DL. Controversies in family planning: timing of ovulation after abortion and the conundrum of postabortion intrauterine device insertion. Contraception 2011; 84:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/71\">",
"      Schreiber CA, Sober S, Ratcliffe S, Creinin MD. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception 2011; 84:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/72\">",
"      Rose SB, Lawton BA. Impact of long-acting reversible contraception on return for repeat abortion. Am J Obstet Gynecol 2012; 206:37.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/73\">",
"      Madden T, Westhoff C. Rates of follow-up and repeat pregnancy in the 12 months after first-trimester induced abortion. Obstet Gynecol 2009; 113:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/74\">",
"      Goodman S, Hendlish SK, Reeves MF, Foster-Rosales A. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception 2008; 78:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/75\">",
"      Heikinheimo O, Gissler M, Suhonen S. Can the outcome of the next pregnancy be predicted at the time of induced abortion? Hum Reprod 2009; 24:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/76\">",
"      Grimes DA, Lopez LM, Schulz KF, Stanwood NL. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev 2010; :CD001777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/77\">",
"      Steenland MW, Tepper NK, Curtis KM, Kapp N. Intrauterine contraceptive insertion postabortion: a systematic review. Contraception 2011; 84:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/78\">",
"      Bednarek PH, Creinin MD, Reeves MF, et al. Immediate versus delayed IUD insertion after uterine aspiration. N Engl J Med 2011; 364:2208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/79\">",
"      Fox MC, Oat-Judge J, Severson K, et al. Immediate placement of intrauterine devices after first and second trimester pregnancy termination. Contraception 2011; 83:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/80\">",
"      Suvisaari J, L&auml;hteenm&auml;ki P. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception 1996; 54:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/81\">",
"      Pakarinen P, Toivonen J, Luukkainen T. Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up. Contraception 2003; 68:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/82\">",
"      Reeves MF, Smith KJ, Creinin MD. Contraceptive effectiveness of immediate compared with delayed insertion of intrauterine devices after abortion: a decision analysis. Obstet Gynecol 2007; 109:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/83\">",
"      Drey EA, Reeves MF, Ogawa DD, et al. Insertion of intrauterine contraceptives immediately following first- and second-trimester abortions. Contraception 2009; 79:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/84\">",
"      Cremer M, Bullard KA, Mosley RM, et al. Immediate vs. delayed post-abortal copper T 380A IUD insertion in cases over 12 weeks of gestation. Contraception 2011; 83:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/85\">",
"      Ortayli N, Bulut A, Sahin T, Sivin I. Immediate postabortal contraception with the levonorgestrel intrauterine device, Norplant, and traditional methods. Contraception 2001; 63:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?24/8/24713/abstract/86\">",
"      Betstadt SJ, Turok DK, Kapp N, et al. Intrauterine device insertion after medical abortion. Contraception 2011; 83:517.",
"     </a>",
"    </li>",
"    <li>",
"     Planned Parenthood Federation of America. Medical Abortion, Planned Parenthood Federation of America, New York, NY 2003.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6708 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-122.72.76.133-ADE281C057-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24713=[""].join("\n");
var outline_f24_8_24713=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      POSTPARTUM",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Sterilization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Barrier methods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Progestin only pills, injections, implants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Intrauterine contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5865405\">",
"      Estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Lactation as a contraceptive method",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Contraceptive choices during lactation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Barrier methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Intrauterine contraception",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Progestin only methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H276839832\">",
"      Postpartum contraception and depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      POSTABORTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H837486\">",
"      Barrier contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H837493\">",
"      Hormonal contraception",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H837478\">",
"      Intrauterine contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2733308\">",
"      EXCLUDING PREGNANCY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H837264\">",
"      Postpartum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H837256\">",
"      Breastfeeding women",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H837248\">",
"      Postabortion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6708\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6708|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/51/21311\" title=\"table 1\">",
"      WHO MEC Personal characteristics and reproductive history",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/13/12506\" title=\"table 2\">",
"      CDC Medical Eligibility Criteria for Contraceptive Use",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?1/1/1052\" title=\"table 3\">",
"      WHO MEC for Depressive disorders",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/38/20070?source=related_link\">",
"      Barrier contraception: Diaphragm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/0/32777?source=related_link\">",
"      Counseling women considering combined hormonal contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34522?source=related_link\">",
"      Depot medroxyprogesterone acetate for contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/27/3512?source=related_link\">",
"      Etonogestrel contraceptive implant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/13/5334?source=related_link\">",
"      Female condoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/29/34265?source=related_link\">",
"      Insertion and removal of an intrauterine contraceptive device",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/62/30696?source=related_link\">",
"      Male condoms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/24/39306?source=related_link\">",
"      Overview of contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32058?source=related_link\">",
"      Overview of intrauterine contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/30/39402?source=related_link\">",
"      Overview of postpartum care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/60/9157?source=related_link\">",
"      Patient information: Birth control; which method is right for me? (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/52/9031?source=related_link\">",
"      Progestin-only pills (minipills) for contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/7/39034?source=related_link\">",
"      Risks and side effects associated with estrogen-progestin contraceptives",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/49/2841?source=related_link\">",
"      Spontaneous abortion: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/42/15018?source=related_link\">",
"      Surgical sterilization of women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f24_8_24714="Necrobiosis lipoidica";
var content_f24_8_24714=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F74010%7EDERM%2F50781%7EDERM%2F63574%7EDERM%2F76411&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F74010%7EDERM%2F50781%7EDERM%2F63574%7EDERM%2F76411&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Necrobiosis lipoidica",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 387px; height: 263px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Note the thin, yellow, atrophic plaque with telangiectasia.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beth G Goldstein, MD and Adam O Goldstein, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Necrobiosis lipoidica, early lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 300px; height: 417px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGhASwDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDW1rW4/DulXmpOQPJjJUep7V8t2Qn8R+J2nuyXaeQzTH2zk/4V6x+0BqvlaVp+mRv80zmSTHcDp+tcj8PNJMdl9skxuuGwoP8AdH/160k9bnNSVotna6bDwsjDgj5c9hWrbIq/6sMfc0yGPEeFAO0DI/pU8ceOMnjsO1YSZvGIyL5mkB5I68VaRTwp+UYzSRoueMn3qYLtUOScjioZqkAiw6/MMA8jrmpwibg4yT0NR2aF1yw5ycVbiWNZHxkt0BPTNJlpAgJVgCNoODj1qSMtGCM7m/hJHSpEUkMEwSOCB3NSQNt2mRQOPu/1pFIhDuJVLqAfX3q4rrnJ5Z+MY6mhERlKr1HJbHrQInZUUjBIJzntUlJkjFo4Thdzr2oIKxZmC4PUkVIFJT5m9gKkRgybJOfUHnigtCrhQHjH3h+dT23m72DRrtPTB61XBJjQRlSnUg9vpUyzHeqkbT90H+tOw/IdGCZH+8OvfFWLIb4XEj8jjApYlJBTKs3dqTyyGwo68kr2o3GStlCqkHjkE8VYhHI8wkYz05qJIhLEPM4ZW59TU0RBGTkqOMikBIYxvDK+0Y9OtKrEShGU8DgnuKNucAPkdQT0PsaSSSTYTIqkKeRnJA9qAJ3KlGfGRTIx/wAtXXafu46g59KU5CqytuGMDPrT0XALiLIHLZ/mKQbAS/kMhWPa/ALdRSRBjtwIztG0n+uKVH2wjbypHVTnePWnRK5wR0PHPWkQ0Q/K8rqsZOD3GPypkjHIOfmPGMdDUxchSuMSZ+8ehHpUEuHO1Sxzzn+7QCK9yV3YIAdhj5e9UHASNvMJyeM9wKvk/MgYqTyMZ61TuQpXB4KngkdaQzLlBDc5IPNT6XcmNyHG0/w1WnUvIQxIOOfSoRmOTDHleh9RT6Bc6+OXeF3YB7kVdQDBOfoaw9MmEgIY5Nau7GCOncGoNCRIwu4nbux1HeopWYjjgr/Kh5s8JnI5qjPNjOWIzQA6Q49Dmq0jJu5H5URTB3xk4A54qFUAUCSRmYfxE4J96oPU+ZvifdSa98Qms4SWWNltkHv3/nXoel2SW8ESxqBHEPLUewGK4DwjENX8calqZH7uOR5Fx6k4FepoilQDkenvXdJnkwWiQ2MqEBwTz19fepk6bicZ4pkmSiqoJ57dqnAVAok5Y8j0FZs3SHwnYrZ5PTNS7dygBx+Xam2y7l8xugOfqKtcfMRyAOAKhlpDYYwGZVySME56VPHIsgbK5YHGcdaitzmMEEnHXA6+1OOUXaiuVH3j0H1pMssWpREbaNrdTjrmpdwkYsQDyOBUVuOhU7R2z3qYKrsy7jz1HrUh1JY4tqNsOQwxil8tjEN5IGMMe9SxYMRL7vl6D/Cj76eWw+XH3qDRCxR4K4G5Qw5x/OpGTakmAQw4JHGajikcZR2+Qjjb3qckMc4JA4AzRYqxBbBlnXCuQV69vpWgvCL5owx49cVGHCbdq5UjnsRU0rOqqQPmOOe1A7XGKxSchyQOxxx9KtyNtjBQbhntyTUW7zLcgj956npT7VZfLxMhC/3h2ppA0ySPAkBYAA9vWnNJtbZ+Q6ZpiMXJRsH8f1p8UYUkAHpkGi3caXctwzC4QI42HpkDFPZCdwOMLyWAzVRdiKN3yliRkjFTWdwG2oByWKjBwPxpMfL2LUboFKqVAPII7GpUMiRqxTYT02nqKYqlZFPygE8AgHd7GrBVUUq8b7X4I6gf4VJDKqwxjJDCNc7uBwc1OY4ldlxIdy5/+uKJUQRL8ox0yf0p7GWJFUj5emG65oewtyvIBIVKs7bRkZ4JFVpEbAYD5wTj6e9XtrybZDncc78dRVKeNgpaNixB+gx7UrCKsqkDcY+BxVd4wmWK7lxkj+tWtrBt/ZuvoKglfERMec5/P3qXoBi3JUMykHGM8iqU23AfsDg1qX6gbOvzHGfSs2aPy8gjk5PWmhSZe0eVTn1HfPWuhjYlVGe2TXI2DFdpznBroo5iYhgjp61D0LjK6CabyW3A8dKqPMHlwFytMuJfvDg/0qODle/rmqKvcsoyh2XGMVKEZwCFyPeqkbKtwD1/rUrNKGO3p2oYpHg/wr08Q+HvPdRuuZS/Tqo4H9a7ckhBkYB4B9qzvD1kLHSLK3XnyolBPvjJ/WrTb3lx1QjNdr1Z58e5aiIyGAye9TYBb5RkiolwmcDLfWrMCExMAST696hlofgfKCcYGSAKeDg5VQSRzShGwcsPlHXFSKMbQW5HOak1jYeQ4GDtOegHrU0cbsqF14HG3NRomVzyR1BNSpu81ZGyQR0B/Wky7DlUqNwxs756ipUMZYtGGwR6VIihuWUMMZxTSoWfaoI6dKQrX2EhDNuTIPfirsMYCBRhmxyc1DHH8uSCF64WrBJVf3aD33HBPsKVy0Pmtw8sSb1Uj58jiltrYKxchs5KkHofekgXzAxGHOQcDr9KsRKx2yZIXOCKNTRETwx5UYO/PrUkG5n2t1HXPUCnzRkK0yAMR8o9qTLKckE7xgleoo3KRKyeXF8sg3n15q5E++Heeo69v0qCNQISsqEPjI//AF1IAVG8fMT17ZpEsSRBFG0h+90AzWc+oMJmiAIAIKgnGDWhKoEavtJJ4we9YFzfotyFEYKyHZuJ5X8K0XmaU43NqeORmRSwKHv1A+lWLdJIsBsHf145I7VlQz5bYFI2dM8k/WtW0mZnjzhZU/EN70ipJpGg0RMQbIaNjjnoPerEBMfys5PHfvVfzIzGyn7w5Jz0oDeYyqylxgY4/mKm9zBq5fZTtLMwUMOjDIIpIYxtMW0AIMg7sn/9VPSdUjJ5GflI7Uk7xiXdCrFdoALdz9RUvYjUjmZYpQyZJIwR61RLli6gHPTrxmrcyFowDnK/Me/P+FQFyWfcw3ONm0DABHtSBFAIFYHOBxz71FcII/mVck8EdqtoOFznAJX6VTcNHuz909h61LBmdcKSxU43D+VZdzwQOu39R6VsSnrlcnGcGsecbskcEdR6UkS2VYHAkIBx9K2YpCkQ6AN3rBjbMpAOOcg1qM+YsN2ORQ0KLHyANIwNXrWHKbT0PXFU4ACQcE5IJ71rRnawxwKTZdynLEkeME5HFVmcFjuY/nWnMA2TgZrPkjXeeP1p3KucGoHkgA7R3oQLv3dPUDqaV1G5d43Kn8PvSwR4nYll5613M4EWQADvPGR1xUkDNyWXAB9aicAso5AxyKkGcfI3y/qag0iS7s5OeT2z0qwqBVUtuCHuD1NVx8scWOWXlt1W4VDoS4B9AOn5VLNEyeJi0hIA9gTT/vz7U3kYwW/wpkBDNkYz9OauBMxq6t8+OOKRSJEQIUj5yeBSiHBGXA28+uaeg811PU4wcetMnIOMdAcA4qGWkPVmSQAE8+ozUxi84qzfdH3RSRQh2U5OB196kaLa+ASe+B3pCBi0LgqSA2BjvmphIzNvwQX4wBUAZfK+7udfm57VIkpC7AuGJyQT2plpkzNtl6kpjGAKkBBjDqD149DUbESKEJIz39PalCeWgCg5B4J5oKJY0bzGeV/b1ANSRkuuH5P8IFQKJJuCfmPXHcUqo8b5ALAdweae40W5NsipyuOh56ViapbxxfvMA7uM/wCNX5bgeYmUwre/Sq2q7XiVgQ6ZwAG+9Qro0pppoxC5hy7yhWA3A44+lbcUjtCHVSshXnjhayZ41Z41Lgxg/eK4b6H1rTa8QwFYjuYgqCvpVJnTPVIq/wBoTW8iySKzR8ocD9TWlpl7h0hyQHxscH7uexNYxiuIkaUvlRww67T6kVNahijuDiYOAYnO1h/nsahkuMWdmJDLOUVgGHLNnKt61ZkUA7M5ZiCSONvp+FctY7Z7lYXJjaMe4MnqG9G+nWujt5ZTtYnYqnYcjII/xpM5KkOUlIdXaN9pUg8k9SO1VnjImU5XOMgqM5z6+9WGRCHT5iQdwU/eAqNmXdKDuzgZAHekZFG42gfxcHa3sfaoJQzJnGQec46VbmDrJhgG39M9jVSUMkef4TxjsDUsCjOQMhRyD+NZVyEYlgCAR90HrWlcHDfLgg9jWVcgO5XHfmktyGjGnzHNux0PatK2fzY8E89xVS9jByT29KdZMI2DElhTJi9TbtgFCbe5q8r+vasrJTGBxmrAnJkyAMDrUtGiRauJQEJXr0rMmO98lsZHSppnBwA24fWqMkmHIpodzkW+Zj7jGKkjyNpwAQO3UGoAQxDFtp/lU0ZBY8DJzwK7pM40W0y4GQAPUnmnyKdyAc56fSoLNjICcYx29KuW6kowZvmzwFOag0SsTRoCTIwygHT1q5EBtycDHKqKpwFvmyDgDAwetSl2y24AdzSZooksiltvl/Kx7jmrSOwjVSpwP71RwRhtpLA4PA7VdDKzrGAzYzj2pdC7WHW+C5JAZh1AOMVJN+8O1cY74FMJyGZQDjjjrRtYAcLu4y2eKixaXUljZtrYUkgY61KFYxqQCPUntTYhw4IAJBIOetCuTuU8OBjg8VI7AkhdnULtVeu7niiNCXJxlWPHGOlTQqQWB2/PgDn9akhG9mUrkDnLDofagmxBDBIJAWwrHI55xVkMynDZ29PxpyYETEoWOelT2qmQfOuO+CMGmwdyEhowCDtGcGh2EfLOY1IyTjpSjyxMyuCY+c5PamXMKli3LAgYOc/hVFxXc5+81N1d0iDMc4Bx9/niqzMZlEwZvdT1FT3SC1Z3kAEQOAQefwqqdyFWYYz03DBH1papnoQtbQnLx7XGDIqj746D2p0PlMVeJ2XqBxkqPWicRF/3m1UIzgHt6/Wlt4WVY5HjLIx3b1PJWpv2G9hyBJXkRt4jZdp2ZG7059R6UrwtEVRgTImAGbOG4/wqWQbN7CbK7d65XGR2q/DG+xUWF99whc4Ofnx2ovpYgLS5l/cLIDvZMQFh05yDnqR1rpbKcyKUdBHKfmKnkMfUH+lYemRvHJG7xksQGjfqGX/Cuia3VZEkBYoVySByh9vWixzVrXsRSLKSH3j93kgnqw9KdHKCQwkyH7Hr9aWdmjLSkJtOAy4zx6iopUKIzxoCcZVR0PtUmFhkjb49ithgep6qf8KqTZwRngcZ96tzEKinGAwz61RmcA/J95j3pEs5bxTqR05FJBYnpj1qvYX0N7bLJAw+brz3pfHlnLPaxXCIzvG2cZ6DvWB4dGy9mEI/cMRtUjGDjmly6XRpypwub1yoU4znI79qr2p3PszxmrkqE4U/garYCSfc57GqRyvc1I4ysZy2QOgNRqQu7b37U0SMsalTuC8GmK58xsgjGKbNEydnHynGKpTSAuen41ZkbdGc8fWs1ptjMDzzSQM5RXZZEUsoz1AH+eatRZByGxjoe496zbRQ8mZckg5X2PrWmkAeZUVyD3DD71dkjmiXoUAiUfMxfqo6ketWwojkCxuFUDnjPFVnDIyBBvIXJxxj2q9BIpD5badvK461HQ1WxIqoGQxnCZ5PrVhRHGxMYDK3PPH6VXQM8YEXAYdPWnwrsABIZyvpjHrSZpFFmJ8gxofkAwOOmeSKn+RSpQMcnbnP+eKrW/zyZYH5OmDj86txx43MS2D1wOnpSloaE8Me2YbQGJ444FOeExna2CC2T3AHamKzGJlC8nuD3pyByhEqncBkjNS0UiSUO3lqmBt4x3P41JtBkUnrxntgU35ZIxsckj7xI61YCgoCNxA/So6jBogj+YehPDE1MpKKwL5x04zge1Dc7t7KAMDJ5pISTDuwdvIBPFMW45C44VsA/NuI5NWBuHzB8lvXqKYgLR5+VsLyT1NMt/3hkPltk9M8ZoCxPtXrldr56jpQEXKqD/utSgLkCTqOME805wUABG30OKLgUrrSo5ztkcKM5GB1/CqlxpHkxEnM/d0x1HoTW+kbE5B5HXNOigkb5mYgZwCP601I0VRrqcZPZIsEEVv5nnt98EAjb6CrenWkscMVsY3WR33R5bG9R1XnityfTylwjqi4U5IDY3D3NSw6fFNJvO8ZOFRyfl+lNo39roUrnT7cwp9oCxTsAFVerH0x9KZLpNxbGJ4S0yI24AEjFdEIVkEcdwBIYmyGPX6A1ad1efI+ZgOT0/P1paGPtmjO05MBQNhU5cBBhVz1A9KvOFVf3a5I7Y5zTxAqkiExhTgnHY+3+FOd1HmZUfORg/3aRjKXM7lKQEqCFG1TlRUU7lOhPlnkA9j3qzKcSN8oweMk96qyKfnGwsp45/pU9QK2795uixzxtFUpuJCoOCB0q/GEEzAA9MZz1xVG6Tc2OSx9u1SyZFS6AkhKsMA8+tYgsVt5mlCgbvyrecq6BcfMo4I7j0qjMCFOeEbpSQLYz33NGcAjNVdmZE2vz/KtGRFCEpnae9VCMZQHB7981aM2tS3FCBFv/SonUtnAII7HvVm2crAQ2csOM1XlxjAz+NDQFV3xhCDzzn/GqcoXdzVu4jDRZGdw61Qd+etOxDZyFkSu2QMA3Aznk1sWqM0vnD5iBk1k2Me6NcDgDFbMCGG0YEEs3AA/lXTJkQRbsmXLzsCRnGBxU8caluRtduevbNMgUraxqoAkXqAOCKtxx/IjkEc5y3b1AqdjUniALADGB05xUpiLPvxyOM/5/nTACyqYwHJ6nOMCrqIvlqO/Tr0qXoWtCMIdyyAbfc+lPhnkcEgZUkg9jn6U8B5JwNxAxg4Hb0qYtj5VjPP3SOopFLQS1Vtjbh0YAcdfpU4zuYRkE9+KTY4jyylSRkkHoafECZCHDBWGN4FS0aBZgoTn7pPU9/ep4ZkzIob7lVoScnCnCnBJ4z9Ks5Up91Tk9BSYDEfdK6ovB4JxgGpjtx5KPjr055pgdCDgFgO54p6puw6lVHfFILklujISz7AuMH1NWFdQCfujpk96rxyEO2SCgGRn1p/3ym5hnrn0pkt9xcMkiZC5AzgjJNXopcnDgZ/hqnbq7A4K+YDjjqfarkKMUG8hW6ZoYm7k0KAjaGYeualVvLX5VycZ2Hv7UyFQFCkruU8MeppxC71Jz8p65PX2pdRIVNksatgqpByp6g1NbxmGVSSrR55BGQRRLhWwy4HAx2qQIETOThTkY6AUyriuyoFdXBAI+X09v61MFiVw6DPy4weeO4FQSgBVZiDCf4ulWJACF+ZcA5+UcD6UkIZEwcsqKVBI4BHQf1FGcgtJgKW6dPpSSKwcvkCQHlWHKmo7kLKjBN3JGCeMD0NMViOaMM5KruHDAdzTUCyRuSx3L2NLJ+7hzg4JzgnkGmIQNwkUnecg5/zzSYyngKP72QckD7tUbrdlduCvWtFhsUqGJbJznvWdI5SYn5cHkKf8ajcT1K4MYJKnaoGcHv7VVuVEp7BV5xnpVuRRLLFtwEJyB6VTmVyzBGC4OB70W6iRWkxsYJ90mqki47c1ousZQqyjd3xVQ8xqgxtzk8c1SYuo+Eg25Uk+o9qjcncd2D6Cp40AHPIPP0qCXO5s9RRuIqSEqGz0PWsuXG87V49605ctESfWsyWRg54zVoxkYOnQgxRMq7d33hmtKdVNxBErBWQZIzTNLhzIdzAqvGMccVaWMyPNIyhWA3E+1bMuCsTwqpfgcKuDz3q+Sshjj3HdjGTVa3jfywwG1mA4FXYgqFeCXU9fepZS3uPX5W3fd2DjAq3gGPO0Etzx2NVYQ670CjdnOSO9WIflZRIRuPpUM0GKCfmTJcdwe9TQMzvIsgIz0yealgPlF14G443HvUZjZJzMUc+47ehprUOpcjBEW0HI+lIXePO1SWIOeetRAOYsxn5hg5BxzUuwru34y2Mn0qGXYYCSN4JVmOCOwqymBAyRdRk8jqPSonCqg2gYAyQeaY8siBUAJJ+Zj7elIlsmcbwFHLbecdqmhyDHwFCrg5qtAXkmR2b5T0HQ1eihIfe/APRaBc1w8oGQEnIPQHnNSQIyswBz6Y/pSRbVfazEc9qtRRoHBkb5Rlsk8imFmPitQSztwp6YHWrEaheCOD0z2qNZwwUY25BJ9x/jVhJFWMSBco3y5xnB+lCv1HZ9SGINj5/vc4I6Yq0ilVUrtO48DPOKiZiDtTGCMknjmrNuh2KVxuxkAdjQTLuIsasuyQEOBkD1qcRtuORnI5z6dKR2BwxVcoeo4zUhlViGhJYqfu9/cUhXZGFWO3aJ48lDnOOvvimq7RXCBztyN4IORjt+HtUm+OZWwMfw59KZIhEUcik+YhHBHf6UId+4XYDQh49xYAjd05/wqLe21QQenIXn8qmLM0hUNkle3Hv0quBsclXZc8sD/Ce1FxoSYs0jxBMxgFlkA5NVllJgX+JlOSO4q05yW5x0JJ6ZqtcKV2jbgkYO3rQ3caILvG/cuemTjtWTdECbGS2Oc4rUuGLSY6nGCT6VkSRqG3MPkz1PrUibHZIQYC/LyKhYksSuCTzQGViyNwfaqyswlKkYyMZFJAhGCEEA5B64NMkjK4G0BscYqXyxGAo4dvlHoaaQ7NyQPTFMlka7kbI5OOmKbMWDEnvVgrvG4Hkiq833xxx3pom5RuUAXA5Gay7jaJOO/OK0pG/h9+tZ04XzTnNaIxkxVUw2bs64bICmliQtGoUjDHJx6UXZMsqwrnOOg5qxEo84ZcYAA4/wrZmmw+FTt3NhTu4wc5FXlKqccMDySDVETq7BQvQ7Rt6A1ajQeV8wGDj5iKzZSHozFwwAADAYHWrUcZEm/kKvPNVjGzOMSbBnbzwDU/mLvMauSq9z0JpM1RbCqzfK43j5jnrild1KEhgQem7iiGIh0eRwTt44psimRN21Tg89qhOzB2YJt8hSMHYeQe5qTduAB5HcjpTDGrYiZiMeh609IxGNgA2gUmMb5YLhwwIB7DrVwW6k59KhhV1ycMAeSAKsgBE2p/F60WFy3ESFSzFQfl5DDj8qlhMjCRGxz19qbbCTaQePTNWG2YTeCpzyc9/pTKSFgAYH5Ny9SxHOfapVCtuJAxnAHakhCfdLEH+I9jT0UKWJwVPGBQMnQlIw2AcDGAOlSKgkjePAHORzjP0qKFCrY5CjlcmkbfvPze4Yjk00Kw7BSNVDcliM4yce9XbaXBUAjCcZ7iqyENuG7JAGeOlOWFbeQlWwTzyOtPclq5b8vexB3BWzjPTNNjiaKbfE22PqcnqfWpI3LklypXI56496bdOUQE4O35FUfdap8iFe9iQFTN5cmxDIM7gMg0y4jcIHOBtIBK8/QiokLtbu6Ro7xjcFY7SPWpoV5D9GZclCc8+lIGrELbVlRyPmU/eAwRnvTJhtc7gd2CAQeDUk6rKqFdyuG4J6H2FDOW+QkHbyOxBpMCmVXI34GRjBqDOWYO2cHIPfFWJ2WZh/snknjmoJl+7IgJz8p2ikXfuQ3LqMsGGSOB61mpl1ztzEOx7Gr1wFWMbjuI9etVTOqsI+QvUcUrkMz5JCpbp8o+Wm26CSSR5CRhcgCrE6oGJYYJOR6VAjje+eM9RjrSuNC/KUUgbiO3vTVQElh26Cmpt28HknpTozuQHoQ3SqQmH8JJxnpUEzZ24xkD86mDDe+FJzyap3HONh5zj6VSIZRuM7SF+91rHmUmQnk/jWrcZV+cnPNUJ9hfOe3atFoYSdhzBzK8p+Vd3GOuasQ4ReMbn6Co2Cyf3lB+7g/rUnIYZ5A4Bx0rRs13LMCgbcFQ+7k+hqzyrkBgcnPPeobeFcNn5SRnHrVmMKFBHLH5QMZxWTepcQRfnKkknrg1JtXcATkgbuemfamrlgGbCjdgZqaJGeXO0FccsegoNLi+eihhkkn24x6VMm14iihsDkGljtF81pA2QRyo+7+FLMUJOBkDj5f61LHuNhODGzZ4J49KtMWaYE4APJJHH0qioBPyYGDycfyq38rMvl7iuORSaKsWHIjQOSTn9fanxlmALHCjtjNRKT0yQCOBjtTlwy/KzAA4YDrVDSLSsRKTtwCP8AJpso38ZHHUjrTkbapZlyc4HPQU+JmMUwkaPP8JHJoGTQxgBm27hwSGPGaT/Vody4HYD1pkO4KqnJ5wWY9aswhDEyyHOG6Yxk+1INh8aK0IbPPdTTlPyZ6ux4A5xTYFIVlG3DHqajWN2kIB3BehzjBppCLSw78OflfPzbegPvUpG5VOAcen9abCgSTbyNx5Ge9SsxQnChsDqKGzNsiiUAExyYGMrkcf8A66dcNIkSrKg+YgFFGcg/xfSm25wjDBV1P8Q6igdFddyKflYkcA+gpph1LEcSmKTaSCehbk56EGojiCIeWhCKR8uc4/wpVhY3LbmyjKAD6GpIm3JIGYmXdjpzx6ipbuIbhJkJ3nafmIHTPr7VFcBt4KZHGCP8+1OhCrFJuZ85ON3II+tRs5JUj+HjNTYCENG0m7qBw2D0qN2BV0zyW4x/SnTIY2Z+mTj2zVVYys0sjFgrfeHofUUrD0KchYyODuwOhPQY9arfLIVYHnPGa0HCKr/7XOazHLK/VVwePcGkIbelVVFY7SGHTpVFmIeQYBBFOu5wZNnJ9T159qgMZJBYhnHIxQgJYQ6o2/GewBqWQ+WQMfe5PtUIkGzcDk+lLuzl2U8/rVIkdKvl4Kv14PFVZWLK/GO9WZORvbIIXGPWqcwJB3H8apENlK4bdll5B9azpJV3e9aN2P3fXA9KxnzuPI/GtEc02adsuSzFSi/dGec1ZVFKFVYbwOM0kO5FT5Cqgcbv5mnEZfPmt15IHf8Awqm7nQtWSGUuqQou189R/DVmOQsgyQMccfzqvEoE+1tuMZPu1WUDCNivBPTaOvrUM0Vi1ar8ztIpOfu7jxirBSQoViAKnjsKhhiCbt24DbgZI5pT823ZwynnNTYqw+NyFIONw7etK42ElVI4BPNMuJMONpywPQUgdJGEgLAqcKB3osUkRqXWQ/u1Zd27g9a0IYCzLjgZ4OeajYIy7kJ3nvjoe4oVyN20lWx6cUi9yyQSWwN2wck02ICLB2YDHIqGKXdgO2xl6DrmrT/NGGyfl6gUD20FfeJSDwPQenrU0DKqsOMntimJ+8QYYj1z/jSyForYmJOBzgU79x+RcYHC7ckDkAVMuGUYznr/APXqvasZ4Fc8AirVsvlFstuDYOAOg70XJY0L5jAqWjzwCR1qZCu8xqMEHBB/iqIRyiRXUny/9n/CrEcDC4eXcBEAPl7k+tNktomLhUAIzJnA47VXkyxUAKgzgZ571KYw2d3TONwqREWQqG5B5HPT0NTsRsK4CMRuzjgt6fWm7glwoBOGOCMZC57inxNvYbkAZiQx78URFYW8mQYP3gN2QT7H+lAIjkQpJuOVIO4beQT71Kkg3E/dD55B7+lNkyzMnR8cDPaktyzHBwGJz7Z7U2D2GqflZHBWM5NVzGIIAh3FAQwLcmrLtjd1+hqNoy8LchlIyD6e1JjRTvAFDKvI25X61Dz5TCQhWAxjPeprokQqzAgeo/z0qF8M6HBIK/jmpL6FGfzHjcAYUYJJ9KzLw5u40K7lAJz29q1Z2JD7RwBWawLI+AT/AIUmJozodrSIz54PHHU0rsSzlRhwOQOlDMfmTGVX8PxqNCcfeHvSM7kwI5UcADpViFiXbfyMZH1qqW5KnHHWpg42KE6dye1UiWNnzs6jOe1UW6tuzn+tWJJPmbC/Sqsznt1I79qtGbZQv24rHkchzggCtW74XBzuPauO1jVrezuxHNIFYruxnHGT/hVo5asrHdyEruZflycYY5pokEkmxWY8fe7A98VBGolkZi4cDnzGOM+1TYMkkZVdi+56D3q7I7Ei3ZxlWBMZORgOx5ArQeaO3jJk+VSvAzmqcbso3nbu6YxxVwwiSIGTaQMDZjNRLUtLuTIwnjjlG5sjGCOM+pp7IiKwcuAcfODzToyd4RgNwH3V6U6N8lg446cUrlR1IvLM+4EFU6Nz19hTrd1jJTG4fwqPb+tOl4+TBx1z6U1MJgcMOgPoaksRCGuCyKBH/CvX60MoTOWIQnIx1FSFt6ZQDf13dCajjRzDvk3BgaQ1IkiCEY69MGrseNxVgckdccflVaNdkG7aTxzUqiUxDyyTIO3rTGW4l2RnGMnjnpTySUG9mOPQUzY5dEMmDncV9KveWpA2qQQOeeP/AK9ILkMOTFGEDN2OOMCrsYRbfylXt36iiFVG0ZGG+YjpippVAdSBnnkjv709CW76EcGXAjYsx4PFXraLygOQ7AFst/L6VWJEbs/ysDxlfSrUUodQrptDDKnvTfkTIR/KuMlQI5GBBC/dz61TjYwlWG4jGCQOn4VcW3C4eIg/w/exmo2bd5olKsqgL1wee+R2paCv0H2yK0DFnCvu6+maJkKlI3KyI4OwoM7se/bFMhWMQrFGR8ucEnJ/H2qS4CwRpztgyPcofWgOom0MzOG2uoydvfiq6bHO8M0YLZY9RTpWETFkyQ3Y0feiLgYAG4IRijYY24wHCNh1PJK9KjVisk8Y6bflyaRmH+uLFYyOnv61E7l58IAQRu3f0qWUkLM2VKBiE2j5T1BqlM2J4irfJ3J6VJd7imANuTgN1qleSiFcOMqcdD3pFJDL5iGwoIx0qsWxGSWwWHOO1R3al7UtuI5qKRsbY3GVKjBz09qTQSWhn3EgYgkYBPTvTJOAQoyRT7rbz5i8jnAqAZCjAznr60kYvcns+WOeuPwpVfaCo5BqNDsA7EjpUcjE4xkEdferM2OkJAABwp68dqqXROOD05q3JJiNcYBqjcsCu7t0qkZtlC+b92Tzk14N8StTaXxXPHGflgRYvxHJ/nXt+qT+RbtJI2EjBdifQc18z6ncm81G5uW6yyM/5mtoGHxSPq2CNfN3N8uRtX296vBIizJISSF4GetQJyyl9w3KBnqcVcXKqqhQ3bOOT9ahyOxEkcRyBsOF+bJ9e1XIJnmOCQ6jPHrWejMJOvHoDnB9KmtWC7m2bdwPFJvQfqXJJd8gdNoZPlbLYAHrTIpAQdwP0B61ESqMFkAw38JGfxpVCSb1jYh8g4HHFSbxWhNbu07fMRtB4ANSLG6EMwUKf4R3qI4tgNq5Tt707cfL8x2IHuKQMluZVUA7VJf1pwlaY5G0D155NMi/epyqk7cZPbNQ23mMWXPzKduAOnvQiox0LsRcRqemeNpGcVajk8uMNkZz9KhhSRSShyT/ABHjH4U61ImJRuShAyf4qYmX0UmZdjcYycjrVpiGYoCODwKit0USjqynJzn07VZCGI72P4Gjcm4iECVMZyBzxSX0jxRoYVJLHGM9B60Z2yGQD5yvQGqsrzzybV/d/LuDEZ59CPetFC41uadvGcAR8kDueBT7i4PlqoIYD+L0qvEJDb5cor9wvTpSQxFWDzEHyznOOPxFKy7kPuMhlKyP5jcMcL2IH9KvC3XyCWACD+EHrVeezaW6jm+63XA/z0qWYuisWU5Ughh0FJ+Qm7joIYkkMpChiuFJ7Y7VXmnkiilCx70Tkr1xnpmrkHlyh2+9uGTu/pWLJHLBePKJVAfKkk8bT2I701Z7lwV3qWftoa3XzUJTAz0yKsrhok+c7WH3SOnpzXNLui3FXJTOM9ifatXTZDKrKDjao/A/SploaTp2V0XJSCjRsDlePl6g1XRiOSCUA4x1p88u2QFgu88EiqzlopiQS6spxjtmsyEiuZ3cYyQM4/CqN9KpmjhyC7nKmlWEWaCPcxHPLHLc1HMd21lA+Qj5vWpuaaCTlhIEPOOCoqrcxhgdvBAOOepqYEJdO4yDs49PeqctwXK7WwBkZxmi5nIz7iXpwcKcMD/KnLjYvGRwfxqm+9pisrZBbIPqfWrKBipOeF5471SMLkqkhvnwcc0xHEjFs8Um9ipbgEjk0ilUQknAp2MmxH6kjkYqhOzY5xjsKsyuw5HRuMmqV5IAD9KtGUmcT8TdR+w+F7oKxEkxES8+vX9K8Gr0j4xaj5lxZWCNnYplcZ7ngV5tW0diKa0ufXBcCQkZVNvynqfpVuMu4CKpBAHzZziqVzGxgn8hSHbAIJyRzxitCzlYoARtwfox/Gpa0OpSsWlUqm4lFCAnrmktT8vmKcBuQW/l7VCJC8xOVTPcAn8PrUkEe/52LBCcLGeeP7xHrU2fUuJZjRZFYEu38WR2P1pJFjhQsuQ2Pm28Z/8ArVU1GUJGmCysp2gDpn3pRGDEu2V5Hbk+3sKTVjZN9C1Fcp5SMVUoTxg85qC7uXePy40YODwccGrVpbrGFXH3ODnBHPSqN0jxTF/MCjfxkdBUKwWL9uC0aRzRsT/EA3f1/wDrVaLmKNEQqpU5xjkj1qO2jkZY5VOF6Ej19asiKIO7ODkcDnnJ9KWpaY8XDLtOB83JLd6ez7F3KQJGYELng1XZtmS5YLj5RjOaZZPGY8zkfNyM8E+goVwt1NcShcMcBs461fIZ/kBHIB681g26yvciQq2QcIewFdDCz4UkDd/F6g1q1Yye4EAfJGPunDH1qYrE0JLbQOg55qvcsPN8yNmVjyUx96pS5eA7ADxkgDlaVwtsPtrcDZtJGW5HXPuasXJjjYq+APQcjFR+Y6xoZDtQdT70/MdzOGzn5cMBRe+5LvuNLs0K7VyyHGVPA96nlaQWqmRW54PqacsKAuY1wwOcDgGnq8ZR2MYOw85PT3oSJMu3iltjICoZZCWQ+ntWfeSwuWRk+dfTjjv+Na9y8scySRMHgBw0ZPTNYOukI8ksZO6MYJPGc9qp2Wp0U1dlWzOblo8MikY2sM5HrWxZW0cT7lYlSOCO9YULF5E52qVwOfXpXQ226NFUnqMAkYrOV3uXVbRI214m3AbuhrOuCCwYhtuCflGa0NoSMqSNxPCnsKrMN0Txqfug5A7VD0MU7HLawznU4JQWbPyle+MdqsyrhFik2r04Hep1haSBnkT5hkBj1FZlxLteJXBJBwSx6VMnsa3voPaVTI2eM/KzH6VmXL7TyQDnG0dSCOtWHkJjkHGMZx2FZ95GzPE64+TOM9OaSMZsTaoO4qSc8e1PIwpUEgDkimqu4orE5UZz2FNcHAcjPOTjuK0Ri3YUSZwoBA6mlyCo3H/69RkhtuOBjI5p8kgZBjGB39aaMpEUxGxsHpWVdsP4j0Her1w+MLkheprj/Heqf2doF9OD85Xy4/8AebirWphN6Hini6+/tLxFfXIbcjSEKfYcCselNJW5olZWPsSXDokSMeV/h6nPXNLFbqkWxSdzDGXH+cU9CyyJ93zA2MntVjZvcbyqkHnHP41kmbNFmKEJFGPu5/iB/lUq2axSLhtw6sc9vemeZ+6JCgnOKkLOs+WCncnQ9CcelJGkYkXlpJIyRKChYgFx3p9ivmDZtVNp+YKcjioWlaDLyj0HoBV6wwzKQcKBnpxSZqlZCrAqCSRmAJJ4rLCfaZGjbBVTkg81e1EsGRWYOWY4x0+pqC2UWyuRgyE/LgdT9KkpaollklhsnT+IDIGOgp9s8swElxHgD7pA6VK+X24yCT82e4qa3ZQrMpJ2/KBmkV0HmTdDmUbgOfpVKRWmiiVEEhLgoAew71aZwGKOy5/uf4U5AFbKqqZ4VUNVHRkN2J7ZZI9pnB57joK0ZQVG87vMPYHms5LmSNMyKc5+XvUUmqIrgh8fQfzqmmxqLZLd3bNcRh2YRL9/aOvpU1peR+Yr7l2dGrLNy8tx80ZbjcSeAw7VI8G6VnTbEM5aM9uO3saNEbcitZnUCaB26kc42Hoau7kh3cDnjGM59q52yyrtnJVcfO3I+ma6O0MDSbZW8tsZB7VFjmnGxPFH5EfnKSg64B6iq13LEAAQQSPmUDG+p55JY0dnxsI+Xb0I9apXbme1jcBVYfdwMZqkZxV3qZuouYo5jaB5I+MAj5h6/lXP3LyXMMoTzTCuWUsMEHvW60U8bQTK+SwPzE5wOn4/0rLIuCjpGUjTDKeck8U5anbTdloUgHeyRXPlypglh1I7YrotNkFzYq3VtvJJrGsrHE0aSq8eFAY5zgmtyxt/sq7UH4H096zZNZofcEsm58BlGD/tCq8/zltoUDbwRwT/AI1dlVZUIB/H3qivzEKwI5JB60nsc/NoU0XMTJtfafTvWNepE1k8jn51k2VuT/J91m2luMdqyLtVlO9VyFY8j1qGwUjAkZomlLDdtJGOhFNYlYwx+bC5OB6+tWJFBVWY5yTyD37VWkzgHngHPtT3YPYYHIi4BU9OKHAJQbvlA60gcMSnIC81C5Jfvt7VdjBsUyEpx3OOB2oYfKqtyAMnFLHglpG6jge9MlPUj73U1SMmytdFiBjFeN/GDUw93badE3CDzZAD3PQflXrmoSpFDJNJny0Usx9AOTXzZr+oPqmsXd45J81yRnsO36VrFGS96RnUUUVZqfZtnmNwQiEbvlB6fjViSMGQOOFxx7n1pot9skbFRkDKgjv7ipVTzNqllULzgdxWKN5blq2iAh2nGS314qRVIlDAgMcpzyMH+tMhYAklOQO/H+TVtsFRJyhH0FGxqkU7i1DqY9u6Nlwc8kVOImRVwpKpwex9hVraNnmB+4wP/rUxN/msHVsZyQKlvSwXZl3kZDhpd2epCnqKnRQsW4bQeAM1dmKujKwAOOKzbiEnap/1e3DHPIPtRy3BSaepPazrIWAIUK2Gbt9KsyrHaRmUHjGVB7mqkPlKi+WVVCfpUs3zIgjO9OmetNJt2KnLS6GabDJcf6VLkHn5cYxmtRU8mNFRVfAwMjkVNa2+y3VZCAwXPJ61A6uAMEeXkEHpmqtdkwXMNuo2MC7sIfc5rKuLYvbtOImDI3OBx6davvL5Xy7jIc5IxVi3luICxsyfKkBZoJBvRh9PaqOiKcUYMPni4DxuFGz51zwD6f8A16vtIwaZ5kIKqPlHTH19PetFLu2kF0WsQHuAq/uuANvJOKpXweAwTbZVjddwRwdpweg9RQ15Gild2aHWMkkTQqkeIZCVyR/SurgC4DHrH8p/izWL50F9psBicW9/FLskjHWQfwkVo6S8sqqGbJxnkdfWoZhV1VyW4YXXmQxswkA+VN2A3vSopEZjVSE25GTyGqxCkUsjPCgd1OMY70y8Hl4JwpIwcd/QULVWML9DGilkWbymUFQTnI4+g7U15LWFJihcFuGDLx+FJqbvPbCRWWPrlWb+IfT+dYl1OZrfzC7byeR3pOWh1Rjc1HulQOUCsRg7Sa0be6EiIzglv1x6Vzbv5YV0+bnaRjOfQ1YiaaGdGblE+YjPX3qHIUoJo3WYfONhUDGG9c/4VCJMwR/Lkng465pYJ/MR+QCcjmgBuR0AWpbOVp9SvcKvlHLYYnPTmsq/gWCykjgQjnkf3s81uyA/ITt3AZx/SsrUWYmYP0PAqdw2OekhCvgNxnkelZ04YPIhxgdDWldyK6jA3E4yQe9ULl+GXOAen1plN6FVxmLPOGpgfk55GMUiyCSJUOcHp7U0gFn4zgYrS1jlkx2c5IH7vHeo3kUMQuScdxTnYjavA4qB3G5towatIybOJ+K2r/2f4aaGN8T3h8sYPO3+KvC67L4p6sNR8TSQxtmG0HlLj171xlapWQ6a0uFFFFMs+2fKIKsDgAfxNndUtvbknG0hM4Z8/wAqkaNFw5YYAwBnH5VJhjLtH3AQevNYp2N2rskEQ3DnJPIxVnbEBtIDZ4/CoUGyRWJ2uBjB4FNtyxkbedw6f/qpGqJHk2SDywdqjj2qc4Ybk+8w9arXLCTLIRkYB44Jq4kbqir8pbqCeppNDaKcpdUAQAHGST3p8UJniby2UYG447VP5Yc7ZOSvQ/0pskX7/K4XP8Qpqz0GNSCJm2yxqx4GT1qxDZRiQhRgDpjtUsCeUuUOSDkt1p5kfy3O3cevvTTfQh6jcDeMng+ncUrpktyeBjgVDZh7hpWlDLGPuHp+VXILVbe2Jh3lgclmJYt7U3puNOxQWAPI3ygpgFuecVKw28yo67mypHUY6Crb/urcTMpQHk5GMVSuT9oEYLM0crBcLwapLQ1jLmFlnRsSOg+QfK3Tn0I71UuJfthRZZZZo1b5VzyvrgVHfWTWVz5TiSaZzhUBwF+tWobWK502cphL2Bgyg8blHXHvRojVWSuT3NtazKslsrvIgC+cxwM+3pkVsadc5hHmEbh/eGM8+veqen5FusgZY5wcnjIPsa0ZikMambHzAscjv34qWc9R390WKRo5rgN8qg9Ohx61RurkHG6RXZT+7J6Af7XvVqWePyVwA6sjYUcnFYVzj7BJeSPxKBHEp+9kHkewApXtqKEbsqXVwVW6ig2mOWPa6ucFcnOVPp2rPZl2FthLhflyOhx1zUMi/agGkDBd+QQeWFSguyFXyELfcbufY1m9Xc6+WxHBMWVFlRl+bH+BqSW4dpo4FkB2Akn1FLGrPAkaowbOcjnHtTJSsMvyJw2CQOorOSs9DRJNmtp7hkZVIfnaQPWr6MzQg4MZzjHvWJpIIkcqDg5znvW8j+ZF1G8jmn0OSsrMZNldgQD5Rjn1rNkaO4MjKOVyMnvWjPKu5fUD6c1kznyoZXHf5iKDnMG4G0ujYK53Kf6VmSsNwYd85xW1fRgtktuLjjHY+lc/dZ8wgghu2OxppXJkyB8rKCMYB4FNZsOcHG6lJIlKnkAEfjUIDGb5egHStNzmkyZjiTPJIrH8S6omkaLe3z8GNDsHqx4H61rFhs6cjrXlvxn1Tba2WmRnBcmaQe3QVpFX0Mnq7HlU0jSyvJISXdizH1JqOiitDcKKKKAPuJYwJcod6+jD271NBhpstlQOtU/OZZCEIKg/5PvVqFcK7Pj5ucdhWLOhIsdJwzDI96fGNrJg56nNVJnbzMBuDgD/AGj61bTCtEQckA0dCkEX/HyQ65UjOcck1YMW2Q4fgHoarwMXuSASFBySOtWnGHUoAQDnmlqa7EaK0kpUnZt6belO2gT5Jxg4IPSrTBVOeMdeP6UyYR+YvzHaRkDvmktQTKzN87Rxs2XOQB1qypkQBSkhA6nHBplrAkMzlPmLHcuex9qtyBvMj2nn6dau6FJobaSbmCsuFc5wOtXQTbwbRngk9c1Bbw7A21DuHIIq3CDJ97bjuAKkye4yVBOoWXdh+pJGc1UntY3gmiu1cbOI5YeCPqK02iJALbgQcbu34VFct5MOQy+YPunru/wq4vQqMmtjm/tttZ6nG2qpJLGI/wB0sZ++cdSamW1jktUumuYxCZQqEZ3KfQj9KtXV2lmMzW8VwjN++SRBtbI6g9VNYttdQ2jeYyKELMfI6+WSeKrTodkU5K6L/wC9tQ6Sq8cjHcMjt65710NvtuoR5jK44wSMfh7Vzc8t1qFwqKEMYw0aDpnuK1rLfHGkTLgjrhs9O49RUPVXMasdL9S9NCHBRl2KOAV6jjqK5bVVZEGzACL8yn2/izXS3Hy5lXkGsLUZgd6xx/fckrjIxjGPpUt3WoqOjMUgK4EwCiNeiNnNSptuhCkjH92+9QO9WL21ikhs50URTlSZVz3HAHtUEiolvvQbZVABB7Vm9DqTuSzSLFM2Nykjgj17flWfcPJlpXUByOM9MVPcObq0IMeJQ24gt196qzq7IpcDc1JvsaQiluaWl3BE0SiMHcOvr71uyBI4zsyD16dawdOUPd5b7oUcY4z/AErfiZl3hgcj1HSktrs469kylNcESowiDIVOVJxz2NZsrFkkDjcCcHHQ4rRu1ADqeuPw5rEvpvKkjRvlRV3Hb/IUPUx9CjNIdm8HG3OKxLk5kPBO4gkDrWlqDt8vPBySBWLM7CdCCchSS1VAwqDC+JWOAFGeBUUGWy3TJ4NNkyUwT8zd6kgG1Mk/N2rVHM2OlbA5xgDknp9a+dvHGpnVfE17OG3Rq/lx+gUcV7Z4z1L+yvDt9chsSBNiZ/vNxXzqSScnrWkUTBXk2JRRRVGwUUUUAfb0b7V3ORtU8DGcU+N1lVtrHaTk1BFKCFRsDsABxVmJfLIRPu4zisep1JWJ4olbbgcnoT0qRyyMcjORjim27ZiyeN3OTRKyiAsgLbTk46/hTQ0ncdHKA6g8KWwSvWrEspEqjOAe9U3tVnTOWCnkjOMmrkcO6JQzHCjjIp2RoPuPNmaOOLaGA+9ntU0ESFNw+YjrnrnvRbYMiAFduOc0+b9yGCgZIyfwpPyJcuhOoDSA8DbxzTwVZsAgHtUMUqsMHuOTjpTHX9/GCfkxn3pJXJtcti6CMV3Eg8ZPPNEM212VU3Y75wopJUiGAqsmeOe9WVjVtgBwvUhetNWDQdbu6ElzhccjPGaivEMkZVigzyMnoO/NTSRSyW7tEpIU4PHWoGLLbNHNkOwB+ntTS10CO9yhJDDaiVg4UsuHLDcGGOMD3qhpsUM8U+5Y4942sJcEr6f5Faot/JiN1uz1j2hsMpPQj/69Q3tjB5CXKywy3TKP3Krwo9j/ADFU9WdCktirbpcI4nhKh94KjHTHT8DVo2lw5jmWUInJZQBwx7e1W7SHzVTyBgk4IbpjHahXNrK4CBvLGGHt64pLQhzvsPgHmRqzO6Nu78g1XvdO8sl0OW7Z75q5du0flvGVaNyOQM0l0TKEAk2Drx39jUuTMk2nc5ueDghSzSZw27gHHNZ7M32mOVRlAD94cgf1rpL+2jZcIdzkj5c9Ky76GXdxIvQlVx61M1fY6qdS+jMlg8yPs4Y8qR696Yquy+V94qwJJ4q9b2z20Gx5ED5yD+NWNNt/MlczYIPC9vzrLltuaupbYl0W3kSSSWbHI4HoK0Ip99u6bjvz35IpbRRATkbR0wOfwqlLdxNdNahZhIvzbtuFB+v9KbsjiqS5ndj7ti29TwRjj1rmNQBkuysrBVJ6jnAroL4qpiZm6kZXvisPUpAWknwBHjHoMikSjEv2HmBd/b8z6VmOd+4ZPp7VNdNmU7+P7uetVMgKNxJ5zVxRz1mMJBYg/Nn5QKnVuoIOR6VVjbMmT2PNWmHCjGSea0OZnmPxp1DbbWNgjHMjGVx6gcCvJq6f4jaidR8VXbD/AFcJEKj6df1rmK1WxdNWiFFFFBYUUUUAfa0MZVVBxtByKvAM28g4AHJJ61XhbLBuTnjAHGamwTuL4GTwayZ19Sa3LAEsuVPp2qfl1O4jngH1poGCrHqeDTQod1HLD60lqWXVSNcAkZxjJ71JEnK9Tk8BqiQBQxClscZY8CrKMNgAH4elDE2SyFI2DevUgVHcp5sYZSWTrwOTTpCDsGCMevSklfDccEHmkmyUhr20hjDCdgoHIA7VI2GX92NxxgEcEU8sJAYwBlhwc1GgaILtPFWpDLixGQBG6lRwasRo0SBU2FicYx978aqSvhlLMASMBRkVdjUNGAW5HUD1pN2JbJbSdo28t0Uc/LzgH2qS5YyK7bTjbnA5zUckIZwXcMAM4psrrAwc5Ukcg9MUC6lGDzDbu8O/bICrAjkj0I9qZbWzyRLGQEVRlW7k/wBK0YsPHJ5ZYMRuJ9vUHvVfZJAAzPuBOWB6DPQ+1WupXO3oiR/lZSqkqo5A9O9V4mZ55XuUCx/dBH8Sn1rQmh8y28xGK4OQyn+YqK5t9+ERhz0U9QalSRNyOJkjiKONoXhXByDVERo0ksyEB8fNluB+HpU6Q+VBt+8pyT/s+tNaJDG7wyAFzjHrSvYa3M5HaK8+dDnB5B4q4YMqkrsOeQuKaDG+1HIEgyBxinyxoUCMX3AZznnNSy3K7K91FFINyqMtxmm29qIpYwfm78DpVloFTCqST3H9aTZHKpU8kHjHtUy2Dm0sK+UWQ/rVdiFTzOxH5n1qbJZX3DGeAT61lTPPbwsZNpAOFUfzqLXFa5WvTu+Z/ukjBFYeqvvhmQ5K9FHT8a2LvLHZ90jng9KyNTYq7Nwwx9c0upEnY57UZAGVBhsnAHtVWVgQdvI6ZqWc7pM8YXk56iq05xymSD2zWsTkqO7EiQ5OeSe9N1a6Wx024uXOBFGX/IVMihQPeuU+Kl6bXwncKDlrhli/qf5VotWYy10PDbiVp55JXOXkYsT7k1FRRWh0BRRRQAUUUUAfa0YkWNMg5P3vY+1aIJaHtjHNVomLs27AwRj1qzGQYs4HHYVk2dfUnA3Iu4YfGBjnmnKQrg4OdvIAoiYGXkde/pSS7jcjYoC59aRoixK2YRj7x7e1Sw7hGSQc9D7Um4bME5IHQ/40o3GMhDwP4gKV+hLHugdowWJx2zzQ8oJCKRkDDHvmq9xeRQ5Nw21D8pYjpUBljyDHvaPHDKOPzrRQe5NzRcImJNvzKOGPUetPzKQrLtYA+nas+F5fs4DYZj1Ujv2rRtC6qu8r8v8ACDxRa2onqT/ZpHZppCct0Aq2XQW/yqQ+PzqCOVWXYT8wJ/GpWUriR5Q2D8hBxn8KV77k2aJInLQsrBUKddvJH1qKGI3Zj80iSJW5OOTVobd6/KMMCGYDNRtGbeIFFIwcbx1+tNOw0STI0KBIHXAOFX+lJkFUM7Agnnsc1GxXaXbZg/NmqbXQlyw24U4PFLUpRuXTO0TE9QG4HbFLmYzpISuwcsapvOH/AHTtjjG8dhU7TL5LAKzsmCCeM/WhobiJfMibmHJcZ2qc1WeRANrOodvmAHT/AOtVhvKKJLIpDnpVW8hYSoyiNFb7x9qSsJJbGaUlW6iZtzRluSBwB61pwTKOOScZGaiuSVT92AV478GrEKDAkJwfTHSlJ31B7DJQfORxwoGCfrUMKBWctlWxnIOcirM+UVmI74H0pJQAijtjJxWbbsO5RuJXYqYyFB+UkdzVC9VgpJBI65FX55Cu0JtI355qnNLvLR55HO7H6UrjM67/AI2x1XPWuev5GG3fnoRxWvfSupPylizbeOg9z7Viam4wuMcZBx3JpIyqPQxmkwrt3bFQA/vCFyDnAqRgTcbByD7YpkA3y88HcQa2SOKT1LBHB556V5Z8arshdMsxwMNKfT0H9a9UYhY/UnrXhPxUvftfi2aNfuW6LEPwGT/OrjuSleSOOoooqzcKKKKACiiigD7btOEAALN3Ldatq20knkg9uBWfAV+0bskKo5FXgcrllwCf0rI7EWA21CwJyOR61LC6sSyq26q3BUBADgY/GprJJEjKkKHx1HpRYofcSKrK5BOAeAM0sM8lyimJTF2ww/pT0iIlODnI6kZxU4jaJOCMZ6elPQi9whJZGSRFKjjJHWlAMVxtY/Jjhe1SMu1Ay4HGT3pztuTzH6jg0rsaRXmOBtAxk5pGnEZLs2GbsKJjHtdGYEjkfWs07JJYB5mPdjwCKa1NIQuX4ryT5pCcgjHI9P6Vr2V1DfQKchVTllPb8euKwkliE8VzLCEtByWD8gg8/LU0M8L3l6+zbGRuRkPBX196q11cqVO505mWOHakhAPIGM/lWfd3+TsY7SACMc/jVSeTyPLjA3vMQAwbKn057GrOheRdyT28uIpsE5fqcdRU2srsyUOVXYNeC4tV+bKjnd0qvqdo3kxXVrIgSQYf5+rey/zquNMlYSzqW8kHapA/iPb3FV7V2jmhkuImDRvhuRge+PenbsbRil8JYkWaCRIZj++HLhevPStOaWTbGufmI25NUtUKXGoKIA0cSjI39vara26SoFkYgjkc0pdyJtWTYXMZFrG75BQHK+tNCrLGDgsxXO1uwqzOSMjAwFGPeoY5AVkkGA3TA7Cp1MruwkbKkcZIBH06U0hzPgMCpHJ9afcupgV0BC5GQR1p9iyLGQBhGJPPJzU3srg9rjX3yeap428VWVxLEV3AP0I96LiZmkJ3YB/WqURPm4ZthBBJA61LWg0h6/MoXb8wJyTWe+BGT03MQa0Jyvmu0QYbhnr3rKnLbnLFdmchagLmXduI42TnJ4JNc5ft+8OSN2ATtrUnZn8xyFOWO30Cise/+d5GjO1mYBT6+tWkc9WRRlOYw4bILE8GltgpKBsnjdmo/lLKABhQRgHqfWrEa/NwOMcVqjk3Y+dwgDsAAPm/CvmnXro3utX1y3WSZm/WvoTxNdi00TUpycFLd9pPY4wK+bCcnJq4FQWrEoooqjUKKKKACiiigD7aRf3SBwGBO044qeRCybUJBHIANQRjHytnOe3NKhc+WG3bi3p2qDoV1sXYYxlXdSc9PrVq3H711blex/pVOY+UYyATzjI6fWraEAhQQARxj1pMpy7kguByzbgc4B9vrUlvOssQKuXz3x1oCeTCFcZUnnvVZpI4FO3Ab2oSXQqNmXwh8kuflY8Y9qfImLchGJ45+tVIpPkTzHYn09qto6Mg4YZB47UNNDehBeIwi+ReQM/WsvTkt551trwGJ2fAzwCexz6Vppve5LS5UL9zHQ/WnX9usyoXO1s5VgOB9aa00Li7aEMmkS2erRLc3scMDDEM6jKN16/yzTHmlV1tofJIgTYrAYBGc/j9aWS32QnzsFsbVyTx+FT6NZi6juWkVXAXaEHXd659KtaI15tLsuabP9nkC+XGkTHaXRc5z6ehputBIdRjkM4F3IgBVTu4H3Wz0ORTtI/0JjFewu9v99Uk4ZPRs1LLZNJbSNGoR0lDq+d6kYyAD2qXuZuylcgSW+04GWN1WOdDmMYPyj+LB6GoLS3Z1WWQHMjFic5B/Cops3D+YjtukJMu5e/+z7VJpsjbxuTbG3AGe9LZDd0rmqscbH51TIPUcA01y4WQbN2OUI7D3olQfNhtqseMdCaRSDGhGS2fvA9frU6dTECXMZZwQWHAqvHHiFnkUqM/Mc96kunG5VXj3pWUS4jDjyyPmTrmpuCdgK+ZbHy843fKDyKYm6KEcDGccU+2Ro0aMrvwfXpSvvVH2/Nz8tS3fQPIrtGVkaTOdwAHtUd4BnOAFxz60+R2MWw4EnQYOapTSMZCjqpKj5h1z9KkVhQVeZVYjC9TWVdOWFxtJ3Z+XHpVp5AJSy4I2569KyrmQKZTvAQqfmzzmpBox7uQND5ScK2RkDnjrWLc4aI5JADfw9c1pSFVtvmYkqM49fese+dzA3l7Q2znPbNaRRzVWVkPzA8nJyT61ciIIbORtqlbDMaggjpxV9AFIxyK0OdHHfFC5+z+FLsZAMrLGPfmvC69b+Mtxs02zgB+/KW/AD/69eSVpHYqn1CiiimaBRRRQAUUUUAfa0b/AL9h0YjGSeh7CtC3Gdu5sMo7Gsh2eO5k+QcnqO9WLJZNxJBVWycsc/lUcrOtGkrDzlXJ6/lU7Ji5V0Xj37VWgLb1ZyAQCMVZkILxtu+8MY7ClsxNNivK7EKxOOg9KmtliRlJCls4zVO8ySFBIBbAINRXEbRTxSQl/L3fMvrVW0Gk9jXmjLSKdoAHcd6lUqqtknOOKpPdrna/ylugqSEmed9xYJtx9aFHuN7F5SpiBVcnH51YULj5gFPXNQxRKsCqchRwNtROJJAd2W5wpXqoFTYaVytfAlCSCUbhT6GpNNsZxbskd0oeQnMSnBU/3j/hUshU/uwS78ZJpmgi9a7uoYPsyuCFDSNyAeTj3q9kbX90vWV5cB4rYW8EksCZ3Z+VgOp5qtBqUcsUlxKkq27/ACLGg4Jz19q0pNNijKNePa707K3Prj3Oe1QzRJqMN3AFIEuHOG2hcdGK1Om6IunqUVX7BdSSRSlnPAR13Bv6VUvXK3PmNHHHu+YInABqxqbSWtmFDrIiD91KjYKg9Q2arWMZlVRLyQMgn0o82Wu7NKF2mRTnCnt6GluH3BD0bPIXvUUqSQ3MZifCBcsuOtPhlDBgy/Kf4umKjzRk11IrxSPLaMs574NCyjy1lUYBGPeoRM48wKgwDwT1pI40ERRX3Rs2T7E9cUPbUdjRgYPGHUHGOT60hf5QrHBJqCD92ojL5CH9KddKTcQbeUzz71m0TbUqPKFuSEGAe3pj3qtdYe1lKgbxyrDjBqxIFTejfLk7ef6VQ1CTyIUUD73BI/nR1G9Sv5u1NpxvCdh61iaxKZIR5SgMw5btitLUJvL+cEcrtAPr71i3Ts7QkDCEHHpULcib6mbcuN2BxkZ9sVlyjcsx65PGec4q3dSYidmG0qSowe1ZUsvyQqR80hLccDHStYnFUepJDu2IrY35xx2+lXAwCHPJz1qGBT9oVV/u5ye1TbSsbEdR2q7md9Dx74xXO/WbS3B+WOIvj6n/AOtXn1dL8RLk3Xi2+JfeIyIx7YHSuarRbFw+EKKKKZYUUUUAFFFFAH2hFmdg2R8h6irVvKr7lLYAODx/KqUDmFwMEA9B3J9DVmGFYn+UfPnPP9KhnZsaWAeMfNjv3qaFVMW9sEjgE1AhLyqf7o/Oml38h/KwG/u9akFqSzORC2Rkg9qmjJVFUhvmHBx0pAV8gBjk4GcdCcVBG7qyRk89sdPwqlqih93aF4lljkXzYz8qsev1q5anaFwCGJy1KkWVZuhPTNJbQnzmDE5x175q73VmBffzCybmAZTux6j0qSKVVdt3BbtVbzGgjw53NnIY+lWGcCIGQBeQagB7KstuBEhJJPzAd6ht4WilZpAI/m6j72P6/Wnpd7FBAzk4H0p8iyXMnmKwCAdOmTVJ9xptaGvZWqs0c1uIRNJlQ83LFvUDtVO+ikbVYklZbiCJvnl7xjH3W/vDNPs9Q8oW0iWsfmFgP3jYKHvk/wAqkuL22W1khiI8yUkDkEqfWs7tMmzuZE+kzPdzw34LLcZeIK2Q5UfdGf0rPsvlxGrbscgY5ArYmu2Sw8p4xMycgMSNr9mHtiqNpuh+cAGYghu4Oad9NTVN21J5Gwv3sgjq1V1nV4uCQo647mpRiYggbWHt0PeoZV+yOWRFdZG3MB2z3xUbiViRCtxbsRwepGetROixQou1gw6Ec/8A66dZ4yCw28cD1FSzyZjLgEbeAxpSunYT3sIMSTeYB2+bnoaVrhRF0wc+vaooJUR5MsVyN2OvNV4l82cucnaCDUbisS3GJZUbjZj8qz53SSVznlBkCrR5SRFwV6jHFUrhika7sEnnaKT0JfYwrp/OUhgQFIJXPesy5fMbKPvDjA6DNaF5IsE8m4Y3c57Z9Kw/NMySMx7bmUjHejrcxk9ClcuPLYe/FZlxtFyFD/LgADv65FXiAZMknZ1VazmHmXTY9QQPQVqkcczUg6tIeh6UMwG4knAXcaIx+6A74P4VjeKLsWHhy+uV+UiNguT3IxTtfQlrQ8E1Wf7Tqd1Oc/vJWb8zVSlPXnrSVsbJWCiiigYUUUUAFFFFAH2nGN7biDleSD1z61YRi116KVz9DVON9rE5yCMHFWI3CLhzxnqKzsdLLDSsGJTOA3zYGcVY09iYWxjA9+aRVCxfKowxzzUqQqGBiOGbqKZa2HqyhgSMDp+NI6tMcFcAHr0IqRV5EYwMdTjk0rBo1OTuPYnvTuMTeyFN5G+rUAbBlcFd/I4qEIrqjHBIOatxs65C8/LgUaWG2PU+Yeh46D1qtfXC7hmTp2x19qsKpjRyW59KyNQkVITIpHDDdn09qSKgrsLaWe/1AIoI3Hg9vpV6xvJPtklrJGcqdu7GQ309TUOgzWasryztFFDLvLIpP6+la51MXV5vtpI2tY5P3fyhdoJ+9j3qrX6FyWtrD2lWN5FkUyj7pJXn/wDXWfcWolu1lgYP5o2oqHJB/pWpNcxCcK0YIduQeM1bjitY5TFAfLkkI+dlyUJ9uhFJOxCfKc6s1wJJo5oy7w9cNkgVoRndHydjMQSCOAKh123ax1eOBFXLDzJGTgD8PSpYWLqqoCQR970FQ9RvVJjvuRbxyc+vP4VQ1Odlkj8tQ6Y5x1q+qKhYSY3dgelUVUNKy48tyc+vFSrJ3CNr3IYN8gTOTsGYyTyR71YO112fNg8k56GnGI+XiLJIAGSe9JEgj3MzYyc9KmTu7jbK95EX2lG2ywglWHRh6GnGUnfHEAAUBNR3chjujED1xtJ70+AqEmz1PSi6SsyHsVzuti8ZA6ZwKqysXjUs+MHdn+lWbxmWAO/yuvqOcVkatL5VngZDkE8nqKzerJepkayitOxY7lP3QaxrhwSNuSSOSfQVcvHMlirvJ8w4ytZV0xSGJmBOVwNvX3q7WOeexXkbBYjkDjjjNVLAbrgkjp0J9KluOEO0ke4pbCIxqoPOeMjrWkUcsi/GP3Y+YDNef/Fy6aPw7bwrkebNg+4AzXfSYVAAef515H8YLxZL6ys0fcIkLnHYk/8A1qqG4LdI87ooorQ1CiiigAooooAKKKKAPsqL/Wt9KsD7g+tFFR1Ol7moOsf+6antvvx/SiikX0LK/wDHwv1FNu/9cv8AnvRRQhjZOkf+e9XE++tFFW9hvYLn/Vfiaw9W6L9aKKUTSjuafgf/AI8NQ/64GtaL/jwb/rotFFaLr6hP42ac3+vsqnb7v/bRv5UUVDMuhha5/wAh8f8AXMfyp+kfcP8Av0UVn0LfwElz/rX/AN01Sb/kJ/8AARRRWfQI7E0X+tP1pt39386KKT3F1Kl7/wAfaf7opqfeb8aKKUtgexT1HrH9RWJ4l+/F/uGiikt0Sjnrr/Up/vH+VZlx/wAs/wDdb+VFFWuhz1dilP8A6j8afZ/w/wC6f50UVSOR7lsdR9K8M+J//I2z/wDXNP5UUVpDdjXxHJ0UUVZqFFFFABRRRQAUUUUAf//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Necrobiosis lipoidica diabeticorum. This diabetic patient has early lesions that consist of yellow-red plaques. Epidermal atrophy and telangiectasias tend to occur later.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Necrobiosis lipoidica",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 420px; height: 365px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Yellow-red or yellow-brown plaques with atrophy and telangiectasias are consistent with necrobiosis lipoidica.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Berg, D, Worzala, K. Atlas of Adult Physical Diagnosis. Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Necrobiosis lipoidica",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 351px; height: 474px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Yellow-red or yellow-brown plaques with atrophy and telangiectasias are consistent with necrobiosis lipoidica.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stedman's Medical Dictionary. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24714=[""].join("\n");
var outline_f24_8_24714=null;
var title_f24_8_24715="Changes venous hypertension";
var content_f24_8_24715=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F80827&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F80827&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Anatomical, histological, and physiological changes associated with venous hypertension",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Category",
"       </td>",
"       <td class=\"subtitle1\">",
"        Primary abnormality",
"       </td>",
"       <td class=\"subtitle1\">",
"        Consequences",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anatomical",
"       </td>",
"       <td>",
"        Valvular incompetence",
"       </td>",
"       <td>",
"        Retrograde transmission of pressure and volume into the superficial venous system, increased venous hypertension producing further valvular incompetence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Histological",
"       </td>",
"       <td>",
"        Elongation and dilation of capillary beds, increased capillary surface area, increased basement membrane type IV collagen, formation of pericapillary fibrin cuff, fragmentation and obliteration of cutaneous microlymphatics",
"       </td>",
"       <td>",
"        Increased interstitial accumulation of vascular water, red blood cells, fibrin, tissue hypoxia, and formation of a subcutaneous panniculitis (lipodermatosclerosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Physiological",
"       </td>",
"       <td>",
"        Loss of reflexive constriction of precapillary arterioles, erythrocyte and leukocyte aggregation",
"       </td>",
"       <td>",
"        Increased capillary hydrostatic pressure, reduced oxygen transport, slowed arteriolar circulation, enlarged capillary spaces, leukocyte aggregation and activation, and formation of a subcutaneous panniculitis (lipodermatosclerosis)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24715=[""].join("\n");
var outline_f24_8_24715=null;
var title_f24_8_24716="Findings - Henoch Schoelein purpura";
var content_f24_8_24716=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F60175&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F60175&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Frequencies of clinical features of children with Henoch Schonlein purpura at presentation and during their disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Clinical features",
"       </td>",
"       <td class=\"subtitle1\">",
"        Taiwan",
"        <sup>",
"         *",
"        </sup>",
"        (%)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Italy",
"        <sup>",
"         &bull;",
"        </sup>",
"        (%)",
"       </td>",
"       <td class=\"subtitle1\">",
"        United States",
"        <sup>",
"         &Delta;",
"        </sup>",
"        (%)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Purpura",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        100",
"       </td>",
"       <td>",
"        100",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Arthralgia/arthritis",
"       </td>",
"       <td>",
"        43",
"       </td>",
"       <td>",
"        74",
"       </td>",
"       <td>",
"        82",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Abdominal pain",
"       </td>",
"       <td class=\"sublist1_start\">",
"        58",
"       </td>",
"       <td class=\"sublist1_start\">",
"        51",
"       </td>",
"       <td class=\"sublist1_start\">",
"        63",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Gastrointestinal bleeding",
"       </td>",
"       <td class=\"sublist_other\">",
"        18",
"       </td>",
"       <td class=\"sublist_other\">",
"        18",
"       </td>",
"       <td class=\"sublist_other\">",
"        33",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Intussusception",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.4",
"       </td>",
"       <td class=\"sublist_other\">",
"        0.6",
"       </td>",
"       <td class=\"sublist_other\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal involvement",
"       </td>",
"       <td>",
"        21",
"       </td>",
"       <td>",
"        54",
"       </td>",
"       <td>",
"        40",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Edema",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        52",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Encephalopathy",
"       </td>",
"       <td>",
"        1",
"       </td>",
"       <td>",
"        3",
"       </td>",
"       <td>",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Orchitis",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        13",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recurrence",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        33",
"       </td>",
"       <td>",
"        33",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     * Chang WL. Acta Paediatr 2004; 93:1427. Chang WL. Pediatr Nephrol 2005; 20:1269.",
"     <br>",
"      &bull; Trapani S. Semin Arthritis Rheum 2005; 35:143.",
"      <br>",
"       &Delta; Saulsbury FT. Medicine (Baltimore) 1999; 78:395.",
"      </br>",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24716=[""].join("\n");
var outline_f24_8_24716=null;
var title_f24_8_24717="PD pressure gradient manometry";
var content_f24_8_24717=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F57715&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F57715&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Sphincter of Oddi manometry",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 167px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Example of elevated basal sphincter of Oddi (SO) pressure and a pressure gradient between the pancreatic duct and duodenum obtained during manometric catheter pull-through of the pancreatic segment of the SO.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Walter J Hogan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24717=[""].join("\n");
var outline_f24_8_24717=null;
var title_f24_8_24718="Methemoglobin reduction";
var content_f24_8_24718=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F53599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F53599&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 544px\">",
"   <div class=\"ttl\">",
"    Metabolic pathways for reduction of methemoglobin",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 524px; height: 471px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The major pathway for methemoglobin reduction is via cytochrome b5 reductase (thick arrows). An alternative pathway, which requires an exogenous electron acceptor such as methylene blue, is via NADPH methemoglobin reductase.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24718=[""].join("\n");
var outline_f24_8_24718=null;
var title_f24_8_24719="Dental celiac PI";
var content_f24_8_24719=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F61446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F61446&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dental celiac",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lisa Papagiannoulis, DDS, MS, School of Dental Medicine, University of Athens, Greece.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f24_8_24719=[""].join("\n");
var outline_f24_8_24719=null;
     